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1. Perception of facial expressions of emotion elicit to a large extent the same neural mechanism in outpatients
with depression and anxiety disorders as in healthy volunteers.
Chapter 3 of this thesis
2. The use of medication alone may not explain the normalization of neural response to emotional stimuli, but
there may be an interaction of illness severity and antidepressant.
Chapter 3 and 4 of this thesis
3. Anxiety, but also depression may be characterized by aberrant neural response during emotional attribution
to words.
Chapter 4 of this thesis
4. Aberrant connectivity of brain areas may be a trait marker for aﬀective disorders. Neuroticism, which may
be considered as starting point for the development of depression or anxiety, seems to modulate functional brain
areas connectivity during emotional processing.
Chapter 5 of this thesis
5. Anxiety disorders, in remission or with mild–to–moderated illness severity, may be associated with distinct
brain areas connectivity even if there are no gross abnormalities in the neural response during emotional pro-
cessing.
Chapter 6 of this thesis
6. It is too often forgotten that our results always speak about a model, that our data is rather statistical and
approximate than an absolute, objective truth. Our experimental setup and our methods constitute our model,
and the slightest change in either of them can have a major inﬂuence on our understanding.
7. Comorbidity of depression and anxiety may be considered a distinct diagnosis.6Contents
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Anteloquy
The subject of this thesis lies in the ﬁeld of neuropsychology and is concerned with the study of neural basis
of emotions in relation to anxiety and depression. This study makes use of functional neuroimaging [1], which
allows for non-invasive identiﬁcation of patterns of human brain activity associated with perceptual, cognitive,
emotional and behavioral processes. This introduction will brieﬂy describe the background and rationale for the
study. First, I will introduce the subject of emotion processing and brain function. I will then describe major
depressive disorder and the anxiety disorders that will be included in our investigations. Finally, I will provide
an overview of the diﬀerent chapters.
In neuropsychology, functional neuroimaging techniques are used to gain a better understanding of brain-
behavior relationships. The aim is to link speciﬁc psychological processes to anatomical areas and physiological
processes in the brain
1.
In recent years, functional magnetic resonance imaging (fMRI) has been a very successful method of studying
diﬀerent cognitive and emotional functions in normal and abnormal behavior [2]. Together with imaging
methods like positron emission tomography (PET) and electroencephalography (EEG), fMRI has contributed
to elucidating the role of diﬀerent neural networks in the brain and in relation to diﬀerent emotions and
cognitive functions and also in exploring the functional abnormalities related to diﬀerent diagnostic entities.
In fMRI, one measures the hemodynamic response, i.e., changes in blood ﬂow, related to neural activity in,
for example, the brain or the spinal cord of biological organisms [1]. The main advantages of this technique
are its low invasiveness, the possibility to record activity in all regions of the brain and the high spatial resolution.
The wide implications of emotions in the social and private life, and the far-reaching consequences of dysfunctions
in emotional processing, have made emotion one of the most widely studied psychological processes [3, 4].
The study of emotion is important not only for understanding its nature, but also for identifying the neural
mechanisms involved in the perception of the diﬀerent types of emotion [5]. In other words, not only the
bodily mechanisms of emotional experience are important, but also the neural mechanisms responsible for the
perception of emotions in others. The latter play a key role in social interactions. Moreover, the identiﬁcation
of neural mechanisms underlying emotional processing may help to understand psychiatric disorders resulting
from dysfunctions in emotional processing.
It is well known by now, that diﬀerent emotions may generate activity in multiple areas across the brain
[6, 7]. Furthermore, research has emphasized the interaction between emotion and cognition and suggested
that emotions inﬂuence memory, learning, attention and perception processes [8]. For a clear picture of the
neural networks involved in emotional processes, and for understanding their complex interactions with other
psychological processes, high resolution images are required of the neural networks involved. Using fMRI, neural
activity in all anatomical locations of the brain can be recorded at good spatial and temporal resolution (images
1A psychological process is deﬁned herein as a change which takes place inside the nervous system of an organism, i.e.,
a biological process, and has implications in the behavior of the organism.
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are usually acquired every 1-4 seconds and the voxels in the resulting image represent cubes of tissue with an
edge length of 2-4 millimeters [1]), a quality that has made fMRI, the method of choice for the study of human
emotions and their neural networks.
Studies in humans and animals have been trying to depict the emotional brain
2, to understand how emotions
are generated by the brain. Classical studies considered that the limbic system
3, which involves the following
structures: hippocampus, mammillary bodies, thalamus, cingulate and parahippocampus brain areas, represents
the core-system of emotions [10]. However, more modern research has revealed that diﬀerent aspects of
emotional processing also involve areas of the brain [11, 9] that mediate other functions beyond emotional
processing [12]. For example, the dorsal medial prefrontal cortex and the ventrolateral prefrontal cortex are
part of the neural circuitry involved in experience of emotion, but are also related to cognitive processes [7].
Barrett and colleagues [7] suggested that emotion experience and cognition represent a ”gradient”, rather than
two independent systems which can interact with each other. Further, it has been suggested that emotional
experience plays an important role in the judgement of perceived emotional stimuli ([13], p. 596-618). Recent
functional neuroimaging studies have provided additional support for this neural model of emotional processing
[14, 15]. Thus, in addition to amygdala and hippocampus, which were already shown as being involved in
emotional processing, the prefrontal cortex (PFC) and the anterior cingulate cortex (ACC) have also been
shown to be activated during emotional processing ([13], p. 8-24). Additional studies [6, 5, 15] have shown
that diﬀerent types of emotion are associated with activity in speciﬁc brain areas. Fear-related emotions were
found to speciﬁcally activate the amygdala, sadness was associated with increased activation in the subcallosal
cingulate cortex, disgust was related to insula activation, positive emotions – and again, disgust (see the above
discussion) – were linked to basal ganglia activation, whereas the medial PFC was suggested to be a shared
region activated across diﬀerent emotions.
The amygdala
4 is considered the key component of the neural mechanism of emotion. Although early studies
considered that the amygdala is the core neural structure of fearful emotion, latter studies reported amygdala
responsiveness also to positive and neutral facial expressions, suggesting a more general role of this brain area
in processing salient visual stimuli rather than in emotion processing per se [16]. Furthermore, it has been
shown that amygdala response to facial expressions is modulated by attention: e.g., implicit or ”automatic”
processing of facial expressions elicited stronger amygdala response, relative to explicit or ”conscious” processing
of emotional facial expressions [17]. In addition, researchers have emphasized the role of the amygdala in
diﬀerent forms of psychopathology [18, 19, 20]. In order to identify the abnormalities in the neural response
associated with psychopathological disorders, we used an implicit emotional perception task, but also an explicit
emotional processing paradigm.
Brain regions work like a network of interconnected areas, rather than like isolated areas reserved solely for
the processing of speciﬁc inputs. It is therefore important to understand how these regions are connected.
As the amygdala is considered to play an important role in emotional processing, neuroimaging studies have
recently examined the anatomical and functional connectivity of this region. Until recently, evidence regarding
anatomical connectivity of the amygdala with other brain areas was based only on animal studies. These studies
have reported that the amygdala has anatomical connections with several forebrain areas including ventromedial
prefrontal cortex, insula, temporal cortex, thalamus and basal ganglia, and this system was associated with
emotional behavior and mood [21]. Functional neuroimaging studies in humans have recently shown that the
amygdala in the human brain is part of a complex network of brain regions, including prefrontal regions, anterior
cingulate cortex, insula and thalamus [22]. The study of this neural network may help us to better understand
the neural mechanism of emotion and cognitive processes in the healthy brain and in psychopathological disorders.
Given the complexity of neural mechanism related to emotional processing, it is not surprising that emotional
dysfunctions characterize a variety of psychopathological syndromes. An emotional dysfunction may be caused
by a disturbance in one or more components of the emotional processing system, such as diﬀerences in cognitive
style (negative cognition may inﬂuence the evaluation process such that ambiguous emotional stimuli are
interpreted as being more negative), aberrant emotional experience or diﬀerences in physiological responses to
2The term ”emotional brain” was used for the ﬁrst time by LeDoux, in 1996, to deﬁne the neural circuitry of emotion [9].
3The limbic system is a set of brain structures that lies on both sides (left and right hemisphere) under the cerebrum
forming the inner border of the cortex. The term limbic comes for Latin limbus meaning ”border” or ”belt”.
4The amygdala is a small structure of the brain, has an almond-shape and its located deep in the medial temporal lobe
of the brain.13
emotional stimuli [23].
In the present thesis, we will focus on two psychological disorders characterized by emotional disturbances:
1) major depressive disorder and 2) anxiety disorders. Anxiety and depression have a high prevalence in the
general population and are related to a decline in the quality of life. Yearly, aproximatively 7% of the adult
population suﬀers from a depressive disorder and 18% suﬀers of anxiety disorders [24]. According to the World
Health Organization, mood disorders rank among the top ten of diseases causing worldwide burden and it is
speculated that in 2020 depression will be on the second place (http://www.who.int/en/).
Identifying abnormalities in brain mechanisms involved in emotional processing in patients with depression and
anxiety disorders may be of a paramount importance in the eﬀort to improve the treatment of these disorders.
Among these patients suﬀering from depression or anxiety, those coming from primary mental health care are the
most numerous and hence, identifying their emotional processing abnormalities could lead to an improvement
of their treatment and to a faster reintegration.
The main goal of the present work is to delineate the neural mechanism of emotional processing in community-
based outpatients with depression and anxiety disorders. The major strength of this study is the large number
of participants and the fact that our ﬁndings, presented in this thesis, may be representative for the clinical
outpatients diagnosed with major depression and anxiety in the general population.
Major depressive disorder (MDD) is characterized by persistent negative mood accompanied by diminished
interest or pleasure, motor and mental speed, appetite, libido, disturbance in attention, anhedonia, feelings of
guilt and suicidal ideation [25]. These symptoms lead to poor social skills and major diﬃculties in community
integration. For example self-focused attention and negative perceptual bias inﬂuence cognitive and perceptual
components of social behavior and are related to poor social skills [26]. Furthermore, patients with MDD were
found to have an impairment in discriminating facial expressions of emotions in others, an impairment which is
likely to interfere with their ability to accurately respond to socio-emotional signals [23]. These ﬁndings show
that a better understanding of speciﬁc emotional dysfunction and the etiology of MDD is crucial in developing
treatments and therapies.
Given the broad spectrum of emotional, cognitive, but also behavioral dysfunctions it is not surprising that
MDD is associated with abnormalities in many brain areas [27]. Mayberg [28] hypothesized that depression is
associated with hypoactivity of dorsal limbic (anterior and posterior cingulate) and neocortical areas (PFC,
premotor and parietal cortex), and hyperactivity of ventral paralimbic regions (subgenual cingulate, anterior
insula, hypothalamus and caudate). Abnormalities in the neural response of the dorsal regions were associated
with impaired cognitive processes, poor task performances involving selective or directed attention, whereas the
ventral system was hypothesized to mediate vegetative and somatic symptoms of depression [28]. Additionally,
depression was associated with prolonged amygdala responses during emotional processing, which may be
related to negative aﬀect [29]. Amygdala hyperactivation to emotional stimuli has been reported by a number
of previous studies, suggesting its important role in major depressive disorder [30, 31, 32]. Nevertheless, other
studies failed to report amygdala hyperactivation to emotional stimuli in depressed patients [33, 34, 35]. These
inconsistencies in ﬁndings may be caused by diﬀerences in experimental design, such as task demands and
stimulus type. Our aim is to identify the neural pattern of activation to facial expressions of emotions and
verbal emotional stimuli in community-based MDD outpatients.
Anxiety disorders are characterized by exaggerated fear response relative to innocuous stimuli, e.g., phobia, or
spontaneous fear response in the absence of a true threat [25]. Neuroimaging studies suggested that anxiety is
associated with amygdala hyperactivation and PFC hypoactivation [36]. Rauch suggested that anxiety in general
may be associated with dysfunctions in the anterior paralimbic cortex, sensory cortex and deep brain structures,
e.g., amygdala, hippocampus, striatum and brainstem nuclei ([13], p. 963-975). Just as depression, anxiety has
also been associated with aberrant amygdala activation during threat-related stimuli [19]. However, the neural
mechanism of emotional processing speciﬁc to anxiety disorders is poorly understood and the delineation of this
mechanism in a large sample of outpatients is an aim of this work.
As mentioned above, aﬀective disorders may be characterized by amygdala hyperactivation to negative emotional
stimuli. Robust evidence showed that neuroticism is a key predictor of psychological disorders, e.g., phobia,
panic disorders and other anxiety disorders, and correlates also with a high risk for depression [37, 38, 39].
Neuroticism is considered a personality trait characterized by tendencies to worry and to be anxious [40, 41].
Eysenck suggested that neuroticism is associated with ”high levels of visceral brain (amygdala, hippocampus,
cingulate, septum and hypothalamus) activity” ([13], p. 933). Recently, fMRI studies have indicated that14 ANTELOQUY
neuroticism (and related personality traits) modulates the neural response of the amygdala and frontal brain
regions during emotional processing [42, 43]. As mentioned previously, the amygdala has functional connections
with frontal regions and this coupling is important for the integration of emotion and cognition [12, 44].
However, little is known about the functional connectivity between the limbic system and the frontal areas
modulated by neuroticism. Thus, elucidating the neural basis of individual diﬀerences in emotional processing
related to neuroticism is the third and last aim of this thesis. The ﬁndings may oﬀer an insight into the neural
mechanism associated with high risk for aﬀective disorders.
The research presented in this thesis is part of the longitudinal study Netherlands Study of Anxiety and
Depression (NESDA) for investigating the course of depression and anxiety disorders. The main aim of NESDA
is to determine the factors that inﬂuence the development and long-term prognosis of depression and anxiety
[45]. Among the anxiety disorders, social phobia was reported to be poor and with a low recovery rates, and
panic disorders has a low to no improvement rates [45].
The prevalence of depression and anxiety disorders is increased in the community – primary care, specialized
health care institutions –, whereas the most severe and longstanding disorders are more likely to be hospitalized
in mental health care. Given the high prevalence of depression and anxiety comorbidity and the severity of the
symptoms within these patients, the NESDA study focused not only on depression and anxiety alone, but also
on their comorbidity, which may gives a better insight of this ”state”. Thus, the aim of the NESDA study is to
provide information about on the course of psychiatric disorders in the community and primary care settings
[45].
Almost three thousand participants, with and without psychopathological symptoms, were selected to participate
in the NESDA study from primary mental health care and specialized mental health institutions. From this
pool of subjects, almost three hundred subjects were included in the NESDA-fMRI study. Three main centers
were involved in this project: University Medical Center Groningen, Amsterdam Medical Center and Leiden
University Medical Center.
The structure and the composition of the present thesis can be summarized as follows: In order to determine
if depressed or anxious patients have an impairment in the discrimination of emotional facial expressions, we
review the studies on the recognition of facial expressions of emotion in patients with depression and anxiety
disorders (Chapter 2). In Chapter 3, we investigate the neural correlates of implicit perception
5 of facial
expression in patients with depression and anxiety disorders relative to healthy participants. Chapter 4 examines
the neural mechanism of explicit emotional processing
6 during attribution of valence to words in depressed and
anxious patients. The task used in Chapter 4 may be well deﬁned as an emotional cognitive task
7.
In the second part of this thesis, we study the functional connectivity during perception of facial expressions and
the eﬀect of neuroticism on this functional connectivity in healthy participants (Chapter 5). We further examine,
in Chapter 6, the brain mechanism of emotion perception involved in social phobia and panic disorder, not only
looking at regional brain activity but also at the functional connectivity between areas involved in emotion
processing. This approach may give a clearer picture of the neural mechanisms involved in anxiety disorders, as
not only speciﬁc brain regions related to aberrant emotional processing are investigated but, additionally, the
functional connectivity of the brain areas that are subserving the processing of emotional stimuli.
Finally, the last part of the present thesis provided a conclusion of the empirical ﬁndings presented in this thesis.
Additionally a critical observation on the methods and suggestions for future research are proposed.
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Abstract
Background: Recognition of others’ emotions is an important aspect of interpersonal communication. In depression, a
signiﬁcant emotion recognition impairment has been reported. It remains unclear whether the ability to recognize emotion
from facial expressions is also impaired in anxiety disorders. There is a need to review and integrate the published literature
on emotional expression recognition in anxiety disorders and depression.
Method: A detailed literature search was used to identify studies on explicit emotion recognition in patients with anxiety
disorders and depression compared to healthy participants. Eighteen studies provided suﬃcient information to be included.
The diﬀerences on emotion recognition impairment between patients and controls (Cohen’s d) with corresponding conﬁdence
intervals were computed for each study.
Results: Over all studies, adults with anxiety disorders had a signiﬁcant impairment in emotion recognition (d = -0.35).
In children with anxiety disorders no signiﬁcant impairment of emotion recognition was found (d = -0.03). Depression was
associated with an even larger impairment in recognition of facial expressions of emotion (d = -0.58).
Conclusion: Results from the current analysis support the hypothesis that adults with anxiety disorders or depression
both have a deﬁcit in recognizing facial expressions of emotion, and that this deﬁcit is more pronounced in depression than
in anxiety.
1920 EMOTION RECOGNITION – REVIEW
2.1 Introduction
The ability to identify and interpret facial expressions
of emotion is essential in human communication and
social interaction. Ekman and Friesen [1] concluded
that six facial expressions are universal across cultures:
happy, angry, sad, anxious, disgusted and surprised,
and each of them is characterized by a particular facial
muscular pattern.
Discrimination of emotion from facial expressions has
been the focus of a number of psychological studies over
the past decades, and was later complemented by neu-
robiological ﬁndings [2, 3]. The speciﬁc way in which
an individual processes and interprets emotional infor-
mation can be a causal factor in the development or
maintenance of emotional disturbances. Studies in sub-
jects with emotional disorders, such as depression and
anxiety, aim to understand the relation between emo-
tional processing and psychopathology.
Emotional dysfunctions (e.g., diﬃculty in understand-
ing emotions, diﬃculty in changing how one feels) are
related to poor social functioning and can be consid-
ered as important features of psychopathology [4, 5].
Poor social and interpersonal relations could arise from
a deﬁcit in the ability to read signals of interpersonal
threat or safety. Psychopathological variables may ex-
plain the variance in the accuracy of recognition of fa-
cial expressions of emotion.
Over the last two decades, research regarding emotional
facial expressions in anxiety and depression has focused
on two areas: attentional bias and the ability to recog-
nize emotions, with much more consideration devoted
to the former. Several types of cognitive bias have been
described in social phobia, generalized anxiety disorder
and panic disorder. Biases involve attention, judgment,
interpretation, imagery and memory (for a review, see:
Hirsch and Clark [6], Lang and Sarmiento [7], Clark
and McManus [8]). Anxiety disorders have been asso-
ciated with a selective attentional bias toward threaten-
ing stimuli, whereas in depression a selective attentional
bias has been observed for negative emotional stimuli
such as those related to sadness, loss and failure [9, 10].
The aim of the present review was to determine, by
conducting a comprehensive meta-analytical synthesis
of previous studies, the magnitude of the impairment in
facial emotion recognition associated with anxiety dis-
orders and depression. Anxious patients are thought
to direct their attention toward threat-related stimuli
and to avoid extended attention toward these stimuli
[11]. Depression is characterized by negative aﬀects and
cognitive impairments [12], which may lead to diﬃcul-
ties in recognition of emotion from facial expressions.
In light of this, we hypothesized that there would be
a small diﬀerence for anxiety patients when compared
to healthy controls in emotion recognition as they do
not have substantial cognitive deﬁcits. In contrast, we
expected to ﬁnd a larger impairment in emotion recog-
nition in depressed patients.
2.2 Methods
2.2.1 Screening procedures and
inclusion criteria
The Web of Science (ISI) and PubMed databases were
searched for the period 1980 – 2009. The search was
performed using ”anxiety” and ”depression” combined
with ”emotion”, ”facial expressions”, ”recognition”,
”discrimination”, ”labeling” as search terms. Addi-
tionally, more speciﬁc terms were used such as ”social
phobia” (SP), ”generalized anxiety disorder” (GAD),
”panic disorder” (PD), ”posttraumatic stress disorder”
(PTSD) and ”major depressive disorder” (MDD).
173 studies on anxiety disorders and 208 studies on
depression were identiﬁed. Subsequently, title and
abstract of the articles were screened for possible
inclusion in the analysis. The identiﬁed studies
were included if they met the following criteria: the
diagnosis of major depressive disorder or anxiety
disorders was made according to the DSM-III or DSM-
IV criteria. Secondly, each study had to deal with a
group of adults or children experiencing depression
or anxiety disorders and a control group. Third,
behavioral measures of emotional facial expressions
discrimination had to be reported with suﬃcient
statistical information for the computation of the
eﬀect size (d-value). This implies that means and
standard deviations, t-values or F-values and the
relevant means, and exact p-values had to be reported.
Lastly, only studies published in English were included.
2.2.2 Data analysis
For each study the eﬀect size (Cohen’s d) was calculated
for the diﬀerence in emotion recognition performance
between the patient group and the control group. The
d was calculated as the diﬀerence between the two
group means, patient group minus control group and
divided by the pooled standard deviation [13]. When
means and standard deviation were not given, d-values
were computed from F-values or t-values. The eﬀect
size was computed using the program developed by D.
Wilson (http://mason.gmu.edu/ dwilsonb/ma.html).
The direction of the eﬀect size was negative if the
performance of the patient group in discrimination of
facial expression was worse than the control group.2.3. Results 21
Table 2.1: Meta-analytic results for facial expressions of emotion discrimination in children with anxiety
disorders, adults with anxiety disorders and adults with depression.
k d 95% CI Z p* I2 Q p**
Anxiety - Children 5 -0.03 (0.08) -0.30, 0.24 -0.21 0.831 0.00 2.99 0.56
Anxiety - Adults 5 -0.35 (-0.51) -0.61, -0.10 -2.69 0.007 22.30 5.15 0.27
Depression - Adults 8 -0.58 (-0.42) -0.79, -0.36 -5.17 0.000 33.75 10.57 0.16
k - number of studies included in the meta-analysis; d - eﬀect size (estimated eﬀect size after correction of publication
bias in parentheses); CI - conﬁdence intervals; p* - indicates the statistical signiﬁcance of association Z; p** - indicates
the signiﬁcance of Q-statistic; I2 - indicator of heterogeneity.
After computing the eﬀect size for each study, a
meta-analytic method was used (Comprehensive Meta-
analysis program, www.meta-analysis.com). The com-
bined eﬀect size was calculated with the corresponding
conﬁdence intervals (95%) indicating the magnitude of
the eﬀect across all studies. The Z-values and p-values
provide an indication of the statistical signiﬁcance
of the association. In addition, the Q-statistic was
calculated [14] as an indicator of homogeneity. A
signiﬁcant Q-statistic points to heterogeneity of the
eﬀects across studies. As the Q test is reported to be
susceptible to the number of studies included in the
meta-analysis, the I-squared [15] was also calculated.
I-squared is an index of heterogeneity describing the
percentage of non-chance inconsistency. I-squared
of 25% indicates low, 50% moderate and 75% high
heterogeneity [15].
Publication bias was tested using the Duval and
Tweedie’s trim and ﬁll, and by inspecting the funnel
plot. The Duval and Tweedie’s trim and ﬁll is
a nonparametric method which concerns a simple
funnel plot-based method of testing and adjusting for
publication bias in meta-analysis, by using the ranks
of the absolute values of the observed eﬀect sizes and
the signs of those eﬀect sizes around the global eﬀect
size [16].
2.3 Results
2.3.1 Search results
Out of 381 identiﬁed studies, twenty-eight studies were
potentially eligible for inclusion based on screening of
the title and abstract, and the full text version of each
of these manuscripts was further evaluated. Six studies
were excluded because of insuﬃcient data needed
to calculated the eﬀect size [17, 18, 19, 20, 21, 22].
Two studies [23, 24] were excluded as they examined
facial emotion recognition in non-clinical participants
(high and low anxiety). One study [25] was excluded
because it did not include a patient group. One study
was excluded because of signiﬁcant diﬀerences in age
between the patient group and the control group [26].
Two studies were excluded because of methodological
diﬀerences [27, 28]. Ten studies targeting facial expres-
sions of emotion discrimination in anxiety disorders
and eight studies in depression met our inclusion
criteria. Characteristics of the included studies and
data are provided in Table 2.2 for the studies on
anxiety disorders and Table 2.3 for the studies on
depression.
2.3.2 Meta-analysis results
The results of meta-analysis of emotion recognition in
anxiety disorders and depression are displayed in Ta-
ble 2.1. Results from the meta-analysis suggest that
children with anxiety disorders do not have an impair-
ment (p = 0.831, d = -0.03) of recognition of facial
expressions of emotion (Table 2.1). The eﬀect size af-
ter adjustment for possible publication bias using Duval
and Tweedie’s trim and ﬁll method remained insigniﬁ-
cant (d = 0.08, 95% conﬁdence interval: -0.16 to 0.32).
In adults with anxiety disorders the meta-analysis
showed a signiﬁcant impairment (p = 0.007) with a
medium magnitude (d = -0.35, 95% conﬁdence interval:
-0.61 to -0.10) of facial emotion recognition. There was
a low variability among the eﬀect sizes (I
2 = 22.30).
Correcting this for publication bias still resulted in a
robust estimated eﬀect size of d = -0.51 (95% conﬁ-
dence interval: -0.73 to -0.29). The overall eﬀect size
was larger than if we ignored a possible publication bias.
More speciﬁcally, Duval and Tweedie’s trim and ﬁll sug-
gested that there may be two missing studies with a
negative eﬀect (impaired emotion recognition in anxi-
ety disorders compared to controls).
The meta-analysis of studies on depression showed
signiﬁcant impairment of emotion recognition with a
medium overall eﬀect size of d = -0.58 (p < 0.001).
There was a moderate variability among the eﬀect sizes
(I
2 = 33.75, Q = 10.57, p = 0.16). Once corrected for
publication bias the relationship between the impair-
ment of emotion recognition and depression remained
robust, although this overall eﬀect size was reduced (d22 EMOTION RECOGNITION – REVIEW
= -0.42, 95% conﬁdence interval: -0.62 to -0.23) relative
to that estimated from the original data.
2.4 Discussion
The purpose of this study was to investigate whether
and to what extent anxiety disorders and depression
are associated with impaired recognition of emotion
in others. The results from the current analysis
support the hypothesis that adults with depression
or anxiety disorders have an impaired recognition of
facial expression of emotion, as substantiated by the
medium eﬀect size. This eﬀect was not observed in
children with anxiety disorders.
The present meta-analysis shows that children with
anxiety disorders do not have an overall emotion recog-
nition deﬁcit, but the possibility of a mild emotion
speciﬁc deﬁcit cannot be discarded. This could not be
investigated in the present meta-analysis because of a
lack of data. Easter et al. [29] found that children with
anxiety compared to controls had more diﬃculties
interpreting the emotional expressions of adults than
of children. They suggested that this deﬁcit reﬂects a
disorder-speciﬁc dysfunction.
Additionally, behavioral studies in children with
anxiety suggested an emotion speciﬁc deﬁcit. For
example, Simonian et al. [30] using pictures of facial
aﬀect of adults portraying happiness, sadness, anger,
fear, surprise and disgust reported that children with
social phobia had diﬃculties relative to controls in
identifying sadness, happiness and disgust. Ellis et al.
[17] reported that children with anxiety disorders
have diﬃculties in recognizing anger and disgust, and
that on 11% of the occasions they misidentiﬁed anger
as disgust. However, other studies did not ﬁnd an
emotion recognition deﬁcit in children with anxiety
disorders compared to healthy children [31, 18, 32, 19].
The inconsistencies between studies may be explained
by sample characteristics, such as a variety of anxiety
disorder diagnoses (e.g., social or speciﬁc phobia,
generalized anxiety disorder, separation anxiety or
posttraumatic stress disorder), whereas others included
children with only one diagnosis, such as social phobia
[33, 30]. Another explanation for these discrepancies
may be diﬀerences in the instruction to subjects, such
as labeling the emotion depicted in a photograph
versus recognition of the emotion named in the story
read by the examiner, from a set of photographs [17],
but also stimulus material used.
Furthermore, the present meta-analysis revealed a
moderate impairment of facial emotion recognition in
adults with anxiety disorders. The underlying mecha-
nism for this impairment is unknown, but attentional
biases might be involved. Indeed, an emotion speciﬁc
impairment has been suggested in association with
anxiety disorders. For example, Kessler et al. [34]
and Mohlman et al. [35] found that socially anxious
patients, as compared to healthy participants, had a
tendency to misclassify neutral expressions as angry.
On the other hand, a high sensitivity has been found
in recognizing negative facial expression [36]. Surcinelli
et al. [23] reported that non-clinical participants with
a high trait anxiety have a better recognition of fearful
faces. A possible explanation might be that anxious
subjects have a negative bias, such that they misin-
terpret neutral expressions as displaying a negative
emotion [37, 38, 39]. This impairment may also be
triggered by the presence of emotional dysregulation
in anxiety disorders [40]. As most studies in the
present meta-analysis did not report emotion speciﬁc
recognition scores, we were not able to systematically
investigate possible biases.
Regarding depression, we also found a moderate over-
all emotion recognition impairment. Thus, patients
with depression may be compromised in recognizing
emotions of other people from facial expressions.
This may contribute to social dysfunction, as it
has been well established that emotion recognition
contributes to proﬁcient social functioning [41]. One
explanation for this perceptual impairment might
be the presence of cognitive deﬁcits associated with
depression, as suggested by Persad and Polivy [42].
Leppanen et al. [43] reported that depressed patients
may have an impairment in recognizing neutral faces
and a tendency to interpret happy faces as neutral,
and interpreting this as a negative shift in emotion
recognition [44, 45, 46]. Thus, deﬁcits in recognition
of facial expressions of emotion in depression may
be determined by patients’ negative emotional expe-
rience as well as by the assessment of their internal
mood state. Depression is characterized by negative
cognitions (worthlessness, self-criticism, hopelessness)
and consequently their evaluation of external stimuli,
including facial expressions, might be more negative
than in healthy subjects [47, 4].
Emotion recognition has been shown to be related to
social functioning [48]. Indeed, neuroimaging studies
have reported that to a large extent regions involved
in emotional processing are also part of the neural
network responsible for social cognitive processes
[49]. Keightley et al. [50] reported that prefrontal
cortical structures, amygdala and inferior temporal
cortex (fusiform gyrus) have a critical role in emotion
recognition processes. At the neural level, anxiety
disorders are associated with amygdala and insula
hyperactivation during perception of threat-related
emotions [51]. In depression abnormal cerebral blood2.4. Discussion 23
ﬂow (CBF) has been shown in amygdala, anterior
cingulate cortex (ACC), ventral striatum, anterior
insula and prefrontal cortex [52, 53]. Thus, neuroimag-
ing studies can oﬀer an identiﬁcation of pathological
mechanisms associated with aﬀective disorders.
Limitations Factors which might inﬂuence our results
are the small sample size, diﬀerences in stimulus
material, and duration of illness which may have an
impact on the outcome of emotion recognition tasks
and cognitive tests. A second limitation concerns
the fact that there were diﬀerences in the degree of
severity of the anxiety disorders, not all of them being
clinical patients. Another limitation is that we could
not distinguish between individual emotions, because
most studies did not report adequately detailed
data to permit such comparisons. It would be of
interest to investigate whether depressed patients are
selectively more impaired for certain expressions (e.g.,
happy) than others (e.g., sad), as was suggested by
Surguladze et al. [22]. Medication use might have been
a confounding variable because manipulation of the
serotonin system, which is a common antidepressant
treatment, produces speciﬁc alterations in the ability
to recognize fear [54].
In summary, we reviewed behavioral studies indicating
the relevance of facial expressions of emotion to
anxiety disorders and depression. The present ﬁndings
suggest a global deﬁcit in recognition of diﬀerent
types of emotions, which was more pronounced in
depression than in anxiety disorders. These emotion
recognition deﬁcits may contribute to compromised
social functioning in these disorders.2
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Table 2.2: The characteristics of included studies in anxiety disorders.
Reference Subjects Mean age Psychopathological Anxiety rating Characteristics of Eﬀect size:
(years) measures score the task Cohen’s d
(95% CI)
Melfsen and
Florin [33]
17 social anxiety; 15
controls
10.24; 10.07;
Range: 8-12
SPAI-C M (s.d.) = 25.72 (8.21);
M (s.d.) = 5.23 (2.09)
72 pictures with neutral, positive
(joyful) or negative (angry, dis-
gusted, sad) facial expressions,
black and white, half of them
showing adults and half children
(Matsumoto and Ekman, 1988).
0.06 (-0.43 to
0.55)
Simonian et al.
[30]
15 social phobia; 14 con-
trols
12.2; 11.0;
Range: 9-15
SPAI-C Score 18 (social phobia)
Score 15 (control group)
36 slices from pictures of facial
aﬀect, black and white, consist-
ing of adult faces, displaying six
emotions (happiness, anger, sad-
ness, fear, surprise and disgust).
-0.24 (-0.97 to
0.49)
Easter et al. [29] 15 anxiety disorder (11
met criteria for GAD, 8
with SP, 3 with SAD, 4
had comorbid major de-
pression); 11 controls.
13.1; 12.5 Kiddie-Schedule for Aﬀective
Disorders and Schizophrenia for
School Age Children (K-SADS-
PL). Pediatric Anxiety Rating
Scale.
Child facial expression and adult
facial expressions subtests of the
DANVA, consisting of 24 pho-
tographs of either children’s or
adults faces displaying happy,
sad, angry and fearful.
-0.48 (-1.28 to
0.31)
Manassis and
Young [32]
14 children with anxi-
ety disorders; 10 healthy
control children.
10.5; 10.4;
Range: 8-12
Anxiety Disorders Interview
Schedule for DSM-IV: Child and
Parent versions (ADIS-C/P)
DANVA2: 24 item series of adult
facial expressions depicting hap-
piness, sadness, anger and fear.
-0.11 (-0.68 to
0.47)
Allen et al. [31] 20 children with anxi-
ety disorders (GAD, sep-
aration anxiety disorder,
speciﬁc phobia, PTSD);
19 control children.
9; 8.9; Range: 7-
15
Revised Child Manifest Anxiety
Scale (RCMAS); ADIS-C/P
Photographic images of facial
emotion expressions depicting:
surprise, anger, happiness, fear,
disgust, sadness.
0.29 (-0.28 to
0.88)
Winton et al.
[38]
13 anxious
1; 11
controls
2
20.6; 22.7 Fear of Negative Evaluation
Scale (FNE), Social Avoidance
and Distress scale (SADS), Beck
Depression Inventory (BDI)
M(s.d.) = 22.5(3.6) on
FNE, M(s.d.) = 8.5(8.2)
on SADS, M(s.d.) =
8.0(5.2) on BDI; M(s.d.)
= 5.3(2.5) on FNE,
M(s.d.) = 2.3(2.7)
on SADS, M(s.d.) =
3.2(4.1) on BDI.
40 slides of negative facial emo-
tional expressions (anger, sad-
ness, disgust, contempt, and
fear) and 40 slides displaying
neutral expressions (Matsumoto
and Ekman, 1988).
-0.39 (-1.20 to
0.42)
Mohlman et al.
[35]
26 GSAD (4 dysthymic
disorder, 2 GAD, 2 panic
disorder, 1 MDD, 6 spe-
ciﬁc phobias); 26 con-
trols.
21.46; 21.08 FNE, Social Phobia Scale (SPS,
Mattick and Clarke, 1998), State
Trait Anxiety Inventory (STAI),
BDI
GSAD criteria score
above 20 on FNE, Con-
trols scored below 9 on
FNE.
Facial expressions depicted: neu-
tral, happy, sad and angry at dif-
ferent aﬀective intensities (25%,
50% and 100%)
-0.22 (-0.76 to
0.32)
Kessler et al.
[34]
37 PD outpatients; 43
controls.
37.8; 36.4 State Trait Anxiety Inventory
(STAI), BDI.
FEEL test, portrait pictures,
conditions: anger, sadness, dis-
gust, happiness, fear, surprise
(Kessler et al., 2002).
-0.74 (-1.20 to -
0.30)
Corcoran et al.
[55]
36 PD; 36 controls. The
patients were recruited
from anxiety disorder
specialty clinics.
34 Anxiety Disorders Interview
Schedule for DSM-IV; Struc-
tured Clinical Interview for
DSM-IV; Yale-Brown Obsessive-
Compulsive Scale; BDI.
Black and white photographs
depicting anger, disgust, fear
and sadness (Ekman and Friesen,
1979).
0.04 (-0.54 to
0.62)
Continued on next page2
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Table 2.2: The characteristics of included studies in anxiety disorders.
Reference Subjects Mean age Psychopathological Anxiety rating Characteristics of Eﬀect size:
(years) measures score the task Cohen’s d
(95% CI)
Campbell et al.
[56]
N = 12 generalized so-
cial phobia (GSP); N =
28 healthy controls (HC)
31.9; 30.4 Liebowitz Social Anxiety Scale
(LSAS); State-Trait Anxiety In-
ventory (STAI); BDI
GSP: M(s.d.) = 90.6
(26.4) on LSAS, M(s.d.)
= 45.8 (11.4) on STAI
and M(s.d.) = 15.8
(10.6) on BDI; HC:
M(s.d.) = 11.5 (10.8)
on LSAS, M(s.d.) =
22.6 (4.3) on STAI and
M(s.d.) = 1.8 (2.5) on
BDI
24 emotional faces selected from
Matsumoto and Ekman (1988)
set depicting: happiness, disgust
and anger.
-0.19 (-0.87 to
0.49)
1 high score on the Fear of Negative Evaluation Scale (FNE);
2 low score on the FNE; SPAI-C – Social Phobia and Anxiety Inventory for Children, EPQ-J – Extraversion
Scale of the Junior Eysenck Personality Questionnaire; DANVA – Diagnostic Analysis of Nonverbal Accuracy; GAD –Generalized Anxiety Disorder; GSAD – Generalized
Social Anxiety Disorder; PD – panic disorder; FEEL test – Facially Expressed Emotion Labeling;2
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Table 2.3: The characteristics of included studies on major depressive disorder.
Reference Subjects Mean age Psychopathological Depression ratings Characteristics of Eﬀect size:
(years) measures score the task Cohen’s d
(95% CI)
Rubinow and
Post [57]
17 inpatients (7 bipolar
I, 5 bipolar II, 5 unipo-
lar), 31 controls.
39; 31 Bunney-Hamburg Depression
Scale (B-HDS), Research Diag-
nostic Criteria (Spitzer et al,
1978)
7 on B-HDS in inpa-
tients
48 photographs of faces: sad,
fearful, happy, angry, disgusted,
surprised and interested (Ekman
et al., 1973).
-1.01 (-1.64 to -
0.38)
Leppanen et al.
[43]
18 depressed patients, 18
controls
45.1; 44.7;
Range: 23-59
BDI; Positive and Negative Af-
fect Scale.
M(s.d.) = 36.8 (9.6) on
BDI in depressed sub-
jects, M(s.d.) = 11.1.
(8.4) on BDI in con-
trols; M(s.d.) = 25.2
(7.0) on positive aﬀect
and 19.7 (9.2) on nega-
tive aﬀect in depression,
M(s.d.) = 31.7 (5.0) on
positive and 11.8 (2.6)
on negative aﬀect in con-
trols.
96 trials. Male and female mod-
els with happy, sad and neutral
expressions selected from Ekman
and Friesen (1976).
-1.00 (-1.70 to -
0.31)
Zuroﬀ and Co-
lussy [46]
15 depressed inpatients
(7 dystihymic disorder,
5 MDD, 3 adjustment
disorder with depressed
mood), 15 controls
37 BDI, D-30 scale from the MMPI M = 14 on BDI and M =
79.5 on D-30 in depres-
sion; M = 1.8 on BDI
and M = 44.8 on D-30 in
controls.
32 black and white prints of
adult male and female faces
(Izard, 1971). Eight emotions:
happiness, anger, surprise, dis-
gust, shame, fear, sadness and
interest.
-0.70 (-1.44 to
0.04)
Persad and Po-
livy [42]
16 DCS
1 , 16 NDCS
2, 16
DPP
3.
26.50; Range:
18-53.
BDI M = 16.19 on BDI in
DCS, M = 3.75 on BDI
in NDCS. -diagnosis of
MDD on Axis I, accord-
ing to DSM-III, a cutoﬀ
score of 22 or higher on
BDI in DPP.
Facial aﬀective booklet, consist-
ing of a set of 14 photographed
facial expressions developed by
Ekman (1976); expressed emo-
tions: fear, anger, surprise, con-
tempt, happiness, sadness and
indiﬀerence.
-0.62 (-1.36 to
0.13)
Hale [47] 48 depressed subjects
(28 outpatients received
antidepressant med-
ication, 15 received
benzodiazepine medica-
tion); 48 controls.
38; 41; Range:
20-69.
BDI M(s.d.) = 27.8 (7.1)
on BDI in depression.,
M(s.d.) = 2.7 (2.6) on
BDI in control group.
12 schematic facial expressions. -0.52 (-0.93 to -
0.11)
Archer et al. [58] 12 depressed inpatients;
12 controls
56.19; 48.04 Hospital diagnosis criteria based
on the DSM-III Manual.
Facial expressions of emotion
(Ekman and Friesen, 1976) de-
picted: happy, sad, fright-
ens, angry, surprised, and dis-
gust. Emotions were presented
in pairs, subject had to indicate
which of the two faces was ex-
pressing the target word pre-
sented on the screen.
-0.52 (-1.10 to
0.06)
Surguladze
et al. [22]
27 depressed inpatients
and outpatients; 29 con-
trols.
46.9; 43 BDI ; Hamilton Depression Rat-
ing Scale (HAMD).
M(s.d.) = 33 (9.9)
depressed patients and
M(s.d.) = 3.1 (3.5) con-
trols on BDI; M(s.d.) =
16.9 (5.5) depressed pa-
tients on HAMD.
10 facial expressions from stan-
dardized series Young et al.,
(2002), displaying happy, sad
and neutral expressions.
-1.21 (-2.47 to
0.05)
Continued on next page2
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Table 2.3: The characteristics of included studies on major depressive disorder.
Reference Subjects Mean age Psychopathological Depression ratings Characteristics of Eﬀect size:
(years) measures score the task Cohen’s d
(95% CI)
Kan et al. [59] 16 depressed inpatients;
20 controls
50.9; 59.0 Hamilton Depression Rating
Scale (HDRS); Zung self rating
depression scale (SDS)
M(s.d.) = 18.3 (8.64) on
HDRS and M(s.d.) =
60.0 (15.3) on SDS in de-
pressed patients.
Videotaped facial expression
from neutral to emotion to neu-
tral. Six basic emotions: happy,
sad, angry, fearful, surprise and
disgust were presented.
0.15 (-0.43 to
0.73)
1DCS – depressed college students,
2NDCS – nondepressed college students,
3DPP – depressed psychiatric patients.28 EMOTION RECOGNITION – REVIEW
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Abstract
Background: Depression has been associated with limbic hyperactivation and frontal hypoactivation in response to
negative facial stimuli. Anxiety disorders have also been associated with increased activation of emotional structures
such as amygdala and insula. This study examined to which extent activation of brain regions involved in perception of
emotional faces is speciﬁc to depression and anxiety disorders in a large community-based sample of outpatients.
Methods: An event-related functional magnetic resonance imaging paradigm was employed including angry, fearful, sad,
happy and neutral facial expressions. One hundred eighty-two outpatients (59 depressed, 57 anxiety and 66 comorbid
depression-anxiety) and 56 healthy controls selected from the Netherlands Study of Depression and Anxiety were included
in the present study. Whole-brain analyses were conducted. In addition, the temporal proﬁle of the amygdala activation
was investigated.
Results: Facial expressions relative to scrambled faces activated the amygdala and fusiform gyrus in depressed patients
with or without anxiety and healthy controls, but this was less evident in patients with anxiety disorders. Response shape
of the amygdala did not diﬀer between groups. Depressed patients showed dorsolateral prefrontal cortex hyperactivation
in response to happy faces, compared to healthy controls.
Conclusion: We suggest that this may reﬂect increased attention to mood-incongruent stimuli. The lack of strong
diﬀerences in neural activation to negative emotional faces, relative to healthy controls, may be characteristic of the
mild-to-moderate severity of illness in this sample and may be indicative of a certain cognitive-emotional processing reserve.
3132 PERCEPTION OF FACIAL EXPRESSIONS OF EMOTION
3.1 Introduction
Facial expressions are essential for social communica-
tion for they provide information concerning emotional
states and intentions of others. Depression has been
considered a disorder of emotion and its regulation
[1]. A high prevalence of depressive and anxiety
disorders has been observed in primary care settings
[2]. Moreover, 63 % of patients with panic disorder
and 35 % of patients with social phobia were reported
to have at least one episode of major depression [3].
Both depression and anxiety disorders have been asso-
ciated with neurophysiological abnormalities regarding
emotion perception [4, 5]. In depressed patients,
stronger amygdala activation has been reported in
response to negative emotional stimuli [6, 7, 8, 9]. In
addition, it has been suggested that depressed patients
have a sustained amygdala response during processing
of negative emotional stimuli, compared to healthy
volunteers [10]. In response to positive stimuli ventral
striatum hypoactivation was reported in depressed
patients compared to controls [11]. The authors
suggested that the lack of ventral striatum activation
may reﬂect anhedonia, i.e., the reduced capacity to
experience pleasure [11].
With regard to anxiety disorders, amygdala hyper-
responsiveness was reported to negative facial
expressions [12, 13, 14], whereas other studies reported
amygdala hyperactivation to neutral [15, 16] or positive
[17] facial expressions. Therefore, it is not clear if
amygdala hyper-responsiveness in anxiety disorders is
speciﬁc to threat-related stimuli or also to positive and
ambiguous facial expressions.
In addition to these abnormalities observed during
emotion processing, Mayberg [18] has hypothesized
that hypoactivation in dorsal neocortical areas (an-
terior and posterior cingulate, prefrontal, premotor
and parietal cortex) and hyperactivation in ventral
paralimbic areas (subgenual cingulate, anterior in-
sula, hypothalamus and caudate) may characterise
depression. Phillips et al. [19] proposed a model
that is consistent with Mayberg [18], but which is
more comprehensive, involving deﬁcient cortico-limbic
interactions in depression. Speciﬁcally, depression
is assumed to be associated with hyperactivation of
limbic regions responsible for emotion identication and
generation of emotional behavior, including subgenual
cingulate gyrus, ventrolateral prefrontal cortex (PFC),
amygdala, anterior insula, ventral striatum and thala-
mus, and hypoactivation of dorsal regions, important
for emotion regulation, including dorsomedial and dor-
solateral prefrontal cortices [19]. In anxiety disorders,
Etkin and Wager [14] concluded that hyperactivation
of the amygdala and insula may constitute a common
pathway in social anxiety disorders and specic phobia.
Emotion dependent abnormal amygdala activation has
thus been reported in both depression and anxiety
disorders, although mainly in reaction to syndrome-
speciﬁc emotional stimuli. Taken together, it appears
that there are both distinct and common neural
substrates underlying processing of various emotional
information in depression and anxiety disorders. We
would therefore expect that the presence of depression
and anxiety diagnoses have a diﬀerential impact on
the neural response to emotional stimuli. However, no
study to date has focused on emotion processing in
depression and anxiety, while explicitly controlling for
their comorbidity.
The present study is part of the Netherlands Study of
Depression and Anxiety (NESDA), a multisite cohort
study aimed to provide an insight into the long-term
course of depression and anxiety disorders in patients
selected from the general practices and the mental
health organisations [20]. Hence, the aim of the present
study was to identify the areas involved in perception
of facial expressions of emotion in large community-
based samples of outpatients with depression, anxiety
and depression-anxiety comorbidity relative to healthy
participants. We further tested for diﬀerences in the
temporal amygdala response to facial expressions
between groups. Outpatients with anxiety-depression
comorbidity were included in order to investigate the
possible implications of comorbidity on the neural
mechanisms involved in emotion perception.
Based on the literature, we hypothesised amyg-
dala and ventral anterior cingulate cortex (ACC)
hyperactivation in response to negative emotional
expressions in depressed outpatients compared with
healthy controls. In response to happy faces we
expected ventral striatum hypoactivation in de-
pressed outpatients compared to healthy controls.
In anxiety disorders, amygdala hyperactivation was
expected in response to angry, fearful and neutral faces.
3.2 Methods
3.2.1 Participants
The present work is a multicentre study, which involved
University Medical Center Groningen (UMCG), Ams-
terdam Medical Center (AMC) and Leiden University
Medical Center (LUMC). This study was approved by
the Ethical Review Boards of each participating centre.
Participants were selected from the Netherlands Study
of Depression and Anxiety (NESDA, Penninx et al.
[20]). After receiving written information, each partic-
ipant gave written informed consent. Participants did3.2. Methods 33
not receive any compensation for their participation in
this study.
Exclusion criteria – a diagnosis of other Diagnostic
and Statistical Manual of Mental Disorders-IV [21]
axis I disorders than major depression, social phobia
and panic disorder and generalised anxiety disorder
such as psychotic disorder or dementia, current alcohol
or substance abuse, presence or history of major in-
ternal and neurological disorder with potential central
nervous system sequelae; current use of beta-blockers;
hypertension >180/130 mm Hg; age over 57 years; and
MRI incompatible implants or tattoos.
We included 68 outpatients with major depressive
disorder (MDD), 61 outpatients with anxiety disorders
(Anx) – with panic disorder with/without agoraphobia,
generalised anxiety disorder and/or social phobia –,
78 outpatients with depression-anxiety comorbidity
(DAC) and 60 healthy controls (HC). All diagnoses
were made prior to the scanning session by trained
clinical staﬀ on the basis of Composite International
Diagnosis Interview - lifetime version 2.1 - [22], in
accordance with DSM-IV criteria. The HC had
never met the criteria for any DSM-IV disorder.
Functional MRI data from 4 Anx patients, 9 MDD
patients, 12 DAC patients and 4 HC participants
were discarded because of technical problems during
scanning, e.g., head movement artifacts (> 3 mm on
any axis) or incomplete coverage of the temporal lobe.
Table 1 represents the demographic characteristics
of the samples. The groups were matched on age
(F[3,234]=1.71, p=0.15), gender (χ
2[3]=2.94, p=0.40)
and handedness (χ
2[3]=0.08, p=0.99), but not on years
of education (F[3,234)=13, p<0.05). Post-hoc tests
using Bonferroni correction (αcrit=0.0167) indicated
that HC had signicantly longer education than MDD
(t[113]=4.76, p<0.001), Anx (t[111]=3.45, p=0.001)
and DAC (t[120]=6.322, p<0.001) patients.
Fifty-four patients were using selective serotonin
reuptake inhibitors: citalopram 20-60 mg (16 pa-
tients), paroxetine 20 mg (30 patients), sertraline 50
mg (two patients), ﬂuoxetine 20 mg (three patients)
and ﬂuvoxamine 50-100 mg (three patients). Ten
patients used the serotonin norepinephrine reuptake
inhibitor venlafaxine 75-225 mg. Three patients used
benzodiazepines infrequently (3 times 2 tablets weekly,
or within 48 hours prior to the scanning): oxazepam 40
mg (two patients) and diazepam 20 mg (one patient).
At the day of scanning, before the scanning session,
all participants were evaluated by means of a battery
of standardised questionnaires and structured inter-
views: Montgomery-˚ Asberg Depression Rating Scale
(MADRS; [23]), Beck Anxiety Inventory (BAI; [24])
and Fear Questionnaire (FQ; [25]).
3.2.2 Faces paradigm
The paradigm employed in the present study was
based on the event-related emotional paradigm used by
Wolfensberger et al. [26]. Color photographs of angry,
fearful, sad, happy, and neutral facial expressions, as
well as a control condition consisting of scrambled faces
were presented to all participants. The photographs
were selected from the Karolinska Directed Emotional
Faces System [27], representing standardised facial
expressions of emotions expressed by amateur actors.
Twenty-four stimuli were selected for each of ﬁve facial
expressions, comprising twelve female and twelve male
faces. Each particular face was not presented more
than four times. The control condition (scrambled
faces) was presented eighty times. The experimental
paradigm was presented using E-prime software
(Psychological Software Tools, Pittsburgh, PA, USA).
In order to reduce anticipatory eﬀects, an event-related
design was employed. This entailed a pseudo-random
presentation of a total of 200 stimuli against a black
background. Each photograph was shown on the
screen for 2.5 s, with an interstimulus (black screen)
interval varying between 0.5 and 1.5 s. The images
were projected onto a translucent screen at the end
of the scanner bed, visible via a mirror above the
participants head. All participants were instructed
to indicate each face’s gender by pressing one of two
buttons with the index ﬁnger of the left or right hand
on two magnet-compatible button boxes. During the
presentation of scrambled faces, participants had to
press left or right buttons in conformity with the
instruction presented on the screen, i.e., an arrow
pointing to the left or to the right. The reaction time
was recorded. The Faces paradigm was administered
as part of a functional scanning session, involving a
planning task, a memory task and a resting state scan,
the results of which will be reported elsewhere.
3.2.3 MRI data acquisition
Images were acquired on a Philips 3T MR-scanner.
SENSE-8 (UMCG and LUMC) and SENSE-6 (AMC)
channel head coils were used for radio frequency
transmission and reception. For each participant
a series of 310 echo planar imaging (EPI) volumes
sensitive to blood oxygenation level dependent eﬀect
were obtained, entailing a T2*-weighted gradient echo
sequence (repetition time [TR]=2300 ms, echo time
[TE]=28.0 ms at UMCG and TE=30.0 ms at AMC
and LUMC, ﬂip angle 90) using axial whole-brain
acquisition, with an interleaved slice acquisition order.
The EPI volumes were acquired at 39 slices at UMCG
and 35 slices at AMC and LUMC (0 mm gap, 334 PERCEPTION OF FACIAL EXPRESSIONS OF EMOTION
mm thickness). The matrix sizes were: 64x64 voxels
at UMCG and 96x96 voxels at AMC and LUMC.
The in-plane resolution was 3x3 mm at UMCG and
2.29x2.29 mm at AMC and LUMC. The images were
acquired parallel to the anterior-posterior commissure
plane. A T1-weighted anatomical MRI was also
acquired for each subject (TR=9 ms, TE=3.5 ms,
matrix size 256x256, voxel size 1x1x1 mm).
3.2.4 Data analysis
The behavioral data were analysed in SPSSv.16.0
(SPSS Inc., Chicago, Il) to test for an eﬀect of group
on reaction time employing an analysis of variance
(ANOVA). In case a signicant eﬀect was identied, post-
hoc tests were conducted using Bonferroni correction.
Functional imaging data were pre-processed and
analysed using Statistical Parametric Mapping soft-
ware (SPM5) implemented in Matlab v.7.1.0 (The
MathWorks Inc., MA, USA). Before pre-processing,
manual origin setting was performed to the anterior
commissure on the EPI volumes. Temporal and spatial
correction of the data included slice timing correction,
spatial realignment to the ﬁrst image, co-registration
between the anatomical and mean EPI images, spatial
normalisation to the standard Montreal Neurological
Institute (MNI), resampling into a 3x3x3 mm grid,
and spatial smoothing using a Gaussian kernel (8 mm
full-width at half-maximum).
In order to remove low-frequency temporal noise, a
high-pass ﬁlter was applied, with a cut-oﬀ of 128 s,
to the fMRI time-series. A canonical haemodynamic
response function (HRF), with the temporal derivative
(TD) and the dispersion derivative (DD) [28] was used
in a general linear model and parameter estimates
were generated for each voxel, for each condition.
For each subject, weighted contrasts were computed
(angry>scrambled, fearful>scrambled, sad>scrambled,
happy>scrambled and neutral>scrambled).
A ﬁve (conditions) by four (groups) repeated measures
analysis of covariance (ANCOVA) was conducted
on weighted contrasts generated at single-subject
level, with centers, age and education (years) added
as nuisance factors. The main eﬀect of condition
is reported at a threshold of p<0.05 corrected for
Family Wise Error (FWE), and groups diﬀerences were
inspected at p<0.001 (uncorrected) and the cluster
surviving p<0.05 corrected are reported.
In order to test for eﬀects of medication on the neural
response to facial expressions, further analysis was
performed excluding medicated patients. A total of
176 participants were included in this analysis (56 HC,
45 MDD, 39 Anx and 36 DAC) employing a ﬁve by
four repeated measure ANCOVA as described earlier.
An additional ANCOVA was performed to test for
diﬀerences between 62 medicated (14 MDD, 18 Anx
and 30 DAC) and 120 unmedicated patients.
To identify brain regions associated with illness
severity, regression analyses were performed within
each group of patients using MADRS, BAI and FQ
scores as regressors.
The temporal prole of amygdala activation was inves-
tigated employing a region of interest (ROI) approach,
using an amygdala anatomical mask [29]. Beta values
(HRF, TD and DD), for each subject, within each
region, were extracted using MarsBar [30]. The mean
and standard deviation of the haemodynamic response
shape within each group and for each condition was
reconstructed and plotted for visual inspection. Fur-
ther, for each subject and for each response curve the
maximum amplitude and the corresponding time point
of the peak amygdala response were calculated in the
haemodynamic response function and imported into
SPSSv16.0. Group eﬀects on these parameters were
investigated with non-parametric tests (Kruskal-Wallis
[H] and Mann-Whitney [U] as post-hoc test).
3.3 Results
3.3.1 Characteristics of the groups
Results of demographic and psychometric assessments
of the participants are shown in Table 5.1. A signicant
group eﬀect was present for MADRS (F[3,231]=58.02,
p<0.001), BAI (F[3,209]=52.01, p<0.001) and FQ
(F[3,223]=37.01, p<0.001) scores. Post-hoc tests us-
ing Bonferroni correction (αcrit=0.0167) indicated that
DAC patients scored signicantly higher on MADRS
compared to MDD (t[122]=5.47, p<0.001) and Anx
(t[119]=5.54, p<0.001). Depressed patients had mild-
to-moderate depressive symptoms (MADRS score be-
tween 9 and 34; [31]). Anx patients showed greater anx-
iety severity compared with MDD (BAI: t[112]=3.93,
p<0.001, FQ: t[107]=4.64, p<0.001). Patients with
DAC scored signicantly higher on BAI and FQ com-
pared with Anx (BAI: t[119]=2.54, p=0.012) and
MDD (BAI: t[121]=7.58, p<0.001, FQ: t[118]=5.40,
p<0.001).
No group eﬀect was found on reaction time during pre-
sentation of angry (F[3,5492]=0.411, p=0.745), fearful
(F[3,5481]=0.656, p=0.579), happy (F[3,5461]=1.206,
p=0.306), neutral (F[3,5458]=1.802, p=0.144) and sad
facial expressions (F[3,5491]=0.773, p=0.509). The
mean reaction times for each condition within each
group are presented in Table 3.2.3.3. Results 35
Table 3.1: Demographic and clinical characteristics of the groups (n represents the number of partici-
pants). HC – healthy controls, MDD – major depression, Anx – anxiety disorder, DAC – depression-
anxiety comorbidity. Mean (and standard deviation) are presented.
Groups Age Education Right-Handed Female SSRIs BAI FQ MADRS AgeOnset MD AgeOnset ANX
(SD) years (SD) (%) (%) users (%) (SD) (SD) (SD) (SD) (SD)
HC 39.75 14.68 91.1 60.7 0 2.32 9.65 1.36 - -
(n=56) (9.67) (2.65) (2.73) (7.61) (2.43)
MDD 36.24 12.29 89.8 66.1 23.7 7.81 20.26 11.16 24.93 -
(n=59) (10.79) (2.72) (6.15) (13.01) (8.66) (10.47)
Anx 35.74 12.74 91.2 75.4 31.6 13.86 35.21 10.89 - 18.16
(n=57) (9.44) (3.28) (9.89) (20.13) (8.74) (10.67)
DAC 36.42 11.47 90.9 65.2 45.5 18.14 36.79 19.55 23.88 18.11
(n=66) (11.25) (2.91) (8.85) (19.49) (8.38) (11.8) (10.61)
Figure 3.1: Main eﬀect of viewing photographs of faces (>scrambled) within each group (p<0.05 FWE).
Main activations were in the fusiform gyrus and amygdala. Color bar indicates t-value. HC – healthy,
MDD – major depression, Anx – anxiety disorder, DAC – depression-anxiety comorbidity. See also table
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Table 3.3: Anatomical regions showing signiﬁcant between-group diﬀerences in activation in response to
facial expressions. MNI coordinates, p<0.001 uncorrected. R – right hemisphere, L – left hemisphere, k
– cluster size in voxels.
Group Condition Region Side Coordinate Z-value k p corrected
x y z cluster–level
MDD>HC Happy > scrambled Superior Frontal gyrus (BA10) R 21 51 3 4.70 60 0.033
Middle Frontal gyrus (BA 9) R 27 36 30 5.90 264 <0.005
Neutral > scrambled Posterior Cingulate L -12 -60 9 4.51 66 0.024
HC>Anx Happy > scrambled Middle Temporal gyrus R 48 -66 6 4.13 90 0.007
Globus Pallidus R 12 0 0 4.44 57 0.040
Putamen R 21 3 3 4.39
Note: : BA - Brodmann area; ACC - Anterior Cingulate Cortex; Side: L - left, R - right; HC healthy, MDD - major
depression, Anx - anxiety disorder, DAC – depression-anxiety comorbidity.
Table 3.2: Behavioral data: mean reaction time
(and standard deviation) in msec.
Groups Reaction time
angry fearful happy neutral sad
HC 731.79 768.30 758.07 787.31 761.61
(n=56) (283.19) (325.03) (305.57) (335.40) (310.34)
MDD 732.96 774.93 763.70 770.81 768.63
(n=59) (286.78) (317.36) (318.24) (321.48) (305.14)
Anx 741.91 761.86 758.84 759.66 750.76
(n=57) (296.16) (324.64) (307.57) (312.42) (306.95)
DAC 740.09 759.23 777.64 765.98 761.08
(n=66) (295.37) (319.59) (319.80) (319.10) (300.52)
Note: HC – healthy, MDD – major depression, Anx –
anxiety disorder, DAC – depression-anxiety comorbidity.
3.3.2 Imaging data
Main eﬀect of task within group – Viewing facial
expressions (>scrambled faces) elicited fusiform gyrus
activation within each group of participants (p<0.05,
FWE corrected). Amygdala activation to facial
expressions (>scrambled) was found in MDD, DAC
patients and HC (p<0.05, FWE corrected, Figure 3.1).
In anxiety patients, amygdala activation to facial
expressions (>scrambled) was not found at p<0.05
FWE corrected, but was present at uncorrected
p<0.005 (right Z=2.59, left Z=2.64).
Full details (coordinates and Z-values) of group
activation maps to facial expressions (>scrambled) are
presented in the Appendix (Table A.1).
Condition by group interaction – A signiﬁcant group
by condition interaction eﬀect was found in the right
dorsal PFC extending to anterior cingulate cortex
(x=27, y=39, z=30, Z=5.54) and left Rolandic oper-
culum (x=-39, y=-6, z=15, Z=3.66).
Between-group comparisons – No signiﬁcant diﬀerences
in the neural response to negative (angry/fearful or
sad) faces versus scrambled were found between MDD
and HC. Patients with MDD showed right superior
frontal gyrus extending into middle frontal gyrus
hyperactivation in response to happy (>scrambled)
faces, compared with HC (Figure 3.2, Table 3.3). In
response to neutral (>scrambled) faces, greater left
posterior cingulate cortex (PCC) activation was found
in MDD compared to HC (Table 3.3).
Anx patients showed right lentiform nucleus hypoac-
tivation to happy>scrambled faces, compared to
HC (Figure 3.3, Table 3.3), whereas no signiﬁcant
diﬀerences in activation to angry, fearful, happy or
neutral (>scrambled) faces were observed in Anx
compared to HC.
Like Anx, DAC patients did not show signiﬁcant diﬀer-
ences in the neural response to any facial expressions
(>scrambled) compared to HC.
Medication eﬀects
After excluding medicated patients, the analysis of de-
mographic and clinical characteristics showed a sig-
niﬁcant group eﬀect on age (F[3,172]=2.85, p<0.05),
years of education (F[3,172]= 8.97, p<0.05), MADRS
(F[3,170]=37.55, p<0.005), BAI (F[3,172]=19.56,
p<0.005) and FQ (F[3,172]=16.97, p<0.005). No sig-
niﬁcant group eﬀect was found on gender (χ
2[3]=3.13,
p=0.37) or handedness (χ
2[3]=0.87, p=0.83). In the
Appendix (Table A.3) psychometric measures of medi-
cated and unmedicated patient groups are presented.
Unmedicated MDD patients showed right middle
frontal gyrus extending into cingulate cortex (BA32)
hyperactivation to happy>scrambled faces relative to
HC (Table 3.4). In response to neutral>scrambled faces
greater right medial frontal gyrus activation was found
in unmedicated MDD patients relative to HC. No signif-
icant diﬀerences in activation to negative (>scrambled)
faces were found between MDD and HC.
No signiﬁcant diﬀerences in the neural response to any
facial expression (>scrambled) were found between un-
medicated Anx and HC.
Unmedicated DAC patients showed right ACC hyper-3.3. Results 37
Figure 3.2: Right frontal cortex activation to happy facial expressions (>scrambled) in MDD compared
to HC (red)/Anx (blue)/DAC (green). White represents the overlapping of the clusters. HC - healthy,
MDD - major depression, Anx - anxiety disorder, DAC - depression-anxiety comorbidity.
Figure 3.3: Increased right putamen activation to happy facial expressions (>scrambled) in HC compared
to Anx outpatients (p<0.001 uncorrected with an extended threshold of 50 continuous voxels). HC -
healthy, MDD - major depression, Anx - anxiety disorder, DAC - depression-anxiety comorbidity.38 PERCEPTION OF FACIAL EXPRESSIONS OF EMOTION
Table 3.4: Anatomical regions showing signiﬁcant diﬀerence in activation, in response to facial expres-
sions between unmedicated and medicated patients, and HC. MNI coordinates, p < 0.001 uncorrected.
R – right hemisphere, L – left hemisphere, k – cluster size in voxels.
Group Condition Region Side Coordinate Z-value k p corrected
x y z cluster–level
unmed MDD > HC Happy > scrambled Middle Frontal gyrus R 27 36 30 5.56 217 <0.005
(BA 9)
Cingulate cortex R 12 33 30 4.75
Inferior Parietal lobule L -42 -51 39 3.83 71 0.019
(BA 40)
Insula (BA 13) R 36 3 15 3.78 71 0.019
Neutral > scrambled Medial Frontal gyrus R 12 39 33 3.62 64 0.028
(BA 9)
unmed DAC > HC Happy > scrambled ACC R 9 33 9 5.24 61 0.033
unmed > med MDD Happy > scrambled Precentral gyrus L -42 -9 33 4.61 171 <0.005
(BA 6)
med > unmed Anx Happy > scrambled Postcentral gyrus L -51 -15 15 4.06 59 0.044
(BA 43)
med > unmed DAC Happy > scrambled Medial Frontal gyrus L -12 24 45 4.04 65 0.032
(BA 8)
Note: : BA – Brodmann area; ACC – Anterior Cingulate Cortex; Side: L – left, R – right; HC – healthy, MDD – major
depression, Anx – anxiety disorder, DAC – depression-anxiety comorbidity.
activation in response to happy faces, compared to HC
(Table 3.4).
Unmedicated versus medicated outpatients – Medicated
patients did not diﬀer on depression and anxiety sever-
ity from unmedicated patients (p<0.05, Table A.3).
Diﬀerences in the neural response to facial expressions
between medicated and unmedicated patients are pre-
sented in Table 3.4.
Correlations of activation with illness sever-
ity
No signiﬁcant correlation was found between amygdala
activation and illness severity in patients groups.
However, we did observe a signiﬁcant correlation
between left fusiform gyrus activation to angry and
fearful (>scrambled) faces and depression severity in
MDD patients. In the Appendix (Table A.2) are listed
the regions showing signiﬁcant correlation with illness
severity.
Amygdala response shape
Figure 3.4 displays the response shape of the amygdala
(mean and standard deviation) during viewing facial
expressions for each group. There was no group eﬀect
on left or right amygdala amplitude and on the time of
the maximum peak (all p values >0.05).
3.4 Discussion
In the present study, we examined neural responses
during implicit emotion processing in a large number
of outpatients diagnosed with MDD, Anx and DAC
disorders. Fusiform gyrus activation to facial expres-
sions (>scrambled) was found within each group.
Amygdala activation was found to all facial expressions
(>scrambled) in MDD, DAC and HC. Thus, a common
neural network was implied in the perception of facial
expressions across all groups. All these regions have
been previously reported to be involved in processing
facial expressions of emotions [32, 33, 34].
In contrast to our expectations and to some of the
previous studies, which reported amygdala hyperacti-
vation to negative emotional stimuli in patients with
major depression [7, 6, 8] and anxiety [4, 35], in our
study we failed to observe signiﬁcant diﬀerences in
amygdala response to facial expressions in outpatients
with depression and/or anxiety relative to HC. This
was the case for both medicated and unmedicated
outpatients. Thus, although antidepressant medication
has been shown to dampen the putatively excessive
activation of the amygdala in depression [36, 8, 37]
and anxiety disorders [38, 39], medication status could
not explain the lack of group diﬀerences in amygdala
activation in the present study.
However, our results are in agreement with previous
ﬁndings in depression which suggest that there is no
amygdala diﬀerence in depressed patients compared to
HC: Gotlib et al. [40], Lawrence et al. [41], Almeida
et al. [42], Lee et al. [43], Norbury et al. [44]. A3.4. Discussion 39
Figure 3.4: Amygdala response shape within each group and for each facial expression. Solid lines
indicate group average for one ROI for one group, dashed lines are conﬁdence intervals (SD). There were
no signiﬁcant group diﬀerences in peak height of activation nor in peak time of activation. HC – healthy,
MDD – major depression, Anx – anxiety disorder, DAC – depression-anxiety comorbidity40 PERCEPTION OF FACIAL EXPRESSIONS OF EMOTION
meta-analysis of functional brain activation to nega-
tive stimuli in depressed patients also failed to ﬁnd
amygdala hyperactivation [45]. In the studies that
did not observe diﬀerences in amygdala activation
between depressed patients and controls, the severity
of the depression was diverse (recovered: Norbury
et al. [44], moderate: Almeida et al. [42], Gotlib et al.
[40], severe: Lawrence et al. [41], Lee et al. [43]), as
was medication use (all unmedicated: Norbury et al.
[44], some medicated: Almeida et al. [42], Gotlib et al.
[40], Lee et al. [43], all medicated: Lawrence et al.
[41]). Nonetheless, the ﬁndings presented herein ﬁt
well and add to the aforementioned studies.
For severe depression, amygdala response showed
abnormalities in previous studies [8, 6, 36] and med-
ication may down-regulate the amygdala response
[8, 36, 41]. In our case, for mild-moderate depression,
with and without medication, no aberrant amygdala
activation was observed, whereas for a group of
patients with severe or moderate depression and
medication use, no aberrant amygdala response was
found by Lawrence et al. [41], Lee et al. [43], Almeida
et al. [42], Gotlib et al. [40]. Taken together, these
studies suggest that amygdala response is inﬂuenced
both by illness severity and medication and that
there is an interaction eﬀect between illness severity
and medication. Antidepressant may down-regulate
amygdala response in severe depressed patients, but
not in patients with mild-moderate illness severity.
This conclusion is supported by recent study [46]
reporting that antidepressants are associated with
reduced illness severity only in severe depression.
The fact that some studies do ﬁnd amygdala hyperacti-
vation and some do not may be due to methodological
factors such as task design (subliminal presentation of
emotional faces [8] or task demands, e.g., unattended
versus attend faces [7], passive viewing [6] and implicit
processing by asking for gender discrimination [40, 41].
Straube et al. [35] reported that implicit (photography
versus schematic faces) processing of angry facial
expression elicited signiﬁcantly larger amygdala activa-
tion in social phobics relative to control participants,
whereas explicit processing of angry faces elicited
larger amygdala activation in both groups. Because we
used an implicit or incidental facial aﬀect-processing
task where participants were not explicitly instructed
to pay attention to facial expressions, we cannot
exclude the possibility that participants may have
consciously processed facial expressions. Hence, in the
present study, the lack of signiﬁcant group diﬀerences
in amygdala activation to facial expressions may
partially be an eﬀect of the employed task, i.e., facial
expressions elicited amygdala hyperactivation in all
groups.
Analysis of the amygdala response shape to facial
expressions corroborated our ﬁndings that amygdala
activation was not abnormal in patient groups. Al-
though a comparatively early response of the left
and the right amygdala activation to fearful faces
was apparent in MDD patients (Figure 3.4), this
diﬀerence was not signiﬁcant compared with HC or
other patient groups. Two other studies did ﬁnd
a diﬀerence in amygdala response shape: sustained
amygdala activation in response to negative emotions
in seven depressed patients [10] and a delayed amyg-
dala response to angry, fearful and happy faces in
fourteen patients with generalised social phobia [13].
There are several factors which may contribute to
this discrepancy, for example sample heterogeneity
in terms of disease severity, the fact that patients in
those two studies were more severely aﬀected, but also
diﬀerences in the experimental design (words versus
pictures).
In the present study, there was no signiﬁcant cor-
relation between illness severity and the magnitude
of the amygdala response in outpatients. A positive
correlation between fusiform gyrus activation to
fearful and angry faces and depression severity was
observed in MDD outpatients. We suggest that this
pattern of activation to angry and fearful faces is
symptom-related in depression. In a previous study
[47] larger fusiform gyrus activation to sad faces was
reported in patients with severe depression compared
to healthy volunteers suggesting an attentional bias
toward sad emotion in major depression.
Contrary to our hypothesis, ventral striatum hy-
poactivation to happy faces was not observed in
MDD outpatients compared to HC. However, whereas
Surguladze et al. [47] and Lawrence et al. [41] reported
putamen hypoactivation in response to happy faces
in nineteen MDD patients relative to controls, other
authors [48, 49, 10] reported no signiﬁcant diﬀerences
in ventral striatum activation to positive stimuli in
depression, consistent with the present ﬁndings. A
possible explanation for these inconsistencies may be
the sample characteristics (severe versus mild depres-
sion, and sample size). Nevertheless, right putamen
hypoactivation in response to happy faces was observed
in Anx outpatients compared with HC. Activation of
the basal ganglia, including the ventral striatum and
putamen, in response to positive emotional stimuli
has been reported previously [32] suggesting its role in
reward-related processes [50]. Previously it has been
reported that decreased gray matter volume in the
right putamen is associated with anxiety severity in
panic disorder [51]. Abnormal putamen function may
be characteristic for anxiety disorders.
We did, however, observe right superior and middle3.4. Discussion 41
frontal gyrus hyperactivation in response to happy
(>scrambled) faces in MDD outpatients compared
to HC. Larger middle frontal gyrus, cingulate cortex
(BA32) activation to happy faces was also found in
unmedicated MDD outpatients relative to HC. We
suggest that this stronger activation for happy faces
may reﬂect increased attention to mood-incongruent
stimuli. Alternatively, it could be argued that MDD
patients suppress positive emotions, and suppression
of emotion has been shown to involve the right lateral
frontal cortex [52]. Consistent with this interpretation,
a recent meta-analysis of emotional reactivity in MDD
showed that reactivity to positive emotional stimuli
was even stronger reduced than reactivity to negative
stimuli [53]. Unmedicated MDD also showed medial
frontal gyrus hyperactivation in response to neutral
faces. Similar to the present study, Frodl et al. [54]
reported increased DLPFC during implicit emotional
processing and failure of deactivation of this region
during explicit emotional processing in patients with
depression. They suggested that depressed patients
activated this region more in order to meet task
demands.
Similar to MDD patients, unmedicated DAC patients
compared to HC showed dorsal ACC hyperactivation
to happy faces. The dorsal ACC activation has been
suggested to mediate conﬂicts between emotion and
cognition [55] and is associated with attentional pro-
cessing of emotional information [56]. Taken together,
we may conclude that dorsal PFC hyperactivation in
depressed outpatients with or without anxiety suggests
increased processing demands for mood-incongruent
stimuli.
Limitations and strengths: As was previously men-
tioned, the MDD patients included in the present
study had mild-to-moderate depression severity (34
depressed outpatients were in remission [MADRS
score<12 [57]], Appendix), which may have limited the
sensitivity of our design. Although we analysed the
potential contribution of medication status, this might
still be a confounder in the present study, as we did not
study type or medication dosage. A major strength
of the present study concerns the large sample size,
relative to previous studies, which lends conﬁdence to
the nontrivial suggestion that altered DLPFC function
is a key feature of the neurobiology of depression. In
conjunction with this, the sample analysed in this
study is likely to represent a community outpatient
population, the most prevalent community in mental
health care practice.
Conclusions: The present study demonstrates that
perception of facial expressions elicits a common
neural response in community outpatients with
mild-to-moderate depression and/or anxiety, and
healthy controls. The lack of group diﬀerences in
amygdala activation to emotional facial expressions
may be characteristic of a community-based sample of
outpatients with depression and/or anxiety. However,
we did observe diagnosis speciﬁc activations for MDD,
including dorsal PFC hyperactivation in response to
happy facial expressions, which may reﬂect increased
processing demands for mood-incongruent stimuli.
Antidepressant and illness severity may inﬂuence
amygdala response to emotional stimuli in major de-
pression. Moreover, medication use seems to inﬂuence
the neural response associated with cognitive control
of emotion in MDD and DAC outpatients.
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A Facial expressions of emotion
In addition to the main analysis presented in the main text, we tested for group diﬀerences during emotional
facial expressions (angry/fearful/happy/sad) relative to neutral faces. A four (condition: angry>neutral,
fearful>neutral, happy>neutral and sad>neutral) by four (groups: MDD, ANX, DAC and HC) repeated
measures ANCOVA was conducted with center (Amsterdam and Leiden as dummy variables), age and years of
education deﬁned as nuisance factors.
We observed increased right middle temporal gyrus activation in response to happy>neutral in HC compared
to ANX and DAC patients. No signiﬁcant diﬀerence was found between MDD and HC participants.
Amygdala temporal proﬁle – data analysis
The temporal prole of amygdala activation was investigated employing a region of interest (ROI) approach, using
an amygdala anatomical mask [29]. Beta values (HRF, TD and DD), for each subject, within each region, were
extracted using MarsBar [30]. The mean and standard deviation of the haemodynamic response shape within
each group and for each condition was reconstructed and plotted for visual inspection. Further, for each subject
and for each response curve the maximum amplitude and the corresponding time point of the peak amygdala
response were calculated in the haemodynamic response function and imported into SPSSv16.0. Group eﬀects
on these parameters were investigated with non-parametric tests (Kruskal-Wallis [H] and Mann-Whitney [U] as
post-hoc test).
Illness severity
Depression severity – Out of 59 outpatient diagnosed with major depression severity 39 were in remission (Mean
= 4.88 ± 3.93, MADRS score < 12 [57]). From DAC outpatients group 12 had a MADRS score < 12 (Mean =
8.67 ± 2.27).
Anxiety severity – Out of 57 outpatients diagnosed with anxiety disorders (PD and/or SP, and GAD), 45 had a
BAI score < 21 (Mean = 9.91 ± 5.49), 7 had moderate trait anxiety (22 < BAI score < 35: Mean = 25.29 ±
2.75) and four had BAI score > 36. 44 outpatients diagnosed with depression and anxiety comorbidity (DAC)
had low trait anxiety (BAI score < 21, Mean = 13.61 ± 5.38), 19 had moderate trait anxiety (22 < BAI score
< 35, Mean = 26.21 ± 3.73) and 2 had high trait anxiety (BAI score > 36).44 PERCEPTION OF FACIAL EXPRESSIONS OF EMOTION
Table A.1: Signiﬁcant brain areas activation in each group in response to viewing facial expressions
(compared with scrambled faces). MNI coordinates, p<0.05 FWE. R – right hemisphere, L – left
hemisphere, k – cluster size in voxels.
Group Facial expression Region Side Coordinate Z-value
x y z
HC all faces>scrambled fusiform gyrus R 39 -48 -24 >8
amygdala L -18 -6 -15 4.78
angry>scrambled fusiform gyrus R 39 -48 -21 6.60
fearful>scrambled fusiform gyrus R 39 -48 -24 7.80
amygdala L -18 -9 -15 5.32
happy>scrambled fusiform gyrus R 39 -51 -21 >8
fusiform gyrus L -39 -60 -18 5.15
neutral>scrambled fusiform gyrus R 39 -48 -24 7.06
sad>scrambled fusiform gyrus R 39 -48 -24 7.58
emotional faces>neutral middle temporal gyrus L -57 -60 3 4.92
precentral gyrus R 42 -18 54 4.87
MDD all faces>scrambled fusiform gyrus R 39 -48 -21 >8
L -39 -51 -21 5.50
amygdala L -21 -9 -15 5.55
R 18 -9 -18 5.49
angry>scrambled fusiform gyrus R 39 -48 -21 7.23
amygdala L -21 -6 -15 4.93
fearful>scrambled fusiform gyrus R 39 -48 -21 7.63
L -42 -54 -21 4.93
amygdala L -21 -9 -15 6.46
R 21 -9 -15 5.67
happy>scrambled fusiform gyrus R 39 -45 -21 >8
L -42 -54 -21 6.12
medial frontal gyrus R 21 33 30 5.72
postcentral gyrus R 45 -21 54 5.06
neutral>scrambled fusiform gyrus R 39 -48 -21 7.74
amygdala R 21 -9 -18 5.22
L -21 -9 -15 4.49
sad>scrambled fusiform gyrus R 39 -54 -21 7.25
L -39 -51 -21 5.07
amygdala R 18 -9 -15 5.31
emotional faces>neutral postcentral gyrus R 45 -24 54 5.33
Anx all faces>scrambled fusiform gyrus R 39 -54 -21 7.39
angry>scrambled fusiform gyrus R 39 -51 -21 6.01
fearful>scrambled fusiform gyrus R 39 -54 -21 6.04
happy>scrambled fusiform gyrus R 39 -54 -21 >8
neutral>scrambled fusiform gyrus R 39 -48 -21 6.28
sad>scrambled fusiform gyrus R 39 -54 -21 6.41
emotional faces>neutral – – – –
DAC all faces>scrambled fusiform gyrus R 39 -51 -21 >8
L -42 -54 -21 5.74
amygdala R 21 -9 -15 4.87
angry>scrambled fusiform gyrus R 39 -51 -21 >8
L -39 -51 -21 5.07
fearful>scrambled fusiform gyrus R 39 -51 -21 >8
L -39 -51 -21 5.76
amygdala R 21 -6 -15 5.68
happy>scrambled fusiform gyrus R 39 -51 -21 >8
L -39 -78 -12 5.71
neutral>scrambled fusiform gyrus R 39 -51 -21 >8
amygdala R 21 -9 -15 4.62
sad>scrambled fusiform gyrus R 39 -51 -21 >8
L -42 -54 -21 5.51
inferior frontal gyrus R 48 24 21 5.26
emotional faces>neutral – – – –
Note: HC – healthy participants, MDD – patients with major depression disorder, Anx – patients with anxiety disorders,
DAC – patients with depression-anxiety comorbidity.A. Facial expressions of emotion 45
Table A.2: Anatomical regions showing an eﬀect of illness severity. MNI coordinates, p<0.001 uncor-
rected. R – right hemisphere, L – left hemisphere, k – cluster size in voxels.
Group / Measure Region Side Coordinate Z-value k p corrected
Condition x y z cluster–level
MDD
angry > scrambled MADRS Lingual gyrus L -9 -72 -9 4.17 318 <0.005
MADRS Fusiform gyrus L -18 -45 -12 4.03 59 0.025
fearful > scrambled MADRS Fusiform gyrus L -24 -75 -6 3.97 53 0.031
Anx
happy > scrambled BAI Insula L -36 -12 15 4.58 70 0.011
BAI Angular gyrus R 42 -60 36 3.61 80 0.006
MADRS Superior Temporal gyrus R 51 -12 -9 3.96 61 0.020
Note: : MDD – major depression, Anx – anxiety disorder, MADRS – Montgomery-˚ Asberg Depression Rating Scale; BAI
– Beck Anxiety Inventory.
Table A.3: Psychometric measures of medicated and unmedicated patients. Mean (standard deviation).
Group MADRS BAI FQ
Anx
med. (n=18) 11.28 (9.16) 11.44 (8.07) 35.56 (22.60)
unmed (n=39) 9.63 (10.80) 13.00 (16.26) 29.18 (24.35)
DAC
med. (n=30) 19.43 (7.09) 17.60 (8.56) 38.80 (21.06)
unmed. (n=36) 19.64 (9.42) 18.06 (9.20) 31.89 (20.16)
MDD
med. (n=14) 13.71 (7.22) 10.57 (7.55) 23.29 (16.39)
unmed. (n=45) 10.34 (8.99) 5.38 (11.73) 17.38 (15.26)
Note: : MADRS – Montgomery-˚ Asberg Depression Rating Scale; BAI – Beck Anxiety Inventory, FQ – Fear
Questionnaire, MDD – major depression, Anx – anxiety disorder, DAC – depression-anxiety comorbidity, med –
medication users, unmed – medication free.46 PERCEPTION OF FACIAL EXPRESSIONS OF EMOTION
References
[1] I H Gotlib and P J Hamilton. Neuroimaging and
depression. Association for Psychological Science,
17(2):159 – 163, 2008.
[2] R M A Hirschfeld. The Comorbidity of Major De-
pression and Anxiety Disorders: Recognition and
Management in Primary Care. Prim Care Com-
panion J Clin Psychiatry, 3(6):244–254, Dec 2001.
[3] M B Stein, M E Tancer, C S Gelernter, B J Vit-
tone, and T W Uhde. Major depression in patients
with social phobia. Am J Psychiatry, 147(5):637–
639, May 1990.
[4] S J Bishop. Neurocognitive mechanisms of anxiety:
an integrative account. Trends Cogn Sci, 11(7):
307–316, Jul 2007.
[5] P B Fitzgerald, A R Laird, J Maller, and Z J
Daskalakis. A meta-analytic study of changes in
brain activation in depression. Hum Brain Mapp,
29(6):736, Jun 2008.
[6] A Anand, Y Li, Y Wang, J Wu, S Gao, L Bukhari,
V P Mathews, A Kalnin, and M J Lowe. Ac-
tivity and connectivity of brain mood regulating
circuit in depression: a functional magnetic reso-
nance study. Biol Psychiatry, 57(10):1079–1088,
May 2005.
[7] C L Fales, D M Barch, M M Rundle, M A Mintun,
A Z Snyder, J D Cohen, J Mathews, and Y I She-
line. Altered emotional interference processing in
aﬀective and cognitive-control brain circuitry in
major depression. Biol Psychiatry, 63(4):377–384,
Feb 2008.
[8] Y I Sheline, D M Barch, J M Donnelly, J M
Ollinger, A Z Snyder, and M A Mintun. In-
creased amygdala response to masked emotional
faces in depressed subjects resolves with antide-
pressant treatment: an fMRI study. Biol Psychia-
try, 50(9):651–658, Nov 2001.
[9] J B Savitz and W C Drevets. Imaging phenotypes
of major depressive disorder: genetic correlates.
Neuroscience, 164(1):300–330, Nov 2009.
[10] G J Siegle, S R Steinhauer, M E Thase, V A
Stenger, and C S Carter. Can’t shake that feel-
ing: event-related fMRI assessment of sustained
amygdala activity in response to emotional infor-
mation in depressed individuals. Biol Psychiatry,
51(9):693–707, May 2002.
[11] J Epstein, H Pan, J H Kocsis, Y Yang, T Butler,
J Chusid, H Hochberg, J Murrough, E Strohmayer,
E Stern, and D A Silbersweig. Lack of ventral
striatal response to positive stimuli in depressed
versus normal subjects. Am J Psychiatry, 163(10):
1784–1790, 2006.
[12] M B Stein, P R Goldin, J Sareen, L T Eyler Zor-
rilla, and G G Brown. Increased amygdala activa-
tion to angry and contemptuous faces in general-
ized social phobia. Arch Gen Psychiatry, 59(11):
1027–1034, Nov 2002.
[13] D W Campbell, J Sareen, M P Paulus, P R Goldin,
M B Stein, and J P Reiss. Time-varying amygdala
response to emotional faces in generalized social
phobia. Biol Psychiatry, 62(5):455–463, Sep 2007.
[14] A Etkin and T D Wager. Functional neuroimaging
of anxiety: a meta-analysis of emotional process-
ing in PTSD, social anxiety disorder, and speciﬁc
phobia. Am J Psychiatry, 164(10):1476–1488, Oct
2007.
[15] R E Cooney, L Y Atlas, J Joormann, F Eugne,
and I H Gotlib. Amygdala activation in the pro-
cessing of neutral faces in social anxiety disorder:
is neutral really neutral? Psychiatry Res, 148(1):
55–59, Nov 2006.
[16] N Birbaumer, W Grodd, O Diedrich, U Klose,
M Erb, M Lotze, F Schneider, U Weiss, and
H Flor. fMRI reveals amygdala activation to hu-
man faces in social phobics. Neuroreport, 9(6):
1223–1226, Apr 1998.
[17] T Straube, H J Mentzel, and W H R Miltner. Com-
mon and distinct brain activation to threat and
safety signals in social phobia. Neuropsychobiol-
ogy, 52(3):163–168, 2005.
[18] H S Mayberg. Limbic-cortical dysregulation: a
proposed model of depression. J Neuropsychiatry
Clin Neurosci, 9(3):471–481, 1997.
[19] M L Phillips, W C Drevets, S L Rauch, and
R Lane. Neurobiology of emotion perception II:
Implications for major psychiatric disorders. Biol
Psychiatry, 54(5):515–528, Sep 2003.
[20] B W J H Penninx, A T F Beekman, J H Smit,
F G Zitman, W A Nolen, P Spinhoven, P Cui-
jpers, P J De Jong, H W J Van Marwijk, W J J
Assendelft, K Van Der Meer, P Verhaak, M Wens-
ing, R De Graaf, W J Hoogendijk, J Ormel, R Van
Dyck, and N. E. S. D. A. Research Consortium.REFERENCES 47
The Netherlands Study of Depression and Anxi-
ety (NESDA): rationale, objectives and methods.
Int J Methods Psychiatr Res, 17(3):121–140, 2008.
[21] American Psychiatric Association. Diagnostic and
Statistical Manual of Mental Disorders, 4th edi-
tion. American Psychiatric Association, 1994.
[22] G Andrews and L Peters. The psychometric prop-
erties of the Composite International Diagnostic
Interview. Soc Psychiatry Psychiatr Epidemiol, 33
(2):80–88, Feb 1998.
[23] S A Montgomery and M ˚ Asberg. A new depres-
sion scale designed to be sensitive to change. Br J
Psychiatry, 134:382–389, Apr 1979.
[24] A T Beck, N Epstein, G Brown, and R A Steer.
An inventory for measuring clinical anxiety: psy-
chometric properties. J Consult Clin Psychol, 56
(6):893–897, Dec 1988.
[25] I M Marks and A M Mathews. Brief standard self-
rating for phobic patients. Behav Res Ther, 17(3):
263–267, 1979.
[26] S P A Wolfensberger, D J Veltman, W J G
Hoogendijk, D I Boomsma, and E J C de Geus.
Amygdala responses to emotional faces in twins
discordant or concordant for the risk for anxiety
and depression. Neuroimage, 41(2):544–552, Jun
2008.
[27] D Lundqvist, A Flykt, and A Ohmann. The
Karolinska Directed Emotional Faces (KDEF).
Karolinska Institute, Stockholm, 1998.
[28] K J Friston, P Fletcher, O Josephs, A Holmes,
M D Rugg, and R Turner. Event-related fMRI:
characterizing diﬀerential responses. Neuroimage,
7(1):30–40, Jan 1998.
[29] S J M C Palmen, S Durston, H Nederveen, and
H Van Engeland. No evidence for preferential in-
volvement of medial temporal lobe structures in
high-functioning autism. Psychol Med, 36(6):827–
834, Jun 2006.
[30] M Brett, J L Anton, R Valabregue, and J B Poline.
Region of interest analysis using an SPM toolbox.
In Presented at the 8th International Conference
on Functional Mapping of the Human Brain, vol-
ume 16. NeuroImage, June 2002.
[31] M J Muller, A Szegedi, H Wetzel, and O Benkert.
Moderate and severe depression. gradations for the
Montgomery-Asberg Depression Rating Scale. J
Aﬀect Disord, 60(2):137–140, Nov 2000.
[32] K L Phan, T Wager, S F Taylor, and I Liber-
zon. Functional neuroanatomy of emotion: a meta-
analysis of emotion activation studies in PET and
fMRI. Neuroimage, 16(2):331–348, Jun 2002.
[33] Haxby, Hoﬀman, and Gobbini. The distributed
human neural system for face perception. Trends
Cogn Sci, 4(6):223–233, Jun 2000.
[34] M L Gorno-Tempini, S Pradelli, M Seraﬁni,
G Pagnoni, P Baraldi, C Porro, R Nicoletti,
C Umit, and P Nichelli. Explicit and incidental
facial expression processing: an fMRI study. Neu-
roimage, 14(2):465–473, Aug 2001.
[35] T Straube, I T Kolassa, M Glauer, H J Mentzel,
and W H R Miltner. Eﬀect of task conditions
on brain responses to threatening faces in social
phobics: an event-related functional magnetic res-
onance imaging study. Biol Psychiatry, 56(12):
921–930, Dec 2004.
[36] C H Y Fu, S C R Williams, A J Cleare, M J Bram-
mer, N D Walsh, J Kim, C M Andrew, E Merlo
Pich, P M Williams, L J Reed, M T Mitter-
schiﬀthaler, J Suckling, and E T Bullmore. At-
tenuation of the neural response to sad faces in
major depression by antidepressant treatment: a
prospective, event-related functional magnetic res-
onance imaging study. Arch Gen Psychiatry, 61
(9):877–889, Sep 2004.
[37] C L Fales, D M Barch, M M Rundle, M A Mintun,
J Mathews, A Z Snyder, and Y I Sheline. An-
tidepressant treatment normalizes hypoactivity in
dorsolateral prefrontal cortex during emotional in-
terference processing in major depression. J Aﬀect
Disord, 112(1-3):206–211, Jan 2009.
[38] M P Paulus. The role of neuroimaging for the diag-
nosis and treatment of anxiety disorders. Depress
Anxiety, 25(4):348–356, 2008.
[39] K Engel, B Bandelow, O Gruber, and D Wedekind.
Neuroimaging in anxiety disorders. J Neural
Transm, 116(6):703–716, 2009.
[40] I H Gotlib, H Sivers, J D E Gabrieli, S Whitﬁeld-
Gabrieli, P Goldin, K L Minor, and T Canli. Sub-
genual anterior cingulate activation to valenced
emotional stimuli in major depression. Neurore-
port, 16(16):1731–1734, Nov 2005.
[41] N S Lawrence, A M Williams, S Surguladze, V Gi-
ampietro, M J Brammer, C Andrew, S Frangou,
C Ecker, and M L Phillips. Subcortical and ven-
tral prefrontal cortical neural responses to facial48 PERCEPTION OF FACIAL EXPRESSIONS OF EMOTION
expressions distinguish patients with bipolar dis-
order and major depression. Biol Psychiatry, 55
(6):578–587, Mar 2004.
[42] J R C Almeida, A Versace, S Hassel, D J Kupfer,
and M L Phillips. Elevated amygdala activity to
sad facial expressions: a state marker of bipolar
but not unipolar depression. Biol Psychiatry, 67
(5):414–421, 2010.
[43] B T Lee, J H Seok, B C Lee, S W Cho, B J Yoon,
K U Lee, J H Chae, I G Choi, and B J Ham. Neu-
ral correlates of aﬀective processing in response to
sad and angry facial stimuli in patients with major
depressive disorder. Prog Neuropsychopharmacol
Biol Psychiatry, 32(3):778–785, Apr 2008.
[44] R Norbury, S Selvaraj, M J Taylor, C Harmer, and
P J Cowen. Increased neural response to fear in pa-
tients recovered from depression: a 3T functional
magnetic resonance imaging study. Psychol Med,
pages 1–8, 2009.
[45] E K Diekhof, P Falkai, and O Gruber. Functional
neuroimaging of reward processing and decision-
making: a review of aberrant motivational and af-
fective processing in addiction and mood disorders.
Brain Res Rev., 59(1):164–184, 2008.
[46] J C Fournier, R J DeRubeis, S D Hollon, S Dimid-
jian, J D Amsterdam, R C Shelton, and J Fawcett.
Antidepressant drug eﬀects and depression sever-
ity. a patient-level meta-analysis. JAMA, 303:47–
53, 2010.
[47] S Surguladze, M J Brammer, P Keedwell, V Gi-
ampietro, A W Young, M J Travis, S C R
Williams, and M L Phillips. A diﬀerential pattern
of neural response toward sad versus happy facial
expressions in major depressive disorder. Biol Psy-
chiatry, 57(3):201–209, Feb 2005.
[48] R J Davidson, W Irwin, M J Anderle, and N H
Kalin. The neural substrates of aﬀective processing
in depressed patients treated with venlafaxine. Am
J Psychiatry, 160(1):64–75, Jan 2003.
[49] R Elliott, J S Rubinsztein, B J Sahakian, and R J
Dolan. The neural basis of mood-congruent pro-
cessing biases in depression. Arch Gen Psychiatry,
59(7):597–604, Jul 2002.
[50] R Elliott, K J Friston, and R J Dolan. Dissocia-
ble neural responses in human reward systems. J
Neurosci, 20(16):6159–6165, Aug 2000.
[51] H K Yoo, M J Kim, S J Kim, Y H Sung, M E
Sim, Y S Lee, S Y Song, B S Kee, and I K Lyoo.
Putaminal gray matter volume decrease in panic
disorder: an optimized voxel-based morphometry
study. Eur J Neurosci, 22:2089–2094, 2005.
[52] B E Depue, T Curran, and M T Banich. Prefrontal
regions orchestrate suppression of emotional mem-
ories via a two-phase process. Science, 317:215–
219, 2007.
[53] L M Bylsma, B H Morris, and J Rottenberg. A
meta-analysis of emotional reactivity in major de-
pressive disorder. Clin Psychol Rev., 28(4):676–
691, 2008.
[54] T Frodl, J Scheuerecker, J Albrecht, A M Klee-
mann, S Mller-Schunk, N Koutsouleris, H J Mller,
H Brckmann, and M Wiesmannand E Meisenzahl.
Neuronal correlates of emotional processing in pa-
tients with major depression. World J Biol Psy-
chiatry, 10(3):202–208, 2009.
[55] R J Davidson. Handbook of Aﬀective Sciences (Se-
ries in Aﬀective Science). Oxford University Press,
USA, 2002. ISBN 0195126017.
[56] K McRae, E M Reiman, C L Fort, and K Chenand
R D Lane. Association between trait emotional
awareness and dorsal anterior cingulate activity
during emotion is arousal-dependent. Neuroimage,
41(2):648–655, 2008.
[57] M Zimmerman, M A Posternak, and I Chelmin-
ski. Derivation of a deﬁnition of remission on the
Montgomery-Asberg depression rating scale cor-
responding to the deﬁnition of remission on the
Hamilton rating scale for depression. J Psychiatr
Res, 38(6):577–582, 2004.Chapter4
Amygdala activation during emotional
evaluation of words in anxiety disorders and
depression
L.R. Demenescu 1, R. Kortekaas 1, R.J. Renken 1, M.J. van Tol 2,
N. van der Wee 2, D.J. Veltman 3, J.A. den Boer 4, A. Aleman 1
1Neuroimaging Center, Department of Neuroscience, University Medical Center Groningen
University of Groningen, The Netherlands
2Department of Psychiatry, Leiden University Medical Center and
Leiden Institute of Brain and Cognition, University of Leiden, The Netherlands
3Department of Psychiatry, Amsterdam Vrije University Medical Center, The Netherlands
4Department of Psychiatry, University Medical Center Groningen, The Netherlands
submitted
Abstract
Background: Anxiety disorders and depression are characterized by increased emotional reactivity that has been as-
sociated with amygdala hyperactivation. However, few studies have examined the neural response during processing of
emotional words in patients with anxiety disorders and depression, and ﬁndings have been inconsistent. We hypothesized
increased amygdala activation to words evaluated as negative by anxious and depressed patients.
Method: Outpatients and healthy controls were recruited from the Netherlands Study of Depression and Anxiety. Sixty
outpatients with anxiety disorders, 65 outpatients with depression, 77 outpatients with comorbid depression and anxiety
and 57 healthy controls rated the emotional valence of words in an event-related functional magnetic resonance imaging
(fMRI) task.
Results: Anxiety patients showed elevated right amygdala activation in response to negatively evaluated (>neutral)
words. Depressed patients with or without anxiety comorbidity showed no signiﬁcant diﬀerences in response to emotional
words relative to healthy controls. A positive association between amygdala activation to negative (>neutral) words and
MADRS score was found in depressed patients.
Conclusions: The present ﬁndings indicate that comorbid depression and anxiety cannot to be regarded as a simple
summation of depression and anxiety. Our ﬁndings also support the hypothesis of aberrant amygdala activation during the
processing of emotional words in anxiety disorders. In depression aberrant amygdala activation is associated with illness
severity.
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4.1 Introduction
Aﬀective disorders such as anxiety disorders and
depression have a high incidence in the general popu-
lation and are both characterized by dysregulation of
emotional processing [1]. In addition, depression and
anxiety disorders are frequently comorbid in primary
care [2].
Neuropsychological studies have reported anxiety dis-
orders to be associated with an information-processing
bias [3], and depression to be associated with a nega-
tive attentional bias to mood-congruent stimuli (sad
faces) [4, 5]. Hence, anxiety is associated with a fast
attentional bias, whereas depression is characterized by
a later, strategic bias [4]. These biases may result from
abnormal perceptual processing, such as enhanced
attention toward emotionally relevant stimuli [6]. At
the neural level, this bias may be associated with
hyperactivation of the amygdala [6], a key structure in
perceptual value judgments and generating emotional
responses.
In healthy participants, functional neuroimaging
studies have highlighted the role of the amygdala
during explicit emotional evaluation Lee and Siegle [7].
While most studies have employed graphical stimuli,
e.g., emotional facial expressions and pictures from
the International Aﬀective Picture System, amygdala
activation has also been observed in response to
semantic stimuli (see for a review Sergerie et al. [8]).
For example, Maddock et al. [9] and Tabert et al.
[10] reported amygdala hyperactivation in response to
negative words, but Hamann and Mao [11] observed
amygdala hyperactivation to negative as well as
positive words. A potential advantage of semantic
stimuli is that the set from which they can be taken
is very large, thereby circumventing the problem of
rapid habituation of the amygdala due to stimulus
repetition, which is diﬃcult to avoid when using
standardized picture sets. In addition, emotional
signals, transmitted either visually or verbally, play an
important role in human experience and behavior.
Abnormalities in detecting, interpreting and reacting
to emotional stimuli characterize many forms of
psychopathology. In patients with anxiety disorders
and depression, limbic structures – including the
amygdala – have been reported to show aberrant
activation during emotion processing [12, 13]. Pre-
vious studies in patients with anxiety disorders have
reported increased amygdala activation in response
to emotional pictures and in anticipation of aversive
stimuli, compared to healthy participants [14, 15, 16].
A recent meta-analysis of functional neuroimaging
studies [17] conﬁrmed the involvement of amygdala in
anxiety disorders. It should be noted, however, that
several studies failed to ﬁnd abnormalities in amygdala
activation in anxiety disorders [18, 19] and depression
[20, 21].
In depression, an increased amygdala activation, as
compared to the pattern in healthy controls, has been
reported in response to personally relevant words,
suggesting increased emotional reactivity [22, 23].
However, other studies using emotional words did
not ﬁnd signiﬁcantly increased amygdala activation
to negative words in depressed patients, relative to
healthy participants [20, 21].
To a large extent, these inconsistencies in the ﬁndings
in these aﬀective disorders may be explained by task
diﬀerences, e.g., conscious or masked forms of emo-
tional processing. In a recent meta-analysis [7], it has
been suggested that ”the amygdala is [only] involved in
the initial emotional processing of explicit evaluation”
which may also be relevant for explaining incongruent
ﬁndings. Furthermore, diﬀerences in medication status
may have confounded previous results, since it has
been reported that antidepressants may normalize
amygdala response to emotional stimuli in patients
with depression [12].
In our text dominated society, words are a common
vehicle for emotional communication, of similar
importance as facial expressions [24]. Remarkably,
so far only a few studies have examined the neural
response during emotional evaluation of words in
patients with depression and/or anxiety disorders. In
the present study, we aimed to investigate to what
extent the amygdala is involved in processing word
valence in patients diagnosed with anxiety disorders
(Anx) and/or major depressive disorder (MDD)
compared to healthy controls (HC), using functional
magnetic resonance imaging (fMRI). Patients with
depression–anxiety comorbidity (DAC) were included
in order to determine whether the comorbid state
can be conceptualized as a summation of depression
and anxiety. We hypothesized that MDD and/or
Anx patients would both exhibit increased amygdala
activation to negatively evaluated words. In response
to positive words we assumed that depressed and
anxious patients would have less amygdala activation.
At the behavioral level, we expected that MDD,
Anx and DAC patients would categorize more words
as negative. Finally, we predicted that the use of
medication in depressed and/or anxiety patients would
attenuate diﬀerences in amygdala activation.4.2. Methods and Materials 51
4.2 Methods and Materials
4.2.1 Participants
Participants included in the present study were
selected from the Netherlands Study on Depression
and Anxiety (NESDA, [25]), a multicenter, longitu-
dinal cohort study. Three centers were involved in
this project: University Medical Center Groningen
(UMCG), Amsterdam Medical Center (AMC) and
Leiden University Medical Center (LUMC). The
study was approved by the Ethical Review Boards
of each participating center. Prior to the scanning
procedure, written informed consent was obtained
from every participant. All participants were native
Dutch speakers.
Inclusion criteria – Patients: (1) a Diagnostic and
Statistical Manual of Mental Disorders fourth edition
(DSM-IV) diagnosis of major depressive disorder
(MDD) and/or anxiety (social anxiety disorder [SAD]
and/or panic disorder with or without Agoraphobia
[PD] and general anxiety disorder [GAD] which was
not an exclusion criterion) within the last six months
prior to the interview, (2) a conﬁrmation of the
diagnosis with the Composite International Diagnosis
Interview - lifetime version 2.1 [26] conducted by
trained clinical staﬀ. Controls: (1) did not meet
the criteria for a DSM-IV diagnosis, no current and
lifetime DSM-IV diagnosis, (2) conﬁrmed absence of
diagnosis as above. In all cases, diagnostic assessment
took place approximately two months prior to the
scanning. Participants were recruited from diﬀerent
health care settings: community, primary care and
specialised mental health care.
Exclusion criteria – (1) a diagnosis other than MDD,
SAD, PD, or GAD on axis I disorders or a history
of bipolar disorders, (2) current alcohol or substance
abuse, (3) a history of major neurological disorder,
(4) current use of psychotropic medication other than
stable use of SSRIs or infrequent benzodiazepines, i.e.,
equivalent to 2 x 10 mg oxazepam three times a week
or use within 48 hours prior to scanning, (5) older
than 57 years and (6) MRI incompatible implants or
tattoos.
Of the subjects participating in this MRI study,
overall, 34 subjects were excluded from the analysis
because of technical problems during scanning, poor
image quality, or excessive head movement (more
than 3 mm on any axis). Our ﬁnal sample consisted
of 60 outpatients with anxiety disorders (Anx), 65
outpatients with major depression disorder (MDD), 77
outpatients with depression and anxiety comorbidity
(DAC) and 57 healthy controls (HC). Regarding the
Anx group, 73.3% had a diagnosis of SAD, 28.3%
had PD without Agoraphobia, 31.7% had PD with
Agoraphobia and 23.3% had additionally GAD. In the
comorbid depression and anxiety group, besides MDD
diagnosis present in all these patients, co-occurrence of
anxiety diagnosis is as follows: 53.2% had a diagnosis
of SAD, 16.9% had PD without Agoraphobia, 33.8%
had PD with Agoraphobia and 61% had additionally
GAD. Fourteen MDD, 16 Anx and 23 DAC patients
were using medication at the time of the study.
Symptom severity was assessed on the scanning day
using the Montgomery-˚ Asberg Depression Rating Scale
(MADRS, [27]), the self-rated Beck Anxiety Inventory
(BAI, [5]) and the Fear Questionnaire (FQ, [28]).
4.2.2 Stimuli and paradigm
We employed an event-related fMRI design with verbal
stimuli displayed using E-prime software (Psycholog-
ical Software Tools, Pittsburgh, PA, USA) during
the scanning session. The stimuli were projected
on a transparent screen at the end of the scanner
bed, visible through a mirror above the participant’s
head. Instructions were presented on the screen at the
beginning of the task. A response button device was
positioned near the right hand of the participant.
The stimuli consisted of 120 study words [29] and
40 control words. Stimuli were presented pseudo-
randomly in 20 blocks of eight words, each block
consisting of two negative words, two positive words,
two neutral words and two control words. The task
was paced by the participants, but words were never
displayed for longer than 5 s. During each stimulus,
response options were indicated at the bottom of the
screen. For the study words participants were re-
quested to evaluate the emotional valence of the word.
The study words were divided in three categories: 40
positive, 40 neutral and 40 negative, and matched
for length (ranging from three to twelve letters)
and frequency of occurrence in the Dutch language.
Participants pressed the left button with the index
ﬁnger if they evaluated the word as being positive, the
middle button with the middle ﬁnger if the word was
judged as neutral or the right button with the ring
ﬁnger if the word was assessed as negative.
The control condition was chosen based on earlier
research by Stark and Squire [30] indicating that an
unconstrained rest condition may not be an optimal
baseline condition because of reﬂective mental pro-
cesses. The 40 control words were ”left”, ”middle” and
”right” (in Dutch) and participants were instructed to
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4.2.3 fMRI data acquisition
Image acquisition was performed in all three centers
(UMCG, LUMC and AMC) on a 3 Tesla Philips
MR– scanner. Volumes of 39 slices at UMCG and 35
slices at LUMC and AMC, acquired parallel to the
anterior commissure – posterior commissure plane (3
mm thickness, no gap, in plane resolution 3x3 mm
at UMCG and 2.29x2.29 mm at AMC and LUMC,
matrix size: 64x64 at UMCG and 92x92 at AMC and
LUMC), were obtained using a T2*-weighted gradient
echo sequence (TR=2300 ms, TE=28 ms at UMCG
and TE=30 ms at LUMC and AMC) sensitive to blood
oxygenation level dependent (BOLD) eﬀect. A high-
resolution anatomical scan was obtained with a sagittal
3D gradient-echo T1-weighted sequence (TR=9 ms,
TE=3.5 ms, matrix 256x256, voxel size 1x1x1 mm, 170
slices).
4.2.4 Preprocessing
Imaging data analysis was conducted using SPM5 (Sta-
tistical Parametric Mapping; Welcome Department of
Cognitive Neurology, London, UK) software imple-
mented in Matlab v.7.1 (The MathWorks Inc., MA,
USA). The time series were corrected for diﬀerences
in slice acquisition time and spatially realigned. The
structural T1 image was co-registered to the mean
EPI obtained after realignment. Subsequently, T1 and
EPIs were spatially normalized into standard Montreal
Neurological Institute (MNI) stereotactic space and re-
sampled to a 3x3x3 mm voxel size. Finally, the EPI
volumes were smoothed using an 8 mm full-width at
half maximum Gaussian kernel.
4.2.5 Statistical analysis
Voxel-wise ﬁxed-eﬀects contrast images were calculated
at the single subject level. Event-related responses
were convolved with a canonical hemodynamic re-
sponse function (modulated by reaction times) and its
time and dispersion derivatives [31]. Positive, negative
and neutral words were classiﬁed according to each
subject’s evaluation. Control words were implicitly
modeled in the design. For each subject, weighted
contrasts were computed for ”positive>neutral words”
and ”negative>neutral words”. The resulting contrast
images were entered into a second level analysis em-
ploying repeated measures 4 (groups) by 2 (contrast:
positive>neutral and negative>neutral words) analysis
of covariance (ANCOVA), with centers (dummy vari-
ables), age and years of education included as nuisance
factors. The main eﬀects are reported at p<0.05
with family–wise error (FWE) correction for multiple
comparisons, whereas group diﬀerences were inspected
at p<0.001 uncorrected and the reported clusters are
those surviving a corrected cluster–level. Because the
amygdala was of special interest in the present study,
a small volume correction using a bilateral anatomical
amygdala mask deﬁned with WFU-pickatlas [32] was
applied (SVC, p<0.05 FWE).
In addition, we repeated the random eﬀect analysis
testing for group diﬀerences, in order to determine
possible medication eﬀects. In this later analysis we
included 126 medication free patients (44 MDD, 40
Anx and 42 DAC) and 56 HC. We further examined,
diﬀerences between unmedicated and medicated
patients within each patient group.
Lastly, voxel-wise regression analyses between the
symptoms severity and the neural response during
emotional evaluation of words were conducted us-
ing multiple regression analysis with a threshold of
p<0.001 uncorrected and the clusters surviving the
threshold p<0.05 corrected at cluster-level are re-
ported. This analysis was performed for the contrasts
”positive>neutral” and ”negative>neutral” words
within each patient groups (MDD, Anx and DAC)
with center, age and years of education included as
nuisance factors. Due to missing data of MADRS, BAI
or FQ scores, some patients (four MDD, eleven Anx
and fourteen DAC) were excluded from this analysis.
Behavioral data analyses (emotional categorization of
words and reaction time) were conducted using re-
peated measures ANOVA (SPSS v.16.0) with group as
between-subject factor and valence (positive, negative
and neutral words categorization) or reaction time
(RT) as within-subjects factors.
4.3 Results
4.3.1 Characteristics of the samples
and behavioral data
Demographic and clinical data are listed in Table 4.1.
Groups did not diﬀer on gender (χ
2(3,259)=2.618,
p=0.454) and handedness (χ
2(3,259)=3.750, p=0.710).
Groups diﬀered with regard to age (F[3,255]=2.720,
p<0.05) and years of education (F[3,255]=7.231,
p<0.001). Post-hoc Bonferroni tests showed that HC
were signiﬁcantly older than Anx patients (p<0.05).
Also, HC had signiﬁcantly more years of education
than MDD and DAC patients (p<0.05). Signiﬁcant
diﬀerences were found on illness severity (MADRS,
BAI and FQ scores) between HC and patient groups
(all p<0.05). Regarding diﬀerences on illness severity
between patient groups, the DAC patients scored4.3. Results 53
Table 4.1: Demographic and clinical characteristics of the samples (n represents the number of partici-
pants). Mean and standard deviation (S.D.) are given. MDD – major depressive disorder, Anx – anxiety
disorders, DAC – depression and anxiety comorbidity, HC – healthy controls.
MDD Anx DAC HC
(n=65) (n=60) (n=77) (n=57)
Mean age (S.D.) 36.29 (10.26) 35.35 (9.49) 36.87 (10.81) 40.40 (10.07)
Mean years of education (S.D.) 12.51 (2.84) 12.88 (3.30) 11.86 (3.29) 14.32 (2.76)
Female (%) 64.6 74.6 68.8 61.4
Right handed (%) 90.8 91.7 92.2 91.2
SSRIs users (%) 32.30 33.33 44.15 0.00
Mean MADRS (S.D.) 13.14 (9.03)** 10.17 (8.38)** 19.69 (8.76)** 1.35 (2.38)
Mean BAI (S.D.) 8.67 (8.29)** 13.48 (9.14)* 17.80 (8.84)* 2.46 (2.89)
Mean FQ (S.D.) 21.05 (15.28)* 35.14 (20.51) 36.17 (18.30)* 8.77 (7.39)
Note: *p<0.05, **p<0.005.
signiﬁcantly higher on MADRS and BAI relative to
MDD and Anx (all p<0.05) and on FQ relative to
MDD (p<0.05).
Categorization results and reaction times for each
group are summarized in Table 4.2. No signif-
icant group eﬀect was found for reaction time
(negative words: F[3,255]=0.783, p=0.504, pos-
itive words: F[3,255]=1.945, p=0.123, neutral
words: F[3,255]=0.515, p=0.672). A signiﬁcant
group eﬀect was found for categorization of positive
words (F[3,255]=3.104, p<0.05) and neutral words
(F[3,255]=3.250, p<0.05), but not for negative words
(F[3,255]=1.070, p=0.362). HC classiﬁed more words
as being positive than MDD (p<0.05) patients. MDD
patients judged more words as being neutral relative
to HC (p<0.05).
4.3.2 Imaging data
Main eﬀect of task
A robust main eﬀect of task (words versus baseline)
was found in left inferior frontal gyrus, left supplemen-
tary motor area (SMA) and bilateral occipital cortex
activation across groups (Appendices, Table A.1).
Across all groups, emotional relative to neutral eval-
uated words did not elicited signiﬁcantly increased
activation (pFWE<0.05). At a slightly more liberal
threshold, uncorrected p<0.001, increased activation
was observed in the left inferior parietal gyrus (-39,
-36, 45, Z=4.45, cluster size=179 voxels), the left
hippocampus (-30, -12, -15, Z=3.71, cluster size=14
voxels) and the right calcarine gyrus (15, -72, 6,
Z=3.58, cluster size=11 voxels).
Group diﬀerences
A group eﬀect by negative versus neutral words was
found on right amygdala (SVC: 27, 3, -21; k=13,
F=5.56, pFWE=0.03; puncorr.=0.001). To positive
versus neutral words a group eﬀect was observed in
ACC (6, 45, 18, k=21, F=8.04, p<0.001).
Anxiety patients showed increased right amygdala
activation in response to negatively>neutral evaluated
words, relative to HC (pFWE=0.015, SVC, Figure 4.1).
As can be seen in Figure 4.1 this diﬀerence in amygdala
response to negative words (>neutral) was driven by
the hypoactivation in HC during negatively evaluated
words. Such an eﬀect was not present in patients
with MDD and DAC compared to HC. Relative to
DAC patients, Anx patients showed increased right
anterior cingulate cortex (ACC) activation to posi-
tively evaluated (>neutral) words Table 4.3. Further,
no signiﬁcant diﬀerence was observed between other
patient groups.
Medication eﬀect
Demographic and clinical data for medicated and un-
medicated patients are provided in Appendices (Ta-
ble A.2). No signiﬁcant diﬀerences between medicated
and unmedicated patients were found on age, years of
education, MARDS, BAI and FQ scores (all p>0.05).
Unmedicated patients versus HC: Following exclusion
of the medicated patients from Anx group, we ob-
served increased right amygdala activation to nega-
tively (>neutral) evaluated words compared to HC
(pFWE=0.007, SVC). Table 4.3 lists the brain areas
showing diﬀerences in activation between unmedicated
patients and HC. No signiﬁcant diﬀerences were found
between unmedicated MDD or DAC patients and HC
to positively or negatively (>neutral) evaluated words.
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Table 4.2: Behavioral data for the evaluation of words. The number of words assigned to the three
categories and the reaction time (RT) in seconds are given. Mean and standard deviation (S.D.) are
given.
MDD Anx DAC HC
(n=65) (n=60) (n=77) (n=57)
”Positive” 37.94 (9.48) 38.15 (8.51) 39.84 (10.51) 42.70 (9.51)
”Neutral” 43.92 (10.35) 42.27 (10.89) 40.18 (11.50) 38.32 (9.43)
”Negative” 38.06 (2.93) 39.53 (5.23) 39.18 (4.89) 38.54 (4.33)
RT ”Positive” 1.47 (0.36) 1.42 (0.27) 1.48 (0.42) 1.35 (0.27)
RT ”Neutral” 1.60 (0.38) 1.56 (0.33) 1.61 (0.42) 1.54 (0.37)
RT ”Negative” 1.27 (0.28) 1.21 (0.23) 1.26 (0.32) 1.21 (0.31)
Table 4.3: Brain regions showing signiﬁcant group diﬀerences in response to positive or negative
(>neutral) words, for uncorrected p<0.001. L – left hemisphere, R – right hemisphere, k – cluster
size. *Small volume correction, pFWE<0.05.
Group Region Side MNI–Coordinates Z-value k puncorrected pcorrected
x y z voxel-level cluster-level
Anx>HC
Negative>Neutral Amygdala R 27 3 -21 4.04 8 <0.001 0.001*
Anx>DAC
Positive>Neutral ACC R 6 45 18 3.95 52 <0.001 0.034
unmed Anx > HC
Negative>Neutral Amygdala R 27 3 -21 4.23 7 <0.001 0.001*
med Anx > HC
Negative>Neutral Amygdala R 27 3 -18 3.69 4 <0.001 0.004*
unmed > med MDD
Positive>Neutral ACC R 3 21 21 4.40 55 <0.001 0.028
Negative>Neutral ACC R 12 24 27 4.33 54 <0.001 0.030
Posterior Cingulate R 0 -24 33 3.82 69 <0.001 0.011
Postcentral gyrus R 27 -36 48 3.64 53 <0.001 0.032
Figure 4.1: Right amygdala activation to negatively (>neutral) evaluated words in Anx patients relative
to HC. Small volume correction, pFWE<0.005.4.4. Discussion 55
Anx patients showed amygdala hyperactivation to neg-
atively evaluated words (>neutral) compared to HC
(Table 4.3, pFWE=0.004, SVC).
Unmedicated versus medicated patients: Unmedi-
cated MDD patients showed increased ACC activa-
tion in response to positively and negatively evaluated
(>neutral) words, compared to medicated MDD pa-
tients (Table 4.3). No signiﬁcant diﬀerences in the neu-
ral response to positively or negatively (>neutral) eval-
uated words were found between medicated versus un-
medicated Anx or DAC patients.
Regression analysis of symptom severity and
neural response to emotional words
A positive association between MADRS score and
amygdala response to negative (>neutral) words was
found in MDD patients (x=-18, y=0, z=-15; k=9,
Z=3.60, pFWE=0.006 SVC, Figure 4.2). No signiﬁcant
association between the neural response to emotional
(>neutral) words and illness severity was found in DAC
or Anx patients.
Secondly, regression analysis on symptom severity and
neural response during emotionally evaluated words
(>neutral) were conducted across all patients groups.
This may help us to diﬀerentiate the eﬀects of anxiety
and depression. Interestingly, no eﬀect of depression or
state or trait anxiety symptoms on the neural response
to emotional words was observed across all patients.
4.4 Discussion
The main hypothesis of the present study was that
Anx and MDD patients would show amygdala hyperac-
tivation in response to negatively evaluated words. We
also investigated this issue in patients with depression
and anxiety comorbidity. Our study provides evidence
of amygdala hyperactivation in Anx patients, but not
in MDD or DAC patients.
At a behavioral level, we expected that patients with
depression, but also patients with depression–anxiety
comorbidity, would judge more words as being negative
than HC. In contrast, we found that MDD patients
categorized signiﬁcantly more words as neutral and
less words as positive compared to HC. No signiﬁcant
diﬀerence regarding valence categorization of words
was found between Anx or DAC patients compared to
HC. Additionally, no signiﬁcant diﬀerences in reaction
times were found between MDD, Anx, DAC and HC.
Anxiety patients, irrespective of medication use, ex-
hibited right amygdala hyperactivation in response to
negatively, but not positively, evaluated words relative
to HC. These results are in line with previous studies
in patients with anxiety disorders reporting amygdala
hyperactivation during anticipation of aversive stimuli
[14], anticipation of public speaking [16] and viewing
emotional images [15]. The present ﬁndings clearly
show that amygdala hyperactivity in Anx patients
is not restricted to complex visual stimuli such as
emotional faces, but is also found during processing of
emotional words.
Anx patients showed increased dorsal ACC activation
(area 32) in response to positively evaluated words,
relative to DAC patients. Lane et al. [33] hypothesized
that this area is involved in selective attention to emo-
tional stimuli. Following this line of argument, Anx
patients were likely to be more attentive to emotional
stimuli than DAC patients, which may imply that the
presence of depressive symptoms reduces attentive
vigilance.
In depression with or without anxiety, no signiﬁcantly
altered amygdala response to emotional (>neutral)
words was present. The same was true after excluding
the medicated patients from analysis, unmedicated
MDD or DAC patients compared to HC showed no
signiﬁcant diﬀerence in the amygdala responses to
negative (>neutral) words. In the present study,
medicated and unmedicated MDD patients were indis-
tinguishable in terms of demographic characteristics.
Thus, medication use seems to not inﬂuence amygdala
response to negative emotional words. However, a
positive correlation between depression severity and
left amygdala activation to negatively evaluated words
was found in MDD patients, which suggests that
increased depressive symptoms severity is associated
with an enhanced emotional responsiveness to nega-
tively evaluated words in MDD. We might conclude
that amygdala hyperactivation to negatively evaluated
words is associated with illness severity, rather than
being a diagnosis eﬀect.
With regarding to positive stimuli, MDD patients
did not show decreased amygdala or ventral system
activation, compared to HC. Although the MDD
patients in our study classiﬁed fewer words as being
positive compared to HC, this was not reﬂected in
activation diﬀerences. In contrast to our ﬁndings,
Epstein et al. [20] reported decreased ventral striatum
activation to positive stimuli in ten unmedicated
MDD compared to twelve HC. They suggested that
depression is associated with inability to experience
positive emotions [20]. Thus, the inconsistencies may
be explained by task demands (emotional evaluation
of the word versus reading the word) or sample size.
In addition to these ﬁndings, unmedicated MDD
patients showed stronger dorsal ACC activation in
response to positive and negatively evaluated words,
relative to medicated patients; also, activation of
the posterior cingulate cortex (PCC) was found in56 EMOTIONAL EVALUATION OF WORDS
Figure 4.2: Positive correlation between left amygdala activation to negatively (>neutral) evaluated
words and depression severity in MDD patients.
unmedicated compared to medicated MDD patients
in response to negatively (>neutral) evaluated words.
Fitzgerald et al. [34] in their meta-analysis concluded
that ACC and PCC are part of the neural circuitry
involved in the pathophysiology of major depression.
Drevets and Raichle [35] suggested that dorsal ACC
activation is associated with attention, and a recent
study reported that stronger dorsal ACC activation
to positive and negative emotion-evoking stimuli was
associated with enhanced emotional awareness [36].
In line with these studies, we may conclude that Anx
as well as unmedicated MDD patients have increased
emotional awareness. PCC hyper–responsiveness has
been previously reported in other studies that exam-
ined emotional processing of stimuli. The ﬁndings
in these studies suggest that this region mediates
the interaction of emotional and memory–related
processes [9, 37, 35, 34]. Thus, we may infer that
rating the valence of words by unmedicated MDD
patients involved greater attention towards their own
emotional experience. Furthermore, our results suggest
a normalizing eﬀect of antidepressants on ACC and
PCC activation during emotional processing.
Contrary to our expectations, we failed to observe
signiﬁcant diﬀerences between DAC patients and HC.
A possible explanation might be that correlations
between symptom severity and neurophysiological
responsiveness to emotional vs. neutral words are
nonlinear, e.g. bell-shaped, as DAC patients had
more severe pathology. However, post–hoc analyses
showed that including a second-order term resulted in
ﬁts that were only marginally better than ﬁrst-order
(linear) models of amygdala response versus illness
severity (data not shown). A similar ﬁnding was
obtained for the DAC group during processing of
pictures of faces (Demenescu et al., in preparation).
Because the medicated DAC patients did not diﬀer
from the unmedicated DAC patients in other aspects,
it is unlikely that the apparently normal amygdala
response is a drug eﬀect. Rather, the presence of de-
pressive symptoms alongside anxious symptoms seems
to counteract the amygdala response to negatively
evaluated words. The mechanism for this is currently
unknown, but adrenal corticosteroids may play a role
because they can dampen the vigilance enhancing
eﬀects of monoamines.
A strength of the present study is the large number
of participants included, so that we found very robust
task related activation. Attribution of emotional va-
lence to words (versus baseline) potently activated left
prefrontal cortex (see Appendices) which is consistent
with current literature on emotional evaluation of
semantic stimuli. Another strength of this study is
that patients were recruited through general practi-
tioners and outpatient clinics using broad inclusion
criteria and are highly representative for everyday
psychiatric practice. A limitation of the study is the
cross-sectional design, so that conclusions regarding4.4. Discussion 57
the eﬀect of medication on amygdala activation need
to be conﬁrmed in a randomized controlled trial.
Secondly, the words used herein were not selected
based on their relevance for anxiety or mood diagnoses,
but have a positive or negative connotation in general.
Taken together, we may conclude that increased
amygdala reactivity as seen during an emotional word
evaluation task underlie anxiety disorders. In depres-
sion amygdala reactivity to emotional stimuli may be
related to illness severity rather than a diagnosis eﬀect,
as suggested by the present ﬁndings.
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Table A.1: Main eﬀect of all words and emotional words versus baseline across all groups and within
each group (pFWE<0.05)
Group Region Side MNI–Coordinates Z-value cluster size
x y z
Across all groups
All words>baseline Inferior Frontal gyrus L -48 21 -6 >8 568
SMA L 0 18 51 >8 170
Inferior Occipital gyrus L -27 -90 -6 7.26 36
Calcarine ﬁssure R 24 -93 0 6.88 29
HC
All words>baseline Inferior Frontal gyrus L -48 21 -6 >8 196
SMA L 0 15 51 5.28 24
MDD
All words>baseline Inferior Frontal gyrus L -48 21 -3 >8 367
SMA L -3 21 48 6.25 44
Inferior Occipital gyrus R 27 -90 -3 6.09 15
Anx
All words>baseline Inferior Frontal gyrus L -45 30 -6 7.82 256
SMA L -3 21 48 5.92 36
Middle Occipital gyrus (BA 18) L -27 -90 0 5.90 9
DAC
All words>baseline Inferior Frontal gyrus L -42 24 -6 >8 366
SMA L 0 15 54 6.20 63
Middle Occipital gyrus R 27 -93 3 5.26 13
Words: positive+negative+neutral, emotional words: positive+negative words. HC – healthy controls, MDD – depressed
patients, Anx – anxious patients, DAC – depression–anxiety comorbidity; SMA – supplementary motor area, BA –
Brodmann area, ACC – anterior cingulate cortex; Side: L – left, R – right.
Table A.2: Characteristics of the unmedicated and medicated patients (n represents the number of
participants). Mean and standard deviation (S.D.) are given.
unmed MDD med MDD unmed Anx med And unmed DAC med DAC
(n=44) (n=21) (n=40) (n=20) (n=42) (n=34)
Mean age (SD) 35.34 (10.07) 38.29 (10.64) 33.92 (9.76) 38.20 (8.45) 36.10 (10.81) 37.94 (11.01)
Mean years of education (SD) 12.68 (2.43) 12.14 (3.60) 12.98 (3.29) 12.70 (3.40) 11.79 (3.38) 11.76 (3.10)
1MADRS Mean (SD) 11.48 (11.65) 14.57 (7.10) 8.25 (7.34) 12.00 (10.07) 19.95 (10.55) 18.06 (7.72)
2BAI Mean (SD) 6.08 (13.93) 8.71 (7.06) 11.45 (15.38) 13.00 (8.68) 17.12 (9.50) 17.85 (8.97)
3FQ Mean (SD) 19.39 (18.36) 18.10 (16.09) 25.80 (25.73) 33.10 (22.99) 27.83 (22.17) 31.32 (22.65)
MDD – major depressive disorder, Anx – anxiety disorders, DAC – depression and anxiety comorbidity, unmed –
medication free, med – medication users, 1Montgomery-˚ Asberg Depression Rating Scale, 2Beck Anxiety Inventory, 3Fear
Questionnaire.60 EMOTIONAL EVALUATION OF WORDS
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Abstract
Background: Neuroticism is associated with the experience of negative aﬀect and the development of aﬀective disorders.
While evidence exists for a modulatory role of neuroticism on task induced brain activity, it is unknown how neuroticism
aﬀects brain connectivity, especially the crucial coupling between the amygdala and the prefrontal cortex. Here we
investigate this relation between functional connectivity and personality in response to negative facial expressions.
Method: Sixty healthy control participants, from the Netherlands Study on Depression and Anxiety (NESDA), were
scanned during an emotional faces gender decision task. Activity and functional amygdala connectivity (psychophysio-
logical interaction [PPI]) related to faces of negative emotional valence (angry, fearful and sad) was compared to neutral
facial expressions, while neuroticism scores were entered as a regressor.
Results: Activity for fearful compared to neutral faces in the dorsomedial prefrontal (dmPFC) cortex was positively
correlated with neuroticism scores. PPI analyses revealed that right amygdala–dmPFC connectivity for angry and fearful
compared to neutral faces was positively correlated with neuroticism scores. In contrast, left amygdala–anterior cingulate
cortex (ACC) connectivity for angry, fearful and sad compared to neutral faces was negatively related to neuroticism
levels.
Conclusions: DmPFC activity has frequently been associated with self-referential processing in social cognitive tasks.
Our results therefore suggest that high neurotic participants display stronger self-referential processing in response to
negative emotional faces. Second, in line with previous reports on ACC function, the negative correlation between
amygdalaACC connectivity and neuroticism scores might indicate that those high in neuroticism display diminished
control function of the ACC over the amygdala. These connectivity patterns might be associated with vulnerability to
developing aﬀective disorders such as depression and anxiety.
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5.1 Introduction
Neuroticism is a widely recognized trait in various
theoretical approaches to human personality [1, 2].
Characteristics of this trait include a tendency to
worry and to be anxious [3], and is related to the
experience of negative aﬀect [1, 4, 5]. Neuroticism is
also associated with aﬀective disorders such as social
anxiety disorder (SAD) and depression [6, 7, 8].
Functional magnetic resonance imaging (fMRI) studies
have provided substantial evidence for the modulatory
role of individual diﬀerences in neuroticism on neural
activity related to emotion processing [9, 10]. Regions
where activity is associated with neuroticism (and
related personality traits) include the amygdala
[11, 12, 13], the anterior cingulate cortex (ACC)
[14, 12] and the medial prefrontal cortex [15, 11, 16].
However, these regions are functionally coupled, and
such connectivity, especially between the amygdala
and prefrontal regions, is crucial for the integration
between emotion and cognition [17, 18]. To gain a
better understanding of the neural basis of individual
diﬀerences in emotion processing related to neuroti-
cism, a focus on functional connectivity between limbic
and prefrontal regions is therefore required.
Neuroticism is associated with alterations in cognitive–
emotional functions such as aﬀect regulation [19],
self-consciousness [20] and self-regulation [21]. Thus,
dysfunctional interactions between the amygdala and
regions related to these functions, such as ventrolateral
PFC (vlPFC), dorsolateral PFC (dlPFC) and ACC
[22, 17] (cognitive control of emotion), and dorsomedial
prefrontal cortex (dmPFC) [23, 24] (self-regulation and
self-referential processing) are likely to be speciﬁcally
associated with individual diﬀerences in neuroticism.
Only recently, fMRI studies have started to investi-
gate personality–associated diﬀerences in functional
connectivity during emotion processing. Whereas
some of these studies focused on traits related to
positive aﬀect [25, 26], one study reported trait anxiety
diﬀerences in amygdala–ACC coupling [27]. A mood
induction study during positron emission tomography
(PET) showed that neuroticism is associated with
changes in subgenual cingulate coupling with prefrontal
regions during mood induction, possibly reﬂecting a
susceptibility marker for depression [28]. Despite these
initial ﬁndings, to the best of our knowledge, no study
has systematically addressed the question on how
individual diﬀerences in neuroticism are associated
with amygdala–prefrontal cortex connectivity for
various negative emotional facial expressions.
To investigate the modulatory role of neuroticism
on amygdala–prefrontal cortex connectivity during
emotion processing, we applied a standardized face
paradigm with diﬀerent negative emotional facial
expressions (angry, fearful and sad) in a large subject
sample. This sample represented the healthy control
subjects as part of the Netherlands Study on Depres-
sion and Anxiety (NESDA) [29]. We hypothesize that
activity in the medial PFC, ACC and the amygdala
is associated with neuroticism scores when processing
negative as compared to neutral facial expressions.
We also hypothesize that connectivity, between the
amygdala on one hand and the lateral and medial
prefrontal regions and the ACC on the other, should
vary with individual diﬀerences in neuroticism.
5.2 Methods and Materials
5.2.1 Participants
Sixty healthy participants were selected from the
general population (mean age=39.9, range: 2156, 37
females). Participants were recruited as healthy con-
trol participants in a large multi-center cohort study,
the Netherlands Study of Depression and Anxiety
(NESDA). Participants were tested at the Amsterdam
Medical Center (AMC), Leiden University Medical
Center (LUMC) and University Medical Center
Groningen (UMCG). The exclusion criteria for these
healthy participants were (1) a lifetime diagnosis of
DSM axis I and/or axis II disorders, psychotic disorder
or dementia, (2) current alcohol or substance abuse,
(3) a history of seizure or head injury, (4) current
use of beta-blockers medication, (5) hypertension
(high blood pressure) 80/130mmHg, (6) more than 5
cigarettes smoked per day, (7) older than 57 years and
(8) MRI incompatible implants or tattoos. During
the preliminary analysis, 4 participants were excluded
because of head movement artifacts. Written informed
consent from each participant was obtained prior to
the scanning session. The study was approved by the
ethical review boards of each participating center.
5.2.2 Personality scores
To asses personality traits, all participants completed
the NEO Five Factor Inventory [30]. This question-
naire consists of 60 items and measures ﬁve diﬀerent
personality traits: neuroticism, extraversion, openness,
agreeableness and conscientiousness. Of these traits,
neuroticism and extraversion are most closely related
to emotion processing and alterations in neural activity
[9]. Examples of the neuroticism questions include,
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completely worthless.
5.2.3 Experimental design
Color photographs of faces depicting angry, fearful, sad,
happy, and neutral facial expressions were presented
together with scrambled faces in an event-related
design. Photographs were selected from the Karolinska
Directed Emotional Faces System [31] representing
standardized facial expressions of emotions presented
by amateur actors. Twenty-four faces were selected
for each of the ﬁve facial expressions, comprising of
12 female and 12 male faces, and 80 scrambled faces.
A total number of 200 photographs were presented
pseudorandomly, such that there were maximally
two faces presented before the presentation of a
scrambled face, and there were no repetitions of the
same emotional expressions. Each photograph was
presented on the screen for 2.5 s, with an inter-stimulus
interval (black screen) varied between 0.5 and 1.5 s
(jitter). The total duration of the task was 747 s. The
experimental paradigm was presented using E-prime
software (Psychological Software Tools, Pittsburgh,
PA, USA). Images were projected onto a translucent
screen at the end of the scanner bed, visible via a
mirror above the participant’s head. Participants were
instructed to indicate the gender by pressing one of
two buttons of two magnet-compatible button boxes
with the index ﬁnger of the left or right hand. During
the presentation of scrambled faces, participants had
to press left or right buttons in conformity with the
instructions present on the screen, indicating either
left or right by an arrow. Responses and reaction
times were recorded. Participants were not aware that
the implicit emotional variable was under study in the
experiment.
5.2.4 Image acquisition
Images were acquired on a Philips Intera 3T MR-
scanner. A sense-8 (UMCG and LUMC) and a sense-6
(AMC) channel head coil was used for radio frequency
transmission and reception. For each subject a series
of echo planar imaging (EPI) – sensitive to the blood
oxygenation level dependent eﬀect – volumes were
obtained, entailing a T2*-weighted gradient echo
sequence (repetition time [TR]=2300 ms, echo time
[TE]=28.0 ms at UMCG and TE=30.0 ms at AMC
and LUMC, ﬂip angle 90 using axial whole-brain
acquisition, with an interleaved slice acquisition order).
The interslice gap was 0 mm and the plane thickness
was 3 mm. The matrix sizes were: 64 x 64 voxels at
UMCG and 96 x 96 voxels at AMC and LUMC. The
EPIs were acquired at 39 slices at UMCG and 35 slices
at AMC and LUMC. The inplane resolution was 3 x
3 mm at UMCG and 2.29 x 2.29 mm at AMC and
LUMC. The axial images were acquired parallel to the
anterior–posterior commissure plane. Functional data
comprising 310 volumes were obtained per subject. A
T1-weighted anatomical MRI was also acquired for each
subject (TR=9 ms, TE=3.5 ms, matrix size 256 x 256).
5.2.5 Analysis
Preprocessing
Functional data were preprocessed and analyzed
using the statistical parametric mapping software
package (SPM5, http://www.ﬁl.ion.ucl.ac.uk) im-
plemented in Matlab 7.2 (The MathWorks Inc.,
http://www.mathworks.com).
The EPI volumes were reoriented in respect to the
anterior commissure selected on the ﬁrst volume. Time
series were corrected for diﬀerences in slice acquisition
times. The reference slice was 39 at UMCG and 2 at
AMC and LUMC. After spatial realignment to the
ﬁrst image, a mean EPI was created. The movement
parameters for each participant were inspected. If a
participant moved more than 3 mm in any direction
(anterior–posterior, right–left, inferior–superior) the
data were excluded from further analysis. The anatomy
scan was coregistered to the mean EPI image. Sub-
sequently, T1, and with it EPI images, were spatially
normalized to a standard stereotaxic space (Montreal
Neurological Institute). During normalization, data
were resampled into a 3 x 3 x 3 mm grid with 7th
degree B-spline interpolation. The functional data
were smoothed with a 3D isotropic Gaussian kernel of
8 mm full-width at half-maximum.
Imaging analysis
Low-frequency noise was removed by applying a
high-pass ﬁlter (cut-oﬀ of 128 s) to the fMRI time
series at each voxel. Signiﬁcant hemodynamic changes
for each condition were calculated using the general
linear model [32], with respect to the event–related
response convolved with canonical hemodynamic
response function. To identify activity in regions
related to face processing, we computed a t-contrast
of all faces combined to the baseline, and tested this
contrast at p<0.05 family wise error (FWE) corrected
for multiple comparisons. To the test the hypotheses
between the relation of neuroticism and negative
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negative emotional facial expressions. T-contrasts
for angry>neutral, fearful>neutral, sad>neutral were
calculated for each subject. Results of these weighted
contrast (contrast images) were then entered in a
second level random eﬀect model. For each negative
emotional facial expression (compared to neutral),
neuroticism, extraversion, age and gender were entered
as regressors.
A one-sample t-test was applied to test the positive
and negative eﬀect of the neuroticism scores regressor.
Eﬀectively, this analysis corresponds to detecting
partial correlations between brain activity and neu-
roticism, when correcting for extraversion, age and
gender. Since the amygdala, the ACC and the dmPFC
all shown to have neuroticism dependent variation in
activity when processing emotional stimuli they were
deﬁned as regions of interest (ROI). The amygdala
and ACC volumes were based on the WFU pickatlas
[33]. The dmPFC was deﬁned as a 10 mm sphere
around the peak voxel coordinates reported in a study
on phobic proneness in relation to the processing of
negative emotional faces [16]. We applied an initial
signiﬁcance threshold of p<0.005 (uncorrected) and
a spatial extent of ﬁve voxels (k>=5), restricted to
our a priori regions of interested (ROI): the amygdala,
the ACC and the dmPFC. Furthermore we report
activation outside our ROIs at p<0.001, k>=10 voxels
uncorrected for multiple comparisons. Activations are
reported in standard Montreal Neurological Institute
(MNI) space.
Functional connectivity analysis: psycho–
physiological interaction (PPI)
Psycho–physiological interaction (PPI) analyses were
used to assess how activity in a brain region of interest
covaries with a source region in response to the
experimental condition [34]. Within each condition
(diﬀerent negative emotional faces compared to neutral
faces), we separately examined functional connectivity
from the left and right amygdala as a source region. To
identify the amygdala activation for each participant
we examined the contrast of all faces compared to
the baseline at p<0.05 uncorrected. The deconvolved
time series from a 5 mm radius sphere around the
individually deﬁned peak activated voxel within the
amygdala (deﬁned by the WFU pickatlas mask) was
extracted (44 participants). The PPI was calculated
as the element by element product of the left and
the right amygdala time series (the ﬁrst eigenvariate
from all voxels’ time series) and a vector coding for
the eﬀect of task (anger>neutral, fear>neutral, and
sad>neutral). This product was subsequently re-
convolved with the hemodynamic response function
(HRF). This interaction term was then entered as
a regressor in a ﬁrst level model together with the
time series of the amygdala and the vector coding
for the task eﬀect. The models were estimated and
contrasts generated to test the eﬀects of positive
and negative PPIs. This analysis identiﬁed regions
that display stronger functional connectivity with the
amygdala for an emotional compared to a neutral facial
expression, and for neutral compared to emotional
facial expressions respectively.
The contrast images for the PPI eﬀects were then
entered in a second level analysis. In a similar manner
to the conventional analysis, neuroticism, extraversion,
age and gender were entered as regressors. Subse-
quently, the eﬀects of neuroticism were tested, which
identiﬁed brain regions that showed connectivity with
the amygdala correlating positively or negatively with
neuroticism scores, respectively. We applied an initial
uncorrected threshold of p<0.005, k>=5, restricted to
our a priori regions of interest, the ACC, the dmPFC,
dlPFC and vlPFC. The ACC mask was based on the
WFU pickatlas, while the dmPFC, dlPFC and vlPFC
(lateral orbitofrontal cortex) masks were deﬁned as a
15 mm sphere around the peak coordinates reported
in a study on amygdala connectivity based on a
large fMRI data set on processing angry and fearful
faces [18]. Furthermore we report activation outside
our ROIs at p<0.001, k>=10 voxels uncorrected for
multiple comparisons.
5.3 Results
Because data were acquired at diﬀerent sites, we con-
ducted additional stepwise regression analyses to test
whether this factor site would aﬀect signiﬁcance levels.
When the model was extended with the factor site, no
signiﬁcant additional variance was explained compared
to the model without the factor site (for each regres-
sion analysis p>0.05 for change in explained variance
of the extended model, while neuroticism remained sig-
niﬁcant, p< 0.005 for each extended model).
5.3.1 Behavioral results
For the entire group, mean reaction times (RT) for
the diﬀerent emotional faces were: angry RT=825 ms,
SD=158, fear RT=879 ms, SD=166, sad RT=874 ms,
SD=163 and neutral RT=888 ms SD=155. There
was a main eﬀect of emotion on reaction time, driven
by a faster RT for angry compared to neutral faces
t(55)=-7.6, p<0.05. Accuracy overall was high: for5.3. Results 67
angry 98.3%, fear 98.5%, sad 96.1% and neutral 95.4%
correct. There were no signiﬁcant correlations between
neuroticism (or extraversion) and the diﬀerences scores
of each negative compared to neutral facial expression
or for accuracy, (for each correlation p>0.05).
5.3.2 Personality scores
The sample scores for neuroticism were mean 24.3
(range: 13–36), SD=5.3. For extraversion these scores
were mean 44.4 (range: 27–56), SD=6.6. There was
a signiﬁcant negative correlation between neuroticism
and extraversion, r=-0.49, p<0.05. Since individual dif-
ferences in extraversion also inﬂuence emotion process-
ing, we aimed to exclude any possible eﬀect by adding
extraversion as a regressor in our model (see Passamonti
et al. [26] for a comparable approach).
5.3.3 fMRI results
Main eﬀects of emotional faces versus base-
line
We compared all emotional faces together against the
scrambled faces baseline to assess activity related to
face processing. Main eﬀects of the face processing were
found in the bilateral fusiform gyrus (left, -42/-54/-24,
z=6.1 k=25; right, 39/-45/-24, z=7.26, k=110), bilat-
eral amygdala (left, -18/-6/-15, z=6.95, k=126; right,
21/-6/-15, z=7.13, k=82), and the right inferior frontal
gyrus (51/27/21, z=6.37, k=174). All activations were
p<0.05, whole brain FWE corrected.
Brain activity for emotional versus neutral
faces and relation with neuroticism
In order to identify activity in brain regions that varied
as a function of neuroticism scores, we tested the eﬀect
of neuroticism in a regression model. This resulted in
the identiﬁcation of activity in brain regions that was
positively or negatively correlated with neuroticism in
response to emotional facial expressions compared to
neutral facial expressions. Table 5.1 shows activation
clusters and peak coordinates. As one can see, of our a
priori regions of interest, only the right dmPFC showed
an eﬀect of neuroticism. We found a positive relation
between activity in this region for fearful compared to
neutral emotional faces and neuroticism scores. The
main eﬀects of each contrast (regardless of individual
diﬀerences) are provided in the supplementary material
(Table A.1).
Functional connectivity: PPI analysis
In order to investigate how neuroticism is associated
with functional connectivity of the amygdala and the
prefrontal cortex, we tested the eﬀect of neuroticism
as a regressor in a model of connectivity with the left
and right amygdala (separately) as source regions.
This analysis resulted in the identiﬁcation of brain
regions showing connectivity with the amygdala that
was either positively or negatively correlated with
neuroticism scores when viewing emotional compared
to neutral facial expressions.
Table 6.3 shows the modulatory eﬀect of neuroticism
on the connectivity of the left amygdala. For angry
and fearful faces, connectivity of the left amygdala
and right ACC was negatively associated with neu-
roticism scores. For sad compared to neutral faces,
a similar relation between neuroticism and amygdala
connectivity (with a more the dorsal part of the ACC)
was observed. Both these ﬁndings indicate that the
higher the neuroticism scores, the lower the functional
coupling for negative emotional compared to neutral
facial expressions between the left amygdala and the
ACC. These eﬀects are shown in Figure 5.1. For
display purposes the partial correlation scores for neu-
roticism (the residuals after correcting neuroticism for
extraversion, age and gender) were linear transformed
(mean added and a scaled standard deviation) to
approximate the original neuroticism scores.
Table 5.3 displays the positive and negative correla-
tions between neuroticism and regions functionally
coupled with the right amygdala for each of the neg-
ative emotional compared to neutral emotional facial
expressions. A positive correlation was found between
the amygdala connectivity with the right dorsomedial
prefrontal (dmPFC) cortex for both angry and fearful
compared to neutral facial expressions. This indicates
that the higher the neuroticism scores, the stronger
the coupling for fearful and angry compared to neutral
faces between the right amygdala and the right dmPFC
(see Figure 5.2).
It is important to note that within each of the
neuroticism related connectivity eﬀects in the ACC
and dmPFC there were no signiﬁcant main eﬀects
(irrespective of individual diﬀerences) of each contrast,
even at a threshold of p<0.05 uncorrected. Within
our other regions of interest we only found signiﬁcant
eﬀects of a positive PPI (with the left amygdala)
for the fear>neutral contrast in the ventral lateral
prefrontal cortex (-36/33/-8, z=3.58, p<0.05 FWE,
small volume corrected). No other contrasts showed a
positive or negative PPI eﬀect in our ROIs.68 NEUROTICISM MODULATES AMYGDALA – PREFRONTAL CONNECTIVITY
Table 5.1: Brain areas displaying a correlation between neuroticism scores and activity for angry, fearful
and sad facial expressions.
Contrast Region Side Voxels Z values p values MNI–Coordinates
x y z
Angry>Neutral – – – – – – – –
Fear>Neutral
Positive dmPFC R 10 2.95 0.002 6 57 33
Calcarine gyrus L 17 3.71 <0.001 -3 -93 6
Sad>Neutral
Positive Posterior cingulate gyrus R 10 3.65 <0.001 6 -48 30
Note: A priori regions of interest are shown in bold. dmPFC: dorsomedial prefrontal cortex. Other activations at a
threshold of p<0.001, and minimal 10 contiguous voxels are also reported. No negative correlations were found.
Table 5.2: Association between neuroticism and functional connectivity with the left amygdala for angry,
fearful and sad facial expressions.
Contrast Region Side Voxels Z values p values MNI–Coordinates
x y z
Angry>Neutral
Positive Parahippocampal gyrus R 12 4.39 <0.001 30 -39 -6
Negative ACC R 7 2.96 0.002 12 36 12
Fear>Neutral
Negative ACC R 15 3.26 0.001 9 30 15
Sad>Neutral
Negative dorsal ACC* R 41 4.08 <0.001 12 12 30
Note: A priori regions of interest are shown in bold. *Small volume corrected, FWE p<0.05. ACC, anterior cingulate
cortex. Other activations at a threshold of p<0.001, and minimal 10 contiguous voxels are also reported.
Figure 5.1: Brain regions displaying association between neuroticism and functional connectivity with
the left amygdala for emotional compared to neutral faces. (a) Right anterior cingulate cortex for angry
compared to neutral facial expressions. (b) Right anterior cingulate cortex for fearful compared to
neutral facial expressions. (c) Right dorsal anterior cingulate cortex for sad compared to neutral facial
expressions. The regression line and 95% conﬁdence intervals are shown. The color bar represents the
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Table 5.3: Association between neuroticism and functional connectivity with the right amygdala for
angry, fearful and sad facial expressions.
Contrast Region Side Voxels Z values p values MNI–Coordinates
x y z
Angry>Neutral
Positive dmPFC R 16 3.37 <0.001 21 42 36
Fear>Neutral
Positive dmPFC* R 49 3.22 0.001 21 42 36
dmPFC* L 15 3.26 0.001 -6 48 36
Sad>Neutral
Positive IFG L 23 3.69 <0.001 -27 42 3
Note: A priori regions of interest are shown in bold. *Small volume corrected, FWE p<0.05. dmPFC, dorsomedial
prefrontal cortex; IFG, inferior frontal gyrus. Other activation at a threshold of p<0.001, and minimal 10 contiguous
voxels are also shown.
Figure 5.2: Brain regions displaying association between neuroticism and functional connectivity with
the right amygdala for emotional compared to neutral faces. (a) Right dorsomedial prefrontal cortex
for angry compared to neutral facial expressions. (b) Right dorsomedial prefrontal cortex for fearful
compared to neutral facial expressions. The regression line and 95% conﬁdence intervals are shown. The
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5.4 Discussion
5.4.1 Neuroticism modulates brain
activity in the dmPFC during
the processing of fearful faces
In this study, we investigated the modulatory role
of neuroticism on brain activity and functional
connectivity while processing negative compared
to neutral facial expressions. Our results showed
that activation in the dmPFC varied as a function
of neuroticism scores in response to fearful facial
expressions. This ﬁnding is broadly in line with studies
in which dmPFC activity was found to be related to
neuroticism [35] and phobic proneness [16] during the
processing of sad, respectively fearful and angry facial
expressions. Both studies discuss these ﬁndings within
a framework of self-referential processing, a construct
strongly associated with this brain region [23, 36]. In
accordance with these notions, neuroticism has been
associated with an individual’s self-schema, i.e. a ”[...]
constellation of self-referent information of one’s own
unique traits [...]” which ”[...] serves to guide the
processing of personally relevant information” [37].
Trapnell and Campbell [20] found that neuroticism
related positively to ruminative self-consciousness
(but not to reﬂective self-consciousness), which is
associated with psychological distress [20]. Hence, our
results may imply that higher levels of neuroticism
are associated with a higher degree of self- referential
negative appraisal during the processing of fearful
expressions.
5.4.2 Neuroticism modulates
amygdala–ACC and
amygdala–dmPFC
connectivity
We did not observe an eﬀect of neuroticism on ac-
tivity in the amygdala during processing of negative
emotional expressions. However, and crucial to our
hypothesis, connectivity analysis showed that neuroti-
cism distinctively modulated connectivity between the
left amygdala–right ACC and right amygdala–right
dmPFC. We found no signiﬁcant main eﬀect for these
regions, which is broadly in line with previous research,
applying the same functional connectivity measure,
that showed relatively small eﬀects of functional
coupling between the amygdala and these prefrontal
regions when processing fearful compared to neutral
faces [38]. Our results suggest that it is worthwhile
to account for individual diﬀerences in neuroticism
when studying functional connectivity related to the
processing of negative emotional facial expressions.
We found that connectivity of the left amygdala
with the ACC for angry and fearful, and dorsal ACC
for sad facial expressions, correlated negatively with
neuroticism scores. This indicates that subjects high
in neuroticism, while processing negative compared to
neutral emotional expression, displayed relatively less
amygdala and ACC functional coupling. Numerous
studies have shown the importance of amygdala–ACC
functional connectivity in the context of emotion
processing. For example, Etkin et al. [39] found that
during high conﬂict trials in an emotional Stroop
paradigm the amygdala and the rostral part of the
ACC were negatively functionally coupled, suggesting
an inhibitory role of the ACC over the amygdala.
In line with our ﬁndings, a study on trait anxiety
[27] showed a negative correlation of this trait with
amygdala–ACC connectivity when viewing negative
compared to neutral scenes. Moreover, Pezawas et al.
[40], found that carriers of the short allele of the
serotonin transporter gene (a polymorphism related
to anxiety) showed relatively less functional coupling
between the amygdala and ACC when processing
angry and fearful faces. These ﬁndings suggest that
persons high in neuroticism (or other individual
diﬀerences related to anxiety) display less ACC related
inhibitory control over the amygdala. It is of interest
that the opposite pattern was found for a personality
trait associated with positive aﬀect and approach mo-
tivation; the behavioral activation system (BAS) [26].
These authors found that BAS positively predicted
amygdala–ACC connectivity for angry compared to
neutral faces. The studies mentioned demonstrate the
relevance of amygdala–ACC connectivity in emotion
processing and emotion regulation. These reports also
suggest that individual diﬀerences in personality traits
modulate amygdala–ACC functional connectivity, and
that the direction of this correlation is diﬀerent for
traits related either to negative or positive aﬀect.
In contrast to our results regarding left amygdala–ACC
connectivity, we found a positive relation between
neuroticism scores and right amygdala–right dmPFC
connectivity. Participants with higher scores on
neuroticism displayed relatively enhanced connectivity
between the right amygdala and right dmPFC during
the processing of angry and fearful compared to neutral
faces. This ﬁnding relates to a study on functional
connectivity in generalized social phobia (GSP) while
processing self-referential praise and criticism [41].
Their results showed that patients (compared to
healthy control participants) displayed stronger func-
tional connectivity between amygdala and dmPFC for
self-referential criticism. The authors argue that this5.4. Discussion 71
ﬁnding may ”[...] reﬂect a negative attitude toward
the self, particularly in response to social stimuli
[...]”, and that the mPFC may modulate amygdala
engagement to initiate and maintain aspects of GSP
[41]. In keeping with our ﬁnding of neuroticism related
diﬀerences in dmPFC activity, our amygdala– dmPFC
connectivity results also suggest that persons high in
neuroticism might demonstrate stronger self-referential
processing in response to negative emotional faces.
There is substantial evidence for the role of neuroticism
in the development of, for example, anxiety disorders
[6, 7]. The pattern we found in the relation between
functional connectivity and neuroticism might provide
insight in the neural basis of neuroticism- linked
susceptibility to negative aﬀect, and its associated
vulnerability for the development of aﬀective disorders.
Taken together, our amygdala–ACC connectivity
results indicate that high levels of neuroticism are
associated with relatively less inhibitory control
over negative facial expressions. Based on dmPFC
activity and amygdala–dmPFC connectivity, we
suggest that those high in neuroticism demonstrate
stronger self-reference to negative facial expressions.
Furthermore, it is of interest to note the apparent
dissociation between neuroticism and connectivity
from the left and the right amygdala. A recent
meta-analysis on amygdala function showed evidence
for a dissociation between the left and right amygdala
regarding temporal dynamics [42], but did not ﬁnd
evidence for speciﬁc interactions between amygdala
lateralization and valence or gender [42] in line with a
previous meta-analysis [43]. Despite this knowledge on
amygdala activity much less is known regarding later-
alization of amygdala connectivity, and future research
should therefore further explore possible lateralization
in functional pathways from the amygdala.
Limitations
The interpretation of our connectivity analysis is
restricted by the inherent limitations of functional
connectivity measures. In our application of psycho–
physiological interaction analysis, it is a measure of
functional, but not eﬀective connectivity [34]. The
main diﬀerence between these concepts is that the
former is a correlation method and its results do not
imply a causal relation between regions involved. PPI
analysis in and of itself, is therefore insuﬃcient to
assess the direction of eﬀects (i.e., reciprocal or unidi-
rectional) between the amygdala and the dmPFC and
ACC. This is an important limitation considering, for
example, the argued regulatory role of the ACC over
the amygdala. Nonetheless, other studies, applying
diﬀerent methodologies, have provided more direct
evidence for a top– down regulatory role of the ACC
over the amygdala. One tracing study, for example,
showed that the ACC has more projections to the
amygdala than vice versa [44]. Furthermore, deep
brain stimulation experiments in depressed patients
suggest that stimulating the ACC – through its
connectivity pathways – aﬀects several subcortical
regions, including the amygdala [45, 46].
In this experiment, we found diﬀerences in amygdala–
prefrontal connectivity associated with neuroticism
during an emotion processing task, with only very
mild demands on cognitive control over emotional
functions. It is therefore very well possible that when
engaged in more cognitively demanding tasks, addi-
tional amygdala–PFC connectivity pathways strongly
involved in inhibitory control, would show associations
related to individual diﬀerences in personality. For ex-
ample, some studies have shown subcortical–prefrontal
connectivity in relation to functions such as re-
appraisal [47, 48], extinction learning [49] and response
conﬂict [39]. Future research on negative aﬀect should
therefore incorporate individual diﬀerences in neuroti-
cism in functional connectivity on more challenging
emotion regulation tasks. We would argue that in
such paradigms individual diﬀerences are likely to be
associated with, for example, amygdala–ventromedial
or ventral lateral prefrontal connectivity.
Conclusion
Our present study indicates that individual diﬀerences
in neuroticism are of importance in modulating
functional connectivity of amygdala and prefrontal
regions when processing negative emotional material.
Neuroticism was negatively associated with amygdala–
ACC, and positively related to amygdala–dmPFC
connectivity when processing negative emotional facial
expressions. These ﬁndings may provide insight into
the neural mechanisms associated with susceptibility
to negative emotional material, and may be relevant
to the development of aﬀective disorders.
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A Main eﬀect of negative emotional expressions versus neutral
faces
We attach here the supplementary material referred to in this chapter.
Table A.1: Main eﬀects of each negative emotional compared to neutral facial expressions
Contrast Region Side Voxels Z values p values MNI–Coordinates
x y z
Angry>Neutral MTG R 19 3.85 <0.001 54 -42 6
MTG L 24 3.76 <0.001 -54 -60 0
Fear>Neutral MTG R 10 3.8 <0.001 51 -39 6
MTG L 14 3.75 <0.001 -57 -60 0
Sad>Neutral Cerebellum L 125 4.81 <0.001 -18 -57 -21
Postcentral gyrus R 81 4.6 <0.001 48 -24 54
MTL R 25 3.73 <0.001 57 -34 0
IFG R 15 3.66 <0.001 54 30 3
Posterior cingulate cortex R 10 3.54 <0.001 60 -36 30
Note: MTG: medial temporal gyrus, IFG: inferior frontal gyrus.74 NEUROTICISM MODULATES AMYGDALA – PREFRONTAL CONNECTIVITY
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Abstract
Background: Patients with anxiety disorders display abnormal neural responses in amygdala and frontal regions dur-
ing emotional processing. However, ﬁndings are inconsistent and the extent to which this abnormal neural response is
speciﬁc to panic disorder and social phobia is unclear. The present study aimed to investigate brain activation and the
psychophysiological interaction between amygdala and frontal regions during perception of emotional facial expressions in
social phobia and panic disorder.
Methods: Functional magnetic resonance imaging was used in outpatients with social phobia and/or panic disorder and
healthy participants, to measure the neural response to facial expressions of emotion. We further examined the interaction
– modulated by emotional compared to neutral faces – between amygdala and frontal regions, using psychophysiological
interaction in outpatients compared to healthy participants.
Results: No signiﬁcant diﬀerence was found in the neural response to facial expressions (>scrambled) between social
phobics and healthy participants. However, outpatients with comorbid social phobia and panic disorder showed less amyg-
dala and fusiform gyrus activation to fearful and happy (>scrambled) faces compared to healthy participants. A negative
left amygdala–middle frontal gyrus coupling during perception of fearful (>neutral) faces was observed in social phobics
compared to healthy participants.
Conclusion: Results suggest that social phobics may have an impairment in regulating their negative emotions during
perception of fearful faces. The comorbidity of social phobia and panic disorder may be associated with an impairment in
perception of fearful and happy faces.
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6.1 Introduction
Anxiety disorders are among the most prevalent mental
disorders constituting 28.8% of the total psychiatric
disorders. Within this percentage, social phobia (SP)
has a 12.1% prevalence and panic disorder (PD)
4.7% [1]. Social phobia is characterized by extreme
fear of negative evaluation and avoidance of social
situations. Panic disorder is characterised by recurrent,
spontaneous panic attacks, acute episodes of intense
fear, accompanied by physical as well as cognitive
symptoms [2].
Given the high share of anxiety disorders in the
total psychiatric disorders and their common base –
threat related stimuli –, an investigation of both their
diﬀerences and common points in comparison with
healthy controls, has the necessary prerequisites for
identifying the speciﬁcs of their neural responses and
psychophysiological interactions. The diﬀerences at
both levels are prone to give an important insight
into the mechanism of emotion perception in social
phobia and panic disorder, a key factor in improving
life quality and ease social burden.
The amygdala has been proposed as a central brain
structure involved in processing threat-related stimuli
[3] and therefore it is likely to play a role in the
aforementioned anxiety disorders. Neuroimaging
studies in subjects with SP using facial expressions
reported amygdala hyperactivation in response to
angry [4], fearful [5], happy [6] and neutral [7, 8] faces.
Regarding PD, Kent and Rauch [9] in their review
concluded that hyperactivation of the hippocampal–
parahippocampal regions reported during symptom
provocation are a ”trait marker” for PD and hy-
pothesised that amygdala may play an important
role. In the last years neuroimaging studies reported
abnormal amygdala activation during processing of
facial expressions of emotion in PD patients. For
example, amygdala hypoactivation was reported in
response to fearful faces in PD patients compared to
HC [10]. During perception of happy faces amygdala
hyperactivation has been found in PD patients [11].
Thus, it seems that the amygdala might be the core
of a shared mechanism involved in PD and SP, as
suggested by Kent and Rauch [9].
In addition to studies reporting abnormal amygdala
activation in anxiety disorders, abnormal neural
responses were also found in frontal areas. For exam-
ple, increased anterior cingulate cortex activation to
disgusted faces has been reported in social phobia [12],
whereas in panic disorder, decreased right prefrontal
cortex activation in response to fearful faces has been
reported [11]. From the abovementioned studies,
we can conclude that not only amygdala plays an
important role in anxiety disorders, but several regions
including prefrontal cortical areas are part of the
neural mechanism associated with anxiety disorders.
However, it is unknown how amygdala coupling to
frontal regions during emotional face perception is
altered in SP and PD and whether possible changes in
connectivity are common to these anxiety disorders.
Recently, functional neuroimaging studies have inves-
tigated the psychophysiological interactions during
emotion perception and processing and the relation
between anxiety disorders and brain connectivity.
Cremers et al. [13] reported a positive association
between right amygdala and dorsomedial prefrontal
cortex (dmPFC) coupling and neuroticism and a
negative association between neuroticism and left
amygdala–anterior cingulate cortex (ACC) coupling.
The authors suggested that these ﬁndings may provide
an insight into the development of aﬀective disor-
ders, because neuroticism is associated with social
anxiety disorder and depression. Additionally, Etkin
et al. [14] reported increased dorsolateral prefrontal–
amygdala functional connectivity during resting state
in generalised anxiety disorder and showed that this
connectivity was negatively correlated with anxiety
measures. Furthermore, Liang et al. [15] suggested
that greater amygdala–right frontal connectivity is
associated with approach tendencies, whereas weaker
amygdala–right frontal connectivity suggests with-
drawal tendencies. It is therefore likely that anxious
patients, who perceive the world as more threatening,
have altered amygdala–frontal functional connectivity,
speciﬁcally a weaker connectivity between cortex and
amygdala.
To our knowledge, no study has investigated the amyg-
dala interaction with other brain areas modulated by
perception of facial expressions of emotions in patients
with social phobia or panic disorder. The present study
takes a step toward this goal examining the pattern
of brain activation and the coupling of amygdala and
frontal areas during emotional face perception in SP
and PD. We hypothesised increased amygdala activa-
tion in response to angry, fearful, happy and neutral
facial expressions in patients with SP. In PD increased
amygdala activation was hypothesised in response to
fearful faces. Patients with SP+PD comorbidity were
included to examine the impact of comorbid PD and
SP on the neural response during emotion perception.
Based on previous ﬁndings mentioned above, we
expected abnormal amygdala–frontal cortex coupling
in SP and PD outpatients relative to healthy controls.6.2. Methods 79
6.2 Methods
6.2.1 Participants
Participants were selected from the database of
the Netherlands Study of Depression and Anxiety
(NESDA, [16]). Three centers participated: University
Medical Center Groningen (UMCG), Amsterdam
Medical Center (AMC) and Leiden University Medical
Center (LUMC). The Ethical Review Board of each
center approved the study. Inclusion criteria required
that all participants: 1) were between 18 and 56 years
of age, 2) had no history of seizures or brain injury, 3)
did not meet the criteria of any DSM axis I disorders
for other disorders than SP, PD or GAD, 4) had no
report of substance abuse and 5) had no physical limi-
tations that prohibited them from undergoing an fMRI
examination. All subjects were native Dutch speakers.
After receiving written information, each participant
gave written informed consent. The participants did
not receive any compensation for their participation.
Twenty-three outpatients diagnosed with social
phobia (SP), eighteen outpatients diagnosed with
panic disorder (PD) and sixteen outpatients with a
double diagnosis – social phobia and panic disorder
– (SP+PD) were included in the present study. The
diagnosis was established by trained clinical staﬀ on
the basis of the Composite International Diagnosis
Interview (CIDI) - lifetime version 2.1 - (Andrews,
1998) in accordance with DSM-IV criteria (2001). All
outpatients met the criteria for primary SP and/or PD,
and some of them had a second diagnosis of general
anxiety disorder (GAD). Twenty healthy controls
(HC) were randomly selected from 56 HC scanned in
the NESDA fMRI study, in order to match the sample
sizes. Healthy controls did not meet the criteria for
any current Axis I disorder and had no history of
psychiatric disorders.
Six SP outpatients, four PD outpatients and eight
SP+PD outpatients were using selective serotonin
reuptake inhibitors (SSRIs) at the time of the study.
Before the scanning session, all participants were
evaluated by means of a battery of standardised
questionnaires and structured interviews. The Beck
Anxiety Inventory (BAI, [17]), Fear Questionnaire
(FQ, [18]) and Montgomery-˚ Asberg Depression Rating
Scale (MADRS, [19]) were applied to all participants.
6.2.2 Faces paradigm
Color photographs of angry, fearful, sad, happy and
neutral facial expressions and scrambled faces (control
condition) were presented to all participants. The
photographs were selected from the Karolinska Di-
rected Emotional Faces System [20]. Twenty-four faces
were selected for each of the ﬁve facial expressions,
consisting of twelve female and twelve male faces, and
80 scrambled faces.
The experimental paradigm was presented using
E-prime software (Psychological Software Tools,
Pittsburgh, PA, USA). Stimuli were presented pseudo-
randomly against a black background. Each stimulus
was displayed on the screen for 2.5 seconds, with an
interstimulus (black screen) interval varying between
0.5 and 1.5 seconds. The images were projected onto
a translucent screen at the end of the scanner bed,
visible via a mirror above the participant’s head.
All participants were instructed to indicate the gender
of each face by pressing one of two buttons of two
magnet-compatible button boxes with the index ﬁnger
of the left or right hand – left for male and right
for female. During the presentation of scrambled
faces, participants had to press left or right buttons
in conformity with the instruction presented on the
screen, i.e., an arrow pointing to the left or to the right.
The participants were not informed that the emotional
expression was under study in the experiment.
6.2.3 MRI data acquisition
Images were acquired with a Philips 3T MR-scanner.
A sense-8 (UMCG and LUMC) or a sense-6 (AMC)
channel head coil was used for radio frequency trans-
mission and reception. For each participant a series
of echo planar imaging (EPI) volumes – sensitive to
the blood oxygenation level dependent eﬀect – were
obtained, entailing a T2*-weighted gradient echo
sequence (repetition time [TR]=2300 ms, echo time
[TE]=28.0 ms at UMCG and TE=30.0 ms at AMC
and LUMC) using axial whole-brain acquisition, with
an interleaved slice acquisition order. The EPI volumes
had 39 slices at UMCG and 35 slices at AMC and
LUMC (0 mm gap, 3 mm thickness). The matrix sizes
were: 64x64 voxels at UMCG and 96x96 voxels at
AMC and LUMC. The in-plane resolution was 3x3
mm at UMCG and 2.29x2.29 mm at AMC and LUMC.
The images were acquired parallel to the anterior-
posterior commissure plane. A T1-weighted anatomical
MRI was also acquired for each subject (TR=9 ms,
TE=3.5 ms, matrix size 256x256, voxel size 1x1x1 mm).
6.2.4 Data analysis
The analyses on clinical and demographic data were
performed with SPSS v.16.0 (SPSS Inc., Chicago,80 AMYGDALA CONNECTIVITY IN ANXIETY DISORDERS
IL, USA). In order to test for signiﬁcant diﬀerences
between groups an analysis of variance (ANOVA)
was conducted. A post-hoc test was conducted using
Bonferroni correction in case a signiﬁcant eﬀect was
identiﬁed. Yates’ chi-squared tests were conducted to
test for gender and handedness eﬀects. In order to
control for multiple comparisons we applied Bonﬀeroni
correction, thus the p-value 0.050 was divided by
the number of tests (six Yates chi-squared tests were
conducted for each variable) performed. A signiﬁcant
eﬀect was identiﬁed if the p-value was smaller than
0.00833.
Functional imaging data were pre-processed and
analysed using the statistical parametric mapping
software package (SPM5) implemented in Matlab
v.7.1.0 (The MathWorks Inc., MA, USA). The EPI
volumes were corrected for slice time acquisition,
realigned to the ﬁrst volume, normalised to standard
stereotaxic space deﬁned by the Montreal Neurological
Institute (MNI) template and spatially smoothed
with a 8 mm full-width at half-maximum Gaussian
kernel. Low-frequency noise was removed by applying
a high-pass ﬁlter (cut-oﬀ of 128 s) to the fMRI time-
series at each voxel.
Signiﬁcant haemodynamic changes were identiﬁed
using a general linear model, with respect to the
event-related response convolved with the canoni-
cal haemodynamic response function (HRF, [21]).
For each subject, a weighted contrast was com-
puted for ”angry> scrambled”, ”fearful>scrambled”,
”happy>scrambled”, ”neutral>scrambled” and
”faces>scrambled”.
A random-eﬀects group analysis was conducted on
weighted contrasts generated at single-subject level
in four (facial expressions) by four (groups) repeated
measures analysis of covariance (ANCOVA), with
centers, age, years of education and medication
(users/non-users) added as nuisance factors. The main
eﬀect of facial expressions is reported at a threshold
of p<0.050 Family-Wise Error (FWE) corrected for
multiple comparisons, whereas the group diﬀerences
were explored at p<0.001 uncorrected and the clusters
surviving corrected cluster-level p<0.050 are reported.
Because the amygdala was of main interest, Small
Volume Correction (SVC) was applied using the
amygdala mask deﬁned by the WFU pickatalas [22].
An additional analysis was conducted in the same way
as mentioned above, testing for group diﬀerences in the
neural response to emotional versus neutral faces in-
cluding the following contrasts images: angry>neutral,
fearful>neutral and happy>neutral.
Psychophysiological Interaction analysis
Psychophysiological interaction (PPI) is used to
test the changes in one brain region in terms of an
interaction with a psychological component (task) and
activity in another brain area [23]. In other words, PPI
analysis captures the modulation of activity in one
brain region by activity in other brain areas dependent
on speciﬁc active tasks.
In the present study, this interaction among neuro-
physiological measures and the experimental factor
was examined for left and right amygdala deﬁned as
”seed” regions. Amygdala activation was identiﬁed
at the subject level for the contrast ”faces>baseline”
inspected at p<0.050 uncorrected. The deconvolved
time series was extracted from a sphere of 5 mm radius
centered around the peak activated voxel within left
and right amygdala (deﬁned by WFU pickatlas) for
each participant. This time-series reﬂects amygdala
reactivity across all facial expressions, i.e., we chose not
to restrict the ”seed” region to only those (amygdala)
voxels that were activated in response to emotional
faces. Choosing only voxels activated by the emotional
faces could bias our results in ﬁnding a task related
(emotion>neutral) connectivity pattern.
The PPI term (PPI regressor) was calculated
as the element-by-element product of the amyg-
dala time series and a vector coding for the task
eﬀect (”angry>neutral”, ”fearful>neutral” and
”happy>neutral”). This product was subsequently
re-convolved with the HRF. The interaction term was
entered as a regressor in a ﬁrst level model together
with the amygdala time series (physiological variable)
and a vector coding for the task eﬀect (psychological
variable). The eﬀect of the interaction term was
examined using the contrast [1 0 0] for a positive PPI
eﬀect and [-1 0 0] for a negative PPI eﬀect, the ﬁrst
column representing the interaction term.
The individual contrast images were then entered into
a second level analysis to identify the ”target” regions
showing changes in connectivity with the ”seed” region
depending on experimental context: angry, fearful or
happy versus neutral faces perception between groups.
It should be noted here that the causal direction of
covariation cannot be determined using this method.
Ten PD, ﬁfteen SP, nine SP+PD and seventeen HC
were included in this analysis. A three (contrasts)
x four (groups) repeated measure ANCOVA was
performed on the contrast images for the PPI eﬀects
with center, age, education (years) and medication
(users/non-user) as nuisance factors. An initial
threshold of p<0.001 uncorrected was applied and
clusters surviving the threshold of p<0.050 corrected
are reported.
Within group analyses testing for the eﬀect of anx-
iety symptoms severity on amygdala coupling were
performed using nonparametric tests. Nonparametric
tests were conducted because of the small number6.4. Discussion 81
of participants included in these analyses. One
patients with SP and one with PD were excluded from
this analysis because of missing scores on the BAI scale.
6.3 Results
6.3.1 Participant characteristics
No group diﬀerence was found on age, years of educa-
tion, gender and handedness (all p>0.050). Table 6.1
presents the group characteristics. A main eﬀect of
group was found on BAI (F[3,72]=12.08, p<0.001), FQ
(F[3,68]=16.17, p<0.001) and MADRS (F[3,71]=9.372,
p<0.001) score. Post-hoc tests showed that patients
groups scored higher on BAI, FQ and MADRS than
HC (all p<0.050).
6.3.2 Imaging data
Main eﬀect of task
Viewing facial expressions elicited activation in bi-
lateral fusiform gyrus, bilateral amygdala and right
inferior frontal gyrus (Table 6.2, Figure 6.1).
Secondly, we examined the neural response to emo-
tional (angry, fearful and happy) versus neutral faces
across all participants. Emotional facial expressions
elicited more left middle occipital gyrus (x=-30,
y=-90, z=-6) activation at p<0.050 FWE. There
was no signiﬁcant diﬀerence in amygdala response to
emotional>neutral faces (uncorrected p<0.050: left
amygdala - no eﬀect, right amygdala: x=27, y=0,
z=-18, Z=2.50, p=0.100 FWE, SVC).
Group diﬀerences
Table 6.2 displays the regions showing group diﬀer-
ences in activation to facial expressions. No signiﬁcant
diﬀerence was found in amygdala response to fearful
or any other facial expression (>scrambled) in PD
compared to HC. In response to happy (>scrambled)
faces greater left amygdala activation was found in
HC compared to PD patients (Table 6.2, Figure 6.2).
In response to angry, fearful or happy>neutral faces
no signiﬁcant diﬀerences in the neural response were
observed between PD and HC.
HC showed greater left temporal pole extended to
amygdala and fusiform gyrus activation to fearful
(>scrambled) faces compared to SP+PD patients
(Table 6.2, Figure 6.4). Relative to neutral faces,
emotional faces did not elicit signiﬁcant diﬀerences in
amygdala activation in SP+PD patients compared to
HC (Table 6.2).
No signiﬁcant diﬀerence in the neural response to
angry, fearful, happy or neutral (>scrambled) faces
was found between SP and HC. Emotional faces com-
pared to neutral faces did not elicit greater amygdala
response in SP compared to HC (Table 6.2).
Relative to SP+PD outpatients, SP outpatients
showed hyperactivation of left temporal pole extended
to amygdala-hippocampus and fusiform gyrus in
response to fearful faces (>scrambled).
PPI analysis
In the Appendix (Table A.1) are displayed the changes
of the amygdala connectivity for emotional (angry, fear-
ful or happy) versus neutral faces observed within each
group.
SP outpatients compared to HC showed a negative cou-
pling of left amygdala to posterior cingulate extended to
precuneus during perception of angry (>neutral) faces.
A negative coupling of left amygdala to right middle
frontal gyrus during perception of fearful (>neutral)
faces was observed in SP compared to HC (Table 6.3).
PD and SP+PD outpatients showed no signiﬁcant
changes in connectivity between amygdala–frontal re-
gions for emotions>neutral faces relative to HC.
Finally, we tested if amygdala–frontal areas coupling
during perception of emotional facial expressions is
modulated by anxiety severity. No signiﬁcant eﬀect of
anxiety severity was found on the left or right amygdala
connectivity during viewing emotional versus neutral
faces.
6.4 Discussion
In the present study we investigated the neural mech-
anism associated with perception of facial expressions
of emotions in patients with SP and/or PD, relative
to HC. We expected amygdala hyperactivation to emo-
tional and neutral facial expressions in SP and PD rel-
ative to HC.
We found that SP+PD outpatients showed amygdala
hypoactivation in response to fearful and happy faces
compared to HC. Amygdala hypoactivation in response
to fearful faces has been previously reported in PD
patients compared to healthy participants suggesting
a diminished emotional response during perception of
fearful facial expressions [10]. Amygdala hypoactiva-
tion was also reported during anticipatory anxiety in
PD patients compared to HC suggesting that PD is
associated with a functional impairment of the amyg-
dala during anticipatory anxiety [24]. Interestingly, in
the present study, outpatients with PD alone showed
less amygdala activation during perception of happy
faces compared to HC. Domschke et al. [11] reported
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Table 6.1: Demographic and clinical characteristics of the groups (n represents the number of partici-
pants).
Group Age Education Right-Handed Male SSRIs BAI FQ MADRS
(SD) years (SD) (%) (%) users (%) (SD) (SD) (SD)
HC 34.75 13.40 90.0 45.0 0 2.10 7.15 0.65
(n=20) (9.81) (2.68) (2.27) (7.89) (1.31)
PD 34.50 12.78 88.9 16.7 22.2 11.12 24.73 9.47
(n=18) (10.36) (3.47) (6.59) (21.82) (7.67)
SP 37.57 12.96 91.3 39.1 26.1 12.74 37.82 10.77
(n=23) (10.02) (3.65) (9.47) (18.95) (10.13)
SP+PD 34.50 12.38 93.8 12.5 50.0 18.38 41.87 12.56
(n=16) (7.43) (2.63) (12.21) (16.91) (7.98)
Figure 6.1: Main eﬀect of task – viewing facial expressions versus scrambled faces at p<0.050 (FWE).
Figure 6.2: Left amygdala activation to happy (>scrambled) faces in HC compared to PD and compared
to SP+PD. The bars indicate the % signal change and the 90 % conﬁdence interval in the left amygdala
within each group during perception of happy (>scrambled) faces. Stars indicate signiﬁcant diﬀerence
relative to HC.6.4. Discussion 83
Table 6.2: Neural response to facial expressions (>scrambled) – within and between groups. BA -
Brodmann area. SP - social phobia, PD - panic disorder, SP+PD - social phobia and panic disorder
comorbidity, HC - healthy controls. *Small Volume Correction.
Region Side MNI Z-value Cluster p-corrected
x y z size cluster-level
Main eﬀect of facial expressions > scrambled faces
fusiform gyrus R 39 -51 -24 > 8 183 < 0.001
fusiform gyrus L -42 -48 -21 > 8 100 < 0.001
amygdala R 21 -6 -15 > 8 134 < 0.001
amygdala L -18 -6 -18 > 8 147 < 0.001
inf. frontal gyrus R 51 30 18 7.14 282 < 0.001
Group diﬀerences
PD > HC
Angry>Scrambled sup. parietal lobule L -30 -75 33 4.40 64 0.032
HC > PD
Happy>Scrambled amygdala L -18 -3 -18 3.37 5 0.008*
HC > SP+PD
Fearful>Scrambled temporal pole (BA38) L -33 3 -21 4.14 58 0.045
amygdala L -21 -6 -15 3.73
inf. occipital gyrus L -51 -69 -3 4.35 78 0.015
(BA37)
inf. temporal gyrus R 48 -45 -18 4.12 103 0.004
(BA37)
fusiform gyrus R 39 -48 -24 3.82
Happy > Scrambled amygdala L -21 0 -21 4.62 15 < 0.005*
SP+PD > HC
Angry>Neutral sup. frontal gyrus R 15 21 48 4.07 62 0.031
SP > HC
Angry>Neutral calcarine gyrus R 21 -72 9 4.50 81 0.011
middle occipital gyrus L -21 -63 6 4.39 54 0.050
sup. parietal gyrus L -21 -63 42 4.46 91 0.007
PD > SP+PD
Fearful>Scrambled inf. frontal gyrus R 48 9 27 4.11 62 0.036
SP > SP+PD
Fearful>Scrambled temporal pole L -36 3 -21 4.91 74 0.019
hippocampus L -24 -12 -12 3.90
amygdala L -21 3 -21 3.68
lingual gyrus R 33 -81 -18 4.89 73 0.020
fusiform gyrus L -39 -45 -21 4.36 58 0.045
Table 6.3: Group diﬀerences in amygdala – cortical regions coupling. BA - Brodmann Area. SP – social
phobia, HC – healthy controls.
Region Side MNI Z-value Cluster p-corrected
x y z size cluster-level
HC > SP: Left amygdala functional connectivity
Angry>Neutral cingulate gyrus (BA31) L -3 -51 42 4.32 177 <0.001
cingulate gyrus (BA31) R 6 -42 42 3.72
middle temporal gyrus L -39 -66 27 4.02 54 0.025
Fearful>Neutral middle frontal gyrus R 30 27 48 4.28 63 0.013
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Figure 6.3: Abnormal amygdala–cortical regions coupling during perception of angry and fearful faces
in SP relative to HC. Left amygdala – posterior cingulate gyrus coupling during angry>neutral faces
(red) and left amygdala – right middle frontal gyrus coupling during fearful>neutral (yellow).
Figure 6.4: Left amygdala activation to fearful
(>scrambled) faces in HC compared to SP+PD.
The bars indicate the % signal change and the 90 %
conﬁdence interval in the left amygdala within each
group during perception of fearful (>scrambled)
faces. Stars indicate signiﬁcant diﬀerence relative
to HC.
in PD patients homozygous for the serotonin 5-HT1A
-1019G allele compared to PD patients with 5-HT1A -
1019C allele suggesting that serotonergic polymorphism
5-HT1A -1019G contribute to disrupted emotional pro-
cessing. It is diﬃcult, however to compare their study
with the present study, because of the lack of healthy
controls in their study. Thus, it is not clear if amygdala
hyperactivation to happy faces reported by Domschke
et al. [11] will diﬀer signiﬁcantly in PD patients com-
pared to healthy participants. Hence, we may conclude
that panic disorder may be associated with a weaker
emotional response during positive emotions, as sug-
gested by amygdala hypoactivation during perception
of happy faces. The same holds true for comorbid SP
and PD, which showed weaker emotional response not
only to positive emotions, but also during perception of
fearful facial expressions.
Furthermore, we found less fusiform gyrus activation
during perception of fearful faces in SP+PD outpatients
compared to HC and SP outpatients. Relative to PD
outpatients, SP+PD outpatients showed right inferior
frontal gyrus hypoactivation in response to fearful faces.
These regions which were found to have lower activa-
tion in SP+PD have been reported to be involved in
face perception and emotional response [25]. Taken to-
gether, we may conclude that outpatients with SP+PD
comorbidity have a disturbed emotional processing of
fearful faces. This mechanism was signiﬁcantly diﬀer-
ent in SP+PD compared to SP or PD alone, thus we
suggest that the comorbidity of PD and SP is not to be
taken as a summation of the two.
In contrast to our hypothesis, we did not ﬁnd signif-
icant amygdala activation during perception of angry,
fearful, happy or neutral facial expressions in SP outpa-
tients compared to HC. In addition we examined if emo-6.4. Discussion 85
tional (angry, fearful or happy) >neutral faces elicited
signiﬁcantly increased amygdala activation in anxiety
patients compared to HC. No signiﬁcant diﬀerence in
amygdala response to emotional versus neutral faces
was observed in SP patients (or in the other groups of
anxiety patients) compared to HC. We may conclude
that neutral faces elicited a similar amygdala activa-
tion as facial expressions of emotion in all participants,
irrespective of the presence of an anxiety diagnosis.
The present ﬁndings are in line with some of the pre-
vious results reporting no diﬀerence in amygdala re-
sponse to emotional faces in SP patients [12, 26]. How-
ever, other studies did report amygdala hyperactivation
to negative [4, 5], positive [6] or neutral [8, 7] emo-
tions in SP patients. Phan et al. [27] reported greater
amygdala activation to harsh (angry, fearful and dis-
gusted) compared to happy faces in generalised social
phobia relative to healthy participants, whereas no sig-
niﬁcant diﬀerences in amygdala responses to happy or
neutral faces compared to baseline (color photographs
of radios) were found between groups. The authors
suggested that the control condition may lead to in-
consistencies in the results. Another explanation for
the discrepancies between ﬁndings may be the task de-
mands (gender discrimination, emotion recognition, va-
lence rating), sample characteristics, e.g., mood disor-
ders comorbidity, illness severity – mild/moderate ver-
sus severe anxiety (BAI score between 8-15, [28]) or
medication use.
In line with our hypothesis, abnormal amygdala–frontal
areas connectivity was observed in SP outpatients com-
pared to HC. However, this was not the case for PD
or SP+PD comorbidity, which showed no signiﬁcant
changes in amygdala–frontal areas connectivity dur-
ing perception of emotional facial expression (>neutral
faces), compared to HC.
SP outpatients showed a negative left amygdala–right
middle frontal gyrus connectivity during perception of
fearful (>neutral) faces, compared to HC. The pre-
frontal cortex was reported to be involved in cognitive
processes and emotion regulation [29] and amygdala–
frontal areas connectivity predicts successful regula-
tion of negative emotions [30]. Increased dorsolat-
eral prefrontal cortex–amygdala connectivity during
resting state was reported in generalised anxiety dis-
orders (GAD) patients compared to HC and this
connectivity was negatively correlated with anxiety
measures [14]. The authors concluded that abnormali-
ties in the amygdala–lateral prefrontal coupling charac-
terised GAD and this coupling suggests the engagement
of a compensatory mechanism [14]. Additionally, a re-
cent meta-analysis on amygdala functional connectivity
reported that amygdala has a complex network con-
nection, including medial and inferior frontal gyri, and
posterior and anterior cingulate, suggesting its impli-
cation in emotion-cognition interaction [31]. Given the
previous ﬁndings, we may conclude that the negative
connectivity of the amygdala–dorsal prefrontal cortex
suggests an impairment of emotion regulation during
perception of fearful faces in the SP outpatients.
Furthermore, SP outpatients showed stronger negative
left amygdala–bilateral precuneus/PCC connectivity
during angry (>neutral) faces, compared to HC. Pre-
cuneus has been associated with evaluation of one’s own
emotional state and self-focused evaluation, but also to
be part of the default mode network [32]. Gentili et al.
[33] reported more precuneus/PCC activation during
face perception in social phobia compared to healthy
participants suggesting that an impairment in the ”de-
fault mode network” is associated with self-focused at-
tention and ”feelings of wariness of others’ judgments”.
According to these ﬁndings, we conjecture that negative
covariation between left amygdala and PCC/precuneus
activation during perception of angry faces represents
an inhibitory inﬂuence through this pathway. We may
surmise that patients with SP have a stronger self-
focused evaluation during perception of angry facial ex-
pressions than HC, because less decreased precuneus
activation to angry faces was observed in SP than in
HC (uncorr p<0.050).
Albeit the number of participants in this study is in the
range of other published studies, we can always con-
sider the sample size as a potential limitation. More-
over, some of the outpatients included herein were un-
der medication at the time of scanning, which may have
been a confound in the present ﬁndings because it has
been reported previously that medication normalised
amygdala response [34]. Thus, although we controlled
for medication use, we cannot completely exclude ef-
fects of the type and dosage of medication. This can
also be considered a limitation of this study.
In conclusion, this study provides evidence of an al-
tered amygdala–frontal cortex coupling during percep-
tion of negative emotions in outpatients with SP com-
pared to HC, which suggests an impairment of emotion
regulation. PD may be associated with a lack of emo-
tional response to positive emotions, as suggested by
amygdala hypoactivation to happy faces, compared to
HC. The same holds true for patients with SP and PD
comorbidity which may be associated with an impair-
ment of emotional processing not only of happy faces
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A Amygdala–cortical regions coupling modulated by the per-
ception of emotional facial expressions.
We attach here the supplementary material referred to in this chapter.
Table A.1: Left and right amygdala functional connectivity. * Small Volume Correction, pFWE<0.050,
ACC – Anterior Cingulate Cortex, BA – Brodmann Area. PD – panic disorder, SP – social phobia,
SP+PD – comorbid social phobia and panic disorder, HC – healthy controls.
Region Side MNI Z-value Cluster p-corrected
x y z size cluster-level
SP+PD: Right amygdala – negative functional connectivity
Happy>Neutral dmPFC R 21 39 30 3.65 26 0.020*
PD: Left amygdala – positive functional connectivity
Angry>Neutral ACC L -12 42 12 3.75 11 0.013*
SP: Left amygdala – negative functional connectivity
Angry>Neutral precuneus R 6 -42 45 4.43 130 <0.001
precuneus L 0 -51 45 3.95 54 0.025
Fearful>Neutral medial frontal gyrus R 15 -6 54 4.89 140 <0.001
middle frontal gyrus L -39 21 39 4.85 53 0.027
(BA9)
middle frontal gyrus R 33 30 48 4.42 89 0.002
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Overview – The subject of this thesis lies in the ﬁeld of neuropsychology and it aimed to identify abnormalities
in the neural correlates of emotional processing in community-based patients diagnosed with depression and/or
anxiety. The importance of uncovering such abnormalities is in gaining a better understanding of the conditions,
hopefully inspiring new treatment ultimately aiming at a faster reintegration of outpatients.
The studies presented in this thesis have made use of functional neuroimaging which, as pointed out also in the
Introduction, allows for non-invasive identiﬁcation of distributed patterns of human brain activity associated
with perceptual, cognitive, emotional and behavioral processes. We used the fMRI method to measure the
hemodynamic response, i.e., changes in blood ﬂow, related to neural activity in patients diagnosed with anxiety
disorders and/or major depression at diﬀerent stages of their illness.
Two experimental paradigms were employed to investigate the neural mechanism related to emotional processing
in MDD and/or anxiety: implicit and explicit emotional processing. The two paradigms were meant to oﬀer a
multifaceted view on emotional processing, i.e., implicit and explicit emotional processing, and hence a clearer
picture of the neural basis involved in the aforementioned disorders. The implicit paradigm employed stimuli
of facial expressions of emotion but participants were not explicitly instructed to pay attention to displayed
emotions. The explicit emotional processing paradigm used word stimuli and involved additional cognitive
processes, language processes (reading the words) and emotional memory retrieval (emotional attribution to
words). With this we aimed to determine if the aberrant neural response is to be associated with perception of
emotion or related to the interaction of diﬀerent processes, e.g., an emotion-cognition interaction.
First we reviewed emotion-discrimination accuracy in patients with aﬀective disorders (see Chapter 2). In
the ﬁrst part of the experimental section of this thesis we studied the neural response to facial expressions
of emotion and emotional words in MDD and/or anxiety patients compared with healthy controls (HC). In
the second part, we examined the degree to which activation in frontal regions is explained by the interaction
between amygdala activity and perception of emotional facial expressions - modulated by the neuroticism score
in healthy participants. Finally, in the third and last part of the experiment section we investigated amygdala
connectivity with frontal regions in patients with anxiety disorders by looking at group diﬀerences.
Emotion discrimination accuracy (see Chapter 2) – Facial expressions of emotion contain information about
one’s feelings and play an important role in social communication and interaction. Thus, an impairment of
emotion recognition of facial expressions may be associated with poor social and interpersonal relations and,
furthermore, can be connected with some of the symptoms the patients present. For example, a common
occurrence in this respect is that patients with social phobia tend to avoid crowded public spaces for the
psychological discomfort these places inﬂict. It is unclear though, to which extent this impairment is speciﬁc
to depression and anxiety disorders. In our review on emotion-discrimination accuracy in aﬀective disorders,
we found that MDD and anxiety disorders are associated with overall emotion recognition impairment. This
impairment was more pronounced in MDD patients, it was not apparent in children with anxiety disorders.
Explanations for this deﬁcit in depression may be determined by patients negative emotional experience, by
the assessment of their internal mood state or by the cognitive impairments present in depression [1]. Because
depression is characterized by negative cognitions (worthlessness, self-criticism, hopelessness) the patients
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evaluation of external stimuli, including facial expressions, might be more negative than the evaluation done by
healthy subjects [2, 3]. It remains unclear whether the impairment in emotion recognition is emotion speciﬁc.
Facial expressions of emotion – fMRI study (Chapter 3) – As concluded in Chapter 2, MDD and anxiety patients
have diﬃculties in recognizing and labelling facial expressions of emotions. We investigated the underlying
diﬀerences at the neural level between these two diagnostically distinct groups. Previous ﬁndings showed that
inpatients with MDD and anxiety have an increase in the amygdala response to emotional facial expressions
[4, 5, 6, 7]. However, as outpatients with MDD and/or anxiety have a variable and less pronounced symptom
severity it is unclear whether or not the aberrant neural response to emotional facial expression is also present
in them. We hypothesized that there would be diﬀerences in the neural response, especially in the amygdala
response during the perception of facial expressions of emotion.
Furthermore, previous studies have shown that antidepressant medication normalized amygdala activation to
emotional stimuli and also reduced symptom severity in patients with MDD or anxiety disorders [8, 9, 10, 11].
This was also under investigation.
Our ﬁndings show that emotional facial expressions elicited to a similar extent the same neural mechanism in
patients with MDD and/or anxiety disorders as in HC. This response involved bilateral amygdala, bilateral
fusiform gyrus and right inferior frontal gyrus, regions that are known to be responsible for face perception
[12]. The groups seemed to apply similar neural strategies. These results show a default network with no gross
abnormalities in activation for perception of facial expressions of emotions in outpatients. It is hence concluded
that patient groups considered in this study have diﬀerences in activation that are statistically insigniﬁcant.
To further substantiate these unexpected ﬁndings we examined the amygdala response shape. Siegle et al.
[13] reported sustained amygdala response to negative stimuli in seven depressed patients, whereas in fourteen
patients with generalized social phobia a delayed amygdala response was found to angry, fearful and happy
facial expressions [14]. Based on these studies, we expected that MDD patients exhibit a sustained amygdala
response compared to HC. In anxiety patients, we expected a later amygdala response to facial expressions of
emotions compared to HC. Strikingly, our data showed also no signiﬁcant group diﬀerences in the amygdala
response shape to facial expressions. Furthermore, after controlling for medication use, unmedicated outpatients
compared to HC did not exhibit aberrant amygdala response to emotional facial expression.
One can consider diﬀerent causes for these inconsistencies in ﬁndings such as diﬀerent task characteristics (words
versus picture stimuli), sample size and sample heterogeneity in terms of e.g., illness severity. Nonetheless,
our large sample size adds weight to our results. For outpatients and implicit emotional processing of facial
expressions we believe our study constitutes a benchmark for further studies.
Emotional words – fMRI study – Visual emotional signals can be transmitted by mime or textually. However,
to our knowledge, only few studies so far have examined emotional processing of textual verbal stimuli in
depression or anxiety disorders. In Chapter 4 we aimed to delineate the neural mechanism responsible for
emotional evaluation of word stimuli in outpatients with depression and/or anxiety. The ﬁndings showed that
anxiety patients had a stronger emotional response to negatively evaluated words than healthy participants. In
MDD patients a positive association was observed between amygdala response to negative evaluated words and
MADRS score. This leads us to conclude that aberrant amygdala response is linked to illness severity rather
than being a binary (i.e., an all-or-nothing) diagnostic characteristic of MDD.
Diﬀerences between the two tasks – The word-evaluation task and the faces task induced diﬀerent neural
responses: perception of facial expressions of emotions induced no signiﬁcant amygdala hyperactivation in
outpatients with MDD and/or anxiety disorders, whereas signiﬁcant amygdala hyperactivation was found in
anxiety patients during emotional evaluation of words.
We could say that the word-evaluation task may be a more demanding task than the faces task, because it
involves explicit emotional judgment and triggers emotional memories, e.g., during emotional evaluation of
negatively perceived words [15]. However, it remains an open question whether emotionally perceived words are
more arousing than facial expressions. Within the experimental framework of this study we could not investigate
this aspect.
Thus, being self-critical, if during perception of facial expressions of emotions no signiﬁcant amygdala hy-
peractivation was observed in outpatients with MDD and/or anxiety disorders, whereas signiﬁcant amygdala
hyperactivation was found in anxiety patients during emotional evaluation of words, we can attribute the93
contrast to the task diﬀerences, e.g., task demand (gender discrimination versus emotional attribution to words)
and stimulus type (faces versus words).
With regard to the comorbidity of depression and anxiety we suggest that it is not to be regarded as a simple
summation of the two diagnoses: the brain activation patterns were very diﬀerent from those in patients
who were only depressed or only anxious. Further, even though the coexistence of depression and anxiety
is associated with more severe clinical symptoms, surprisingly the amygdala response to emotional stimuli
(facial expressions of emotion or words) in DAC patients was indistinguishable from that in HC (Chapter 3 and 4).
Amygdala connectivity – Connectivity modeling of brain functions associated with emotional and cognitive
processes has become increasingly popular over the last years. In this framework, at the end of almost a decade
of neuroimaging studies with diﬀerent methods, the amygdala was conﬁrmed by a meta-analysis to be part
of a complex network of connections having direct or indirect connections with regions involved not only in
emotional processing but also in cognitive processes [16, 17].
An exciting new ﬁeld of the last years is functional connectivity of brain regions associated with emotional
processing in conjunction with personality traits [18, 19]. For example, a mood induction study with positron
emission tomography (PET) showed that neuroticism is associated with changes in subgenual cingulate coupling
with prefrontal regions during mood induction, possibly reﬂecting a susceptibility marker for depression [19].
Furthermore, amygdala–ACC coupling was suggested to be modulated by trait anxiety [20]. In generalized
anxiety disorder increased dorsolateral frontal cortex–amygdala functional connectivity was reported during
resting state and this coupling was negatively correlated with anxiety [21].
Considering the above studies and the ﬁndings presented in the ﬁrst chapters of this thesis, it was only natural
for us to wonder about the existence of diﬀerences in connectivity that may be even more relevant than
diﬀerences in neural activation. The main aim of the ﬁfth and sixth chapters of this thesis was to examine how
amygdala–frontal regions connectivity is inﬂuenced by neuroticism scores and, in addition, to look for diagnosis
speciﬁc eﬀects in patients with anxiety disorders. In other words, we aimed for a better understanding of the
neural basis associated with vulnerability for the development of aﬀective disorders. Furthermore, we continued
the investigation of the BOLD eﬀects in the emotional neural network in anxiety disorders, such as panic
disorder (PD) and social phobia (SP).
We observed that individual diﬀerences in neuroticism corresponded with diﬀerences in functional connectivity
of amygdala with prefrontal regions during processing of negatively perceived emotional material (Chapter 5).
Persons high in neuroticism might have less ACC related inhibitory control over the amygdala during perception
of negative facial expressions of emotions. The opposite was also observed: a positive association between
neuroticism and amygdala– dmPFC coupling. This suggests that persons with high neuroticism may have more
pronounced self-referential processing during processing of negative emotions. This connectivity pattern provides
insight into the neural mechanism associated with vulnerability to aﬀective disorders, such as depression and
anxiety.
In Chapter 6 we aimed to examine the neural basis of emotional processing in PD and SP patients relative to HC
looking not only at diﬀerences in amygdala–frontal cortex coupling but also at abnormal brain activation during
perception of positive and negative facial expressions of emotion. We observed that during perception of happy
facial expressions PD patients with or without SP had amygdala hypoactivation, relative to HC. Additionally,
patients with SP+PD comorbidity showed amygdala hypoactivation to fearful faces, compared to HC. One
explanation for this apparently paradoxical result (usually hyperactivation is found in anxiety disorders) may be
that enhanced amygdala activation may also be present during the control condition (scrambled faces) so that
no signiﬁcant activation is seen when subtracting baseline from the fearful or happy faces conditions. Another
explanation may be a lack of emotional response to positive emotions in PD with or without SP.
Interestingly, SP patients showed no signiﬁcant diﬀerences compared to HC in the neural response to perception
of facial expressions of emotions. However, a negative amygdala–frontal coupling was found during perception
of fearful faces in SP compared to HC. The frontal cortex–amygdala circuit has been previously associated
with emotion regulation processes [22, 23]. We may conclude that even though SP patients showed no gross
abnormalities at the neural activation level, they did show a diﬀerent functional connectivity within the brain
network responsible for emotional perception, relative to HC.
The studies presented in Chapter 5 and 6 add to the existing literature on the presence of abnormal neural
network activity associated with vulnerability to aﬀective disorders and anxiety disorders. At ﬁrst glance, the94 EPILOGUE
ﬁndings do not seem to be entirely consistent. The level of neuroticism was found to correlate with connectivity
between amygdala on the one hand and anterior and medial frontal regions (ACC and dmPFC) on the other
during negative emotions.
However, in patients with (only) SP abnormal amygdala–middle frontal gyrus coupling was observed during
perception of fearful facial expressions. The abnormal functional pattern of connectivity seen in high neuroticism
is similar, but not identical to that in anxiety disorders patients. This suggests a potential vulnerability marker
for aﬀective disorders during negative emotional perception. A long-term approach may reveal markers of
disease vulnerability. Hence, further studies are needed to support our hypothesis in anxiety disorders. Dynamic
causal modeling may give a better insight in the neural mechanism of emotional processing in anxiety patients,
such as the direction of these connections, i.e., top-down or bottom-up regulation.
Remarks on the studies – The ﬁndings presented in this thesis are characteristic for community patients with
MDD and/or anxiety disorders selected from primary care.
We observed that patients with depression and anxiety comorbidity are not to be considered as people with a
summation of depression and anxiety. Depression and anxiety often arise sequentially in one patient [24] and
because depression and anxiety comorbidity has a high prevalence and DAC patients are less likely to respond to
treatment [25], it is important to further understand the neural mechanism - its development and manifestations
- of this state.
In the last years there was some debate regarding the validity of a categorical distinction between depression
and anxiety [26]. For the new DSM-V it has been proposed that the coexistence of depression and anxiety be
considered as a separate diagnosis deﬁned therein as Mixed Anxiety Depressive Disorder (MADD). Research
criteria for such a diagnostic category were already included in the DSM-IV [27]. Reports based on large
samples from primary care suggested the existence of this mixed condition (e.g., Ormel et al. [28]). However,
distinguishing MADD as a separate category has also been criticized on conceptual and empirical grounds [29].
Further studies are needed to conﬁrm if MADD may be considered as a separate diagnosis, not only looking at
symptoms severity, course and outcome, but also looking at the neural mechanism associated with emotional
or cognitive processes. The same holds true for the comorbidity of anxiety disorders (social phobia and panic
disorder) which does not seem to be a summation of SP and PD at the neural level. Thus, we suggest that
future studies should control for the co-existence of a second diagnosis because – as observed in our study – the
presence of comorbidity should be considered as a distinct diagnosis.
The neural mechanism associated with emotional processing may be studied using diﬀerent paradigms. From
our study the importance of the paradigm used to study emotional or cognitive processes, is more than apparent.
For example, it is diﬃcult to even directly compare the two studies presented in Chapter 3 and 4, because there
are diﬀerences not only in the task demands (gender discrimination versus emotional attribution), but also in
the stimuli used (faces versus words).
We observed no signiﬁcant diﬀerence in illness severity between medicated and medication-free patients. This
may lead us to conclude that aberrant amygdala response is associated with symptom severity rather than
being diagnosis speciﬁc. This may not be the case for anxiety disorders when it comes to explicit emotional
processing, where greater amygdala activation to negatively evaluated words was observed relative to controls.
One explanation may be, as mentioned earlier, that amygdala is involved in earlier processing underlying
emotional evaluation, as suggested by Lee et al. [15]. Another explanation may be that emotional evaluation of
words trigger emotional memory leading to a stronger emotional response in anxiety patients and in depressed
patients. However, given the structure of our experiment, it is not possible to conclude for the studies presented
in Chapter 3 and 4 that words are perceived as more arousing or more emotional than facial expressions.
Finally, we observed that even if there are no gross abnormalities in the neural response in social phobia
compared to HC, it might be that a distinct neural network is involved in emotional processing. Thus, further
studies will need to test our hypothesis that outpatients with depression or anxiety disorders have an aberrant
connectivity but no large diﬀerences in regional brain activation.
Novelty – The research presented in this thesis is a step forward in understanding the neural mechanisms
associated with emotional processing in outpatients diagnosed with major depressive disorder (MDD) and/or
anxiety disorders. Two features distinguish this thesis: the ﬁrst one is that the study herein is based on large
sample and the second one is that this study employs not only MDD and anxiety subjects, but it concurrently
considers depression and anxiety as an extra group. Whereas the ﬁrst aspect allows for a high degree ofReferences 95
conﬁdence in the detected diﬀerences at statistically signiﬁcant levels, the second feature may help to determine
if the co-occurrence of depression and anxiety disorders can be conceived of as a summation of the two disorders
or as a separate condition.
In terms of novelty, this thesis identiﬁes the default network of emotion perception of community outpatients
for two diﬀerent types of emotional stimuli. We observed that perception of facial expressions of emotions in
community-based outpatients relied to a large extent on the same neural mechanism as in healthy participants.
It should be noted, however, that negative emotional evaluation of words elicited a stronger emotional response
in anxiety outpatients relative to healthy volunteers. This indicates that evaluation of emotional words lead to
an increased emotional response in patients with anxiety disorders.
Furthermore, this work shows that even if signiﬁcant abnormalities in the neural response of certain regions are
lacking, abnormalities related to their connectivity can occur. This shows that emotional perception is aﬀected
not only by the abnormalities in the neural response but also by abnormalities in connectivity. It is obvious
that this unveils a much more intricate picture of emotional perception, one that is not necessarily restricted to
outpatients. Indeed, our ﬁndings support the notion that psychiatric disorders are not due to dysfunction in
single brain regions, but may be a consequence of disturbed interactions in large-scale networks. The precise
dynamics thereof should be further determined in future research, e.g., using advanced analysis methods such
as dynamic causal modelling (DCM) or Granger causality mapping.
Conclusion – The work presented in this thesis contributes to the existent literature in that it oﬀers an insight
in the neuropsychopathology of MDD and anxiety in community outpatients. We suggest that co-existence of
depression and anxiety disorders are not to be considered as summation of the two. The diﬀerential pattern
of activation may be regarded as consistent with proposals of mixed anxiety depressive disorder as a distinct
condition. MDD was not associated with trait-related functional brain abnormalities, as illness remission did not
seem to be associated with changes in brain areas responding to emotional stimuli. Indeed, our ﬁndings suggest
that functional abnormalities in brain activation are more related to illness severity – a state marker –, rather
than being a trait marker. This hypothesis is also supported by antidepressant or anxiolytic medication studies,
which showed that after treatment, there was reduced symptom severity and less aberrant neural activation
[4, 30, 10]. We also found that explicit emotional processing triggers stronger amygdala response in patients
with anxiety or depressions, which is consistent with prior ﬁndings in groups with more severe psychopathology.
Whit regard to vulnerability for aﬀective disorders, the present work showed that level of neuroticism predicts
coupling of amygdala–fronto-medial regions and abnormalities of this network may be a marker for vulnerability.
Lastly, we may conclude that even if there are no gross abnormalities at the level of regional brain activation,
there may be an abnormal neural network connectivity associated with emotional or cognitive processes in
patients compared to controls.
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